nifedipine has been researched along with Angina Pectoris in 930 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Preliminary experimental and clinical data suggest that nifedipine can abort early acute myocardial infarction (AMI) or decrease infarct size by reversal of coronary artery spasm, improved coronary flow to the ischemic zone, reduction in myocardial oxygen demand or protection of ischemic cells." | 10.15 | Nifedipine in acute myocardial infarction. ( Pearle, DL, 1984) |
| "A retrospective analysis of the database from A Coronary Disease Trial Investigating Outcome with Nifedipine (ACTION) evaluated the effectiveness of nifedipine gastrointestinal therapeutic system (GITS) (i) in combination with renin angiotensin system (RAS) blockers and (ii) in patients with isolated systolic hypertension (ISH)." | 9.15 | Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the 'ACTION' database in patients with angina. ( Elliott, HL; Meredith, PA, 2011) |
| "The stroke and heart failure risk reduction by nifedipine GITS in patients with stable angina can be attributed partly to its BP lowering effect, whereas effects on coronary procedures are likely to be related almost entirely to its antianginal effects." | 9.12 | Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions. ( de Brouwer, S; Kirwan, BA; Lubsen, J; Poole-Wilson, PA; Vokó, Z, 2007) |
| "Little data is available concerning the prognostic implications of renal function abnormalities, their evolution over time and the effects of nifedipine on such abnormalities in patients with stable angina pectoris." | 9.12 | Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome. ( Danchin, N; de Brouwer, S; Fox, KA; Kirwan, BA; Lubsen, J; Poole-Wilson, PA; Ruilope, LM; Segura, J; Wagener, G, 2007) |
| "These results indicate that nifedipine more effectively prevented admission for angina pectoris by inhibiting the progression of coronary artery disease in patients with a history of MI." | 9.12 | Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy). ( Haze, K; Hirayama, A; Hosoda, S; Kawai, C; Kodama, K; Nonogi, H; Shinoda, E; Sumiyoshi, T; Yui, Y, 2007) |
| "The salutary effects of the addition of nifedipine GITS to the basic regimen of patients with concurrent stable symptomatic coronary artery disease and hypertension emphasize the need for blood pressure control." | 9.11 | Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial. ( de Brouwer, S; Kirwan, BA; Lubsen, J; Poole-Wilson, PA; Wagener, G, 2005) |
| "The effects of nifedipine on inflammation and endothelial function in the coronary circulation were studied in patients who had angina pectoris (n = 17)." | 9.11 | Effect of nifedipine on C-reactive protein levels in the coronary sinus and on coronary blood flow in response to acetylcholine in patients with stable angina pectoris having percutaneous coronary intervention. ( Dohi, Y; Goto, T; Hayashi, K; Ikeda, K; Nakazawa, A; Sato, K; Sugiura, T; Sugiyama, M; Takase, H; Toriyama, T; Ueda, R, 2005) |
| "This double-blind study compared the efficacy and safety of once daily amlodipine (5-10 mg/day) vs twice daily nifedipine (40-80 mg/day) in 244 patients with chronic stable angina pectoris." | 9.09 | [Amlodipine versus nifedipine retard. A randomized double-blind comparative study on long-term efficacy and safety of amlodipine and nifedipine retard in the monotherapy of chronic stable angina pectoris]. ( Kupper, W; Sauerbrey-Wullkopf, N, 2001) |
| "Although the combined administration of atenolol and nifedipine has been shown to be effective in the treatment of angina pectoris the optimum dosage level of the combination has not yet been established." | 9.08 | A cross-over study comparing the efficacy of a combination of atenolol and nifedipine at different doses in angina pectoris. ( Jennings, K; Metcalfe, MJ, 1995) |
| "This study was designed to investigate whether combination therapy with metoprolol and nifedipine provides a greater anti-ischemic effect than does monotherapy in individual patients with stable angina pectoris." | 9.08 | Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. ( Ardissiono, D; Bae, EA; Egstrup, K; Marraccini, P; Merlini, PA; Omland, T; Rasmussen, K; Rehnqvist, N; Savonitto, S; Schjelderup-Mathiesen, PM; Wahlqvist, I, 1996) |
| " To evaluate the efficacy and safety of this formulation and to compare this with the beta-blocker atenolol, we conducted a double-blind, randomised, multi-centre study in 129 male patients with documented exercise induced angina pectoris." | 9.08 | Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN). ( Bernink, PJ; Claessens, RJ; de Vries, RJ; Dunselman, PH; Kingma, JH; Lok, DJ; Pasteuning, WH; van den Heuvel, AF, 1996) |
| "This study showed that use of short-acting nifedipine and diltiazem in this postmyocardial infarction population was associated with a 24% higher cardiac event rate, but this strong adverse trend did not reach statistical significance." | 9.08 | Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. ( Hama, J; Ishikawa, K; Kanamasa, K; Katori, R; Kimura, A; Nakai, S; Ogawa, I; Oyaizu, M; Takenaka, T; Yabushita, H; Yamamoto, K; Yamamoto, T, 1997) |
| "The purpose of the study was to compare the antianginal and hypotensive efficacy and tolerability of 8 weeks of treatment with amlodipine taken once daily and nifedipine taken twice daily in patients with stable exertional angina pectoris and mild-to-moderate hypertension." | 9.08 | [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension]. ( Hlawaty, M; Kubler, G; Negrusz-Kawecka, M; Olszowska, M; Salamon, P; Tracz, W; Witkowska, M, 1997) |
| "MIBEFRADIL IN THE TREATMENT OF HYPERTENSION: The antihypertensive efficacy of mibefradil, a new selective transient (T)-channel calcium antagonist, was studied in eight randomized, double-blind, parallel-design trials: four placebo-controlled and four active drug-controlled versus other calcium antagonists." | 9.08 | Differential properties of mibefradil in hypertension and angina. ( Kobrin, I, 1997) |
| "This double-blind, randomised multicentre study compares nifedipine gastrointestinal therapeutic system (GITS) with atenolol in 129 male patients, with exercise-induced angina pectoris." | 9.08 | Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN). ( de Vries, RJ; Dunselman, PH, 1997) |
| " Fifteen male patients with stable angina pectoris treated with atenolol were studied after undergoing routine cardiac catheterisation." | 9.07 | A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease. ( Dawkins, KD; Donaldson, KM; Waller, DG, 1993) |
| "To determine the relative efficacy of nifedipine gastrointestinal therapeutic system (GITS) and diltiazem, 20 patients with angina pectoris and coronary artery disease were studied in a double-blinded, placebo-controlled randomized crossover trial." | 9.07 | Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris. ( Jacoby, RM; Nesto, RW; Phillips, RT; Siu, SC, 1993) |
| "The effects of single doses of felodipine (5 and 10 mg) and nifedipine (10 and 20 mg) on chronic stable effort angina pectoris were assessed in a placebo-controlled, double-blind, crossover study of 24 patients receiving beta blockers and short-acting nitroglycerin." | 9.07 | Effects of felodipine versus nifedipine on exercise tolerance in stable angina pectoris. ( Aberg, A; Ekelund, LG; Ulvenstam, G; Walldius, G, 1994) |
| "Compared with placebo, adding betaxolol 20 mg every day to nifedipine (up to 60 mg/day in divided doses) or diltiazem (up to 360 mg/day in divided doses) for a 3-week treatment period in 135 patients with stable angina pectoris significantly (p < 0." | 9.07 | Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris. ( Friedman, R; Glasser, SP; Smith, LK; Talibi, T; Weir, EK, 1994) |
| "An interim analysis of patient compliance is reported in 234 hypertension outpatients who were entered into a large-scale, open, crossover, comparative study between a new-generation calcium antagonist, amlodipine (5 mg, once daily), and nifedipine SR (20 mg, twice daily)." | 9.07 | Patient compliance and therapeutic coverage: amlodipine versus nifedipine SR in the treatment of hypertension and angina: interim results. Steering Committee and Cardiologists and General Practitioners involved in the Belgium Multicentre Study on Patient ( Detry, JM, 1994) |
| "Patients with stable, effort-induced angina pectoris and a typical combination of anginal pain and ischemic ST depression in exercise tolerance tests were randomized to treatment for 8 weeks with nicorandil (a newly developed antianginal and anti-ischemic drug) or nifedipine." | 9.07 | Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study. ( Diderholm, E; Frithz, G; Gudbrandsson, T; Hedbäck, B; Höglund, C; Moelstad, P; Perk, J; Sverrisson, JT; Ulvenstam, G, 1992) |
| "In a randomized, cross-over, double-blind study, the effects of nifedipine were compared with those of diltiazem in 20 patients with severe stable angina pectoris and multivessel coronary artery disease treated with nitrates and beta-blockers." | 9.07 | Effects of nifedipine and diltiazem on myocardial ischemia in patients with severe stable angina pectoris treated with nitrates and beta-blockers. ( Meluzín, J; Simek, P; Stĕtka, F; Zeman, K, 1992) |
| "To monitor the tolerance and long-term efficacy of a low-dose fixed combination of 50 mg atenolol and 20 mg nifedipine (slow release formulation) in patients with stable angina pectoris, 157 patients received treatment twice daily in a multi-centre, open-label fashion for periods up to 12 months following a four week run-in period on atenolol 50 mg twice daily." | 9.07 | Tolerance and long-term efficacy of a fixed combination of atenolol and nifedipine in the treatment of angina pectoris. Stuart Clinical Research Group. ( Oliver, IM; Russell, WA; Saul, PA, 1992) |
| "In a double blind crossover five-week trial with a randomized onset in 12 patients with normal blood pressure, stable angina pectoris and more severe left ventricular dysfunction (ejection fraction less than or equal to 40%) the effect of placebo nifedipine and diltiazem on left ventricular function and tolerance of exercise was compared." | 9.07 | [The effect of nifedipine and diltiazem on left ventricular function in patients with stable angina pectoris and severe left ventricular dysfunction]. ( Groch, L; Meluzín, J; Nechvátal, L; Novák, M; Spinarová, L, 1991) |
| "In a double blind crossed ten-week study with a randomized beginning the authors compared in 25 patients with chronic stable angina pectoris (II-III according to NYHA classification) and with normal blood pressure the effect of placebo, nifedipine, diltiazem and in 16 of the patients (who completed treatment with the combined drugs) also a combination of nifedipine and diltiazem." | 9.06 | [Effectiveness of nifedipine, diltiazem and their combination in the treatment of chronic stable angina pectoris]. ( Koukalová, H; Lupínek, Z; Meluzín, J, 1990) |
| "Nicardipine and nifedipine are structurally similar dihydropyridine calcium channel blockers with demonstrated efficacy in the treatment of stable angina pectoris." | 9.06 | Randomized double-blind comparison of side effects of nicardipine and nifedipine in angina pectoris. The Nicardipine Investigators Group. ( DeWood, MA; Wolbach, RA, 1990) |
| "The antianginal efficacies of nifedipine (40 to 120 mg/day) and diltiazem (120 to 360 mg/day) were studied in 21 normotensive patients with chronic stable angina pectoris, using a randomized, double-blind, crossover design." | 9.06 | Comparison of antianginal efficacies and exercise hemodynamic effects of nifedipine and diltiazem in stable angina pectoris. ( Liang, CS; Murphy, GW; Wallace, WA; Wellington, KL, 1989) |
| "The antianginal effects of propranolol 160 mg/day, diltiazem 240 mg/day, nicardipine 80 mg/day, nifedipine 40 to 80 mg/day and verapamil 320 mg/day were compared in 12 patients with chronic stable angina pectoris using a symptom-limited exercise test." | 9.06 | Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris. ( Azzollini, F; Cereda, A; Pelosi, G; Picca, M, 1989) |
| "The primary aim of this multicentre, randomised, double-blind, crossover study in 529 patients with stable angina pectoris was to compare the tolerability of epanolol, a novel antianginal agent, administered as a single oral daily dose of 200mg, with an oral retard formulation of twice-daily nifedipine 20mg and to determine patient preference (VISA 2)." | 9.06 | Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris. ( Readman, AS, 1989) |
| "The clinical utility of nifedipine and diltiazem blood levels in patients with angina pectoris receiving monotherapy (N = 14) and combination treatment (N = 9) were assessed in a placebo run-in, double blind, randomized, crossover study." | 9.06 | Clinical utility of nifedipine and diltiazem plasma levels in patients with angina pectoris receiving monotherapy and combination treatment. ( Frishman, WH; Goldberger, J, 1989) |
| "This study evaluated the safety, antianginal and antiischemic effects of amlodipine, a dihydropyridine calcium antagonist, in patients with chronic stable angina pectoris." | 9.06 | Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris. ( Glasser, SP; West, TW, 1988) |
| " Nineteen patients with chronic stable angina pectoris were studied using a prospective, randomized, Latin-square crossover protocol in an effort to determine the differential effects of nifedipine-propranolol combination therapy, diltiazem-propranolol combination therapy and high dose diltiazem monotherapy on exercise treadmill performance." | 9.06 | Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high dose diltiazem monotherapy for stable angina pectoris. ( Morse, JR, 1988) |
| "Labetalol, a combined alpha- and beta-receptor antagonist, was compared with nifedipine in a placebo-controlled, randomized double-blind cross over study (four week treatment periods) of 11 normotensive patients with stable exertional angina pectoris." | 9.06 | Labetalol in the treatment of stable exertional angina pectoris: a comparison with nifedipine. ( Crake, T; Fox, K; Mulcahy, D; Wright, C, 1988) |
| "The antianginal effects of nifedipine 20 mg three times a day and atenolol 100 mg once a day singly and in combination were investigated in 16 patients with angina pectoris." | 9.06 | Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. ( Dargie, HJ; Elliott, AT; Findlay, IN; Ford, M; Gillen, G; MacLeod, K, 1986) |
| "The antianginal efficacy of nitroglycerin (NTG), given in a new transdermal therapeutic system (TTS), was compared with that of nifedipine and verapamil, both in slow-release (SR) formulation, in a randomized, double-blind, placebo-controlled study, carried out in 8 patients with stable exercise-induced angina pectoris." | 9.06 | Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil. ( De Ponti, C; Gibelli, G; Mazzocchi, F; Negrini, M; Pollavini, P; Prina, L, 1986) |
| "Atenolol and nifedipine have been shown to be effective single agents in angina pectoris, but reports suggest that additional benefits may be conferred by combining the 2 drugs." | 9.06 | Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report. ( Foale, RA; Sandberg, M, 1988) |
| "To compare the clinical efficacy and dose equivalency of standard nifedipine versus a new gastrointestinal therapeutic system (GITS) formulation of nifedipine, 98 patients with chronic stable angina pectoris participated in a 14-week, multicenter, open-label, crossover trial." | 9.06 | Nifedipine gastrointestinal therapeutic system in stable angina pectoris. Results of a multicenter open-label crossover comparison with standard nifedipine. ( Cole, S; Parker, VE; Procacci, PM; Tabatznik, B; Terry, R; Vetrovec, GW, 1987) |
| "The two dihydropyridine calcium antagonists, nicardipine and nifedipine, were compared in 12 patients with both stable angina pectoris and systemic hypertension using a double-blind, crossover protocol." | 9.06 | A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. ( Bonandi, L; Dei Cas, L; Feroldi, P; Metra, M; Nodari, S; Nordio, G; Raddino, R; Visioli, O, 1988) |
| "To study the acute effects of ISDN, nifedipine, propranolol and placebo on cardiac function in patients with myocardial ischemia and to characterize their hemodynamic effects by PANOVA, we repetitively performed exercise radionuclide angiography (RNA) following random assignment of each drug in 20 patients with effort angina pectoris." | 9.06 | The effects of antianginal drugs on left ventricular function in patients with effort angina pectoris. Comparison among isosorbide dinitrate, nifedipine and propranolol by PANOVA. ( Takeuchi, J; Taniguchi, K; Umezawa, S, 1988) |
| "The efficacy and safety of oral nifedipine and diltiazem were compared in 20 patients with stable angina pectoris with use of a placebo run-in, randomized, double-blind titration to maximal effect crossover protocol." | 9.06 | Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment. ( Allen, L; Charlap, S; Cinnamon, J; Frishman, W; Kimmel, B; Strom, J; Teicher, M, 1988) |
| "In order to evaluate the therapeutic effects of metoprolol, nifedipine, and their combination, 11 patients with secondary angina pectoris and with thallium tomographic findings indicating coronary artery disease were studied before and after these three treatment regimes in a single-blind cross-over study." | 9.06 | Hemodynamic effects of metoprolol and nifedipine in angina pectoris measured by isotope technique. ( Boström, PA, 1988) |
| "The relative efficacy of nifedipine and slow-release nifedipine (Adalat Retard) in the treatment of stable exertional angina pectoris was evaluated in a double blind randomised crossover study in eight patients on no concomitant antianginal treatment and in 10 patients who were additionally on atenolol." | 9.06 | Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol. ( Crake, T; Fox, KM; Mockus, L; Quyyumi, AA; Wright, C, 1987) |
| "The short-term effect of oral nifedipine on effort tolerance was tested in 10 patients with effort angina pectoris and a positive effort test (GXT)." | 9.06 | Short-term effect of nifedipine on effort tolerance in patients with angina pectoris. ( Flugelman, MY; Gotsman, MS; Halon, DA; Shefer, A; Witt, H, 1986) |
| "To explore beneficial and harmful effects of various combinations of antianginal drugs, we compared antianginal and cardiorespiratory effects of nifedipine and isosorbide dinitrate in low and high doses in combination with nadolol, a long acting beta-adrenoceptor blocker in a double-blind study in 19 patients with stable angina pectoris." | 9.05 | A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation. ( Mir, MA; Tirlapur, VG, 1983) |
| "The duration of effect of single oral doses of 10 and 20 mg of nifedipine was studied in 10 patients with angiographically proven coronary artery disease and with stable exercise-induced angina pectoris." | 9.05 | Efficacy, duration and mechanism of action of nifedipine in stable exercise-induced angina pectoris. ( Ardissino, D; Bobba, P; De Servi, S; Mussini, A; Previtali, M; Salerno, JA; Specchia, G, 1983) |
| "To characterize the potential of nifedipine in the therapy of unstable angina pectoris we implemented a blinded, randomly assigned, titrated schedule of conventional therapy (propranolol, if not contraindicated, and isosorbide dinitrate) or nifedipine for 14 days in 126 patients hospitalized in a coronary care unit for ischemic chest pain of less than 45 min duration." | 9.05 | Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. ( Morrison, J; Muller, JE; Pearle, DL; Rosner, B; Rude, RE; Schneider, JF; Serfas, DH; Sobel, BE; Stone, PH; Turi, ZG, 1984) |
| "5 and 10mg intravenous nicardipine were measured in 20 male patients with uncomplicated angina pectoris due to angiographically confirmed coronary artery disease." | 9.05 | Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris. ( Hafizullah, M; Jackson, NC; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "The effectiveness of verapamil in the management of patients with unstable angina pectoris associated with obstructive coronary artery disease was evaluated in 2 double-blind placebo-controlled randomized clinical trials." | 9.05 | Verapamil therapy for unstable angina pectoris: review of double-blind placebo-controlled randomized clinical trials. ( Conti, CR; Mehta, J, 1982) |
| "To assess the effects of verapamil and nifedipine on left ventricular function at rest and during exercise in patients with Prinzmetal's variant angina pectoris, 10 patients (6 men and 4 women with a mean age of 52 years) with variant angina were each treated for 2 months periods with placebo, verapamil (400 +/- 80 mg/day, mean +/- standard deviation [SD]) and nifedipine (82 +/- 31 mg/day)." | 9.05 | Effect of verapamil and nifedipine on left ventricular function at rest and during exercise in patients with Prinzmetal's variant angina pectoris. ( Corbett, J; Dehmer, GJ; Hillis, LD; Johnson, SM; Lewis, SE; Mauritson, DR; Willerson, JT, 1981) |
| "To evaluate the hemodynamic effects of nifedipine on anginal patients during exercise in the upright position, a placebo (P) and 20 mg of nifedipine were administered in a double-blind random sequence to ten patients presenting with exertional angina and a healed myocardial infarction." | 9.05 | Acute effects of chewable nifedipine on hemodynamic responses to upright exercise in patients with prior myocardial infarction and effort angina. ( Angelino, PF; Baduini, G; Marra, S; Paolillo, V; Spadaccini, F, 1983) |
| "Twenty patients suffering from angina pectoris with co-existing fixed or labile airways obstruction, were administered fortnightly treatment periods of nifedipine or matching placebo over an 8-week period." | 9.05 | Efficacy of nifedipine in the treatment of angina pectoris and chronic airways obstruction. ( Chatterjee, SS; Jaiprakash, SS; MacDonald, G; Sahay, JN, 1980) |
| "Nifedipine was administered to 21 patients with angina pectoris which was refractory to conventional medication." | 9.05 | Nifedipine in medically refractory angina pectoris. ( O'Rourke, MF; Sammel, NL, 1981) |
| "1 A double-blind cross over study was carried out to assess the effects of the combination of nifedipine and propranolol in 25 patients with chronic stable angina pectoris at beta-adrenoceptor blockade." | 9.05 | The combination of nifedipine and propranolol in the management of patients with angina pectoris. ( Beattie, JM; Hutton, I; Murray, RG; Tweddel, AC, 1981) |
| "The clinical and hemodynamic effects of propranolol, propranolol-verapamil (P-V), propranolol-nifedipine (P-N) and propranolol-diltiazem (P-D) were studied in 19 patients with chronic exertional angina pectoris." | 9.05 | Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study. ( Humen, DP; Johnston, DL; Kostuk, WJ; Lesoway, R, 1985) |
| "Nicardipine, 30 and 40 mg thrice daily, was administered to 66 patients with stable angina pectoris in a multicentre, randomised, double-blind, cross-over trial." | 9.05 | Nicardipine for stable angina pectoris. ( Freedman, D; Hermanovich, J; Lewinter, MM; Scheidt, S; Venkataraman, K, 1985) |
| "In a randomized, double-blind, placebo-controlled crossover trial, diltiazem and nifedipine were compared in 10 patients with stable angina pectoris and mild to moderate hypertension (supine diastolic blood pressure greater than or equal to 90 mm Hg)." | 9.05 | Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension. ( Allen, L; Charlap, S; Dorsa, F; Frishman, WH; Goldberger, J; Kimmel, B; Stroh, J; Strom, J, 1985) |
| "A single blind randomized parallel study designed to assess the anti-anginal efficacy of pindolol and nifedipine was carried out in 42 ambulatory coronary patients with stable angina pectoris." | 9.04 | Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. ( Amrein, R; Castagnoli, E; Chu, D; Cocco, G; Strozzi, C, 1979) |
| "To test if nifedipine, 10 mg sublingually, could increase exercise tolerance, ten patients with angina pectoris each performed two types of bicycle exercise test, one with a stepwise increase in load and the other with a continuously increasing load." | 9.04 | Effect of nifedipine on exercise tolerance in patients with angina pectoris. ( Atterhög, JH; Ekelund, LG; Melin, AL, 1975) |
| "Developed by Bayer in Germany, nifedipine was shown to be effective in the treatment of patients with angina pectoris by Japanese investigators." | 8.83 | [Clinical experience with nifedipine in the treatment of angina pectoris in Japan]. ( Hosoda, S, 2006) |
| "Nifedipine, as most calcium-antagonist drugs, is widely used for the treatment of angina pectoris and primary hypertension." | 8.80 | [Edema and skin ulcers of the lower limbs as a collateral effect of nifedipine. A clinical case report]. ( Luca, S; Romeo, S, 1999) |
| "In patients with coronary disease, the use of short-acting nifedipine in moderate to high doses causes an increase in total mortality." | 8.79 | Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. ( Furberg, CD; Meyer, JV; Psaty, BM, 1995) |
| "Nifedipine and atenolol are first choice drugs in the treatment of arterial hypertension and angina pectoris." | 8.78 | [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris]. ( Verdecchia, P, 1993) |
| " Benidipine treatment was associated with higher cardiovascular- and cardiac event-free rates than diltiazem treatment, and higher stroke- and ESRD-free rates than nifedipine." | 7.74 | Prognostic effects of calcium channel blockers on cardiac events, stroke and end-stage renal disease in patients with angina pectoris. Retrospective comparative study of benidipine, diltiazem and nifedipine. ( Arioka, I; Dohi, S; Sakai, K, 2008) |
| "Nifedipine GITS was not effective in slowing down the progression of calcium in advanced atherosclerotic plaques in patients with stable angina pectoris." | 7.74 | Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy. ( de Brouwer, S; Kirwan, BA; Motro, M; Poole-Wilson, PA; Shemesh, J, 2007) |
| "Effects of CD-832 on isoproterenol (ISO)-induced myocardial ischemia were studied in dogs with partial coronary stenosis of the left circumflex coronary artery and findings were compared with those for nifedipine or diltiazem." | 7.69 | Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis. ( Araki, H; Higuchi, S; Kishi-Tanikawa, S; Takahashi, K; Takahashi, T; Tsuchida, K, 1996) |
| "We investigated the effect of abrupt cessation of nifedipine after regular administration (20 mg, four times daily) for 5 weeks in seven patients with stable angina pectoris." | 7.68 | Withdrawal phenomenon after abrupt cessation of nifedipine in stable angina pectoris. ( Koutishenko, N; Martsevich, SY; Metelitsa, VI, 1993) |
| "The nifedipine gastrointestinal therapeutic system (GITS) was recently approved for use in the treatment of angina and hypertension." | 7.68 | P&T Committee review of nifedipine GITS: new modality for angina and hypertension. ( Horn, J; Krakoff, L; Vetrovec, G; Weintraub, M, 1990) |
| "Gingival hyperplasia is an adverse reaction of nifedipine therapy." | 7.68 | Nifedipine-induced gingival hyperplasia. ( Barak, S; Ben Yehuda, A; Katz, J; Rotstein, I, 1992) |
| "Nifedipine-induced gingival hypertrophy is a rare side effect reported by the producers of this drug but, surely, not well known in all its aspects." | 7.68 | [Nifedipine and gingival hypertrophy]. ( Borgia, MC; Calpicchio, A; De Paola, G; Di Folco, G, 1991) |
| "In 18 patients (12 females) presenting with effort-induced chest pain and normal coronary angiograms (syndrome X), 10 mg sublingual nifedipine increased the lumen of major coronary arteries (quantitative angiography) by 13% +/- 10 (p less than 0." | 7.68 | [Acute coronary vasomotor effects of nifedipine and its therapeutic efficacy in syndrome X]. ( Annoni, L; Cozzi, S; De Cesare, N; Fabbiocchi, F; Guazzi, MD; Loaldi, A; Montorsi, P; Polese, A, 1990) |
| " The possibility of development of tolerance to the anti-ischaemic and anti-anginal effects of nifedipine during sustained administration for 2 months was studied in 15 patients with stable angina pectoris by means of repeated exercise tests on a treadmill." | 7.68 | Development of tolerance to nifedipine in patients with stable angina pectoris. ( Egorov, LV; Martsevich, SY; Metelitsa, VI; Piotrovskii, VK; Rumiantsev, DO; Slastnikova, ID; Vygodin, VA, 1990) |
| "This prospective study was undertaken to evaluate the safety of nifedipine, a calcium channel blocking agent, on 60 subjects with asthma, chronic obstructive pulmonary disease (COPD), angina, and normal subjects." | 7.67 | Safety of nifedipine in subjects with bronchial asthma and COPD. ( Bewtra, A; Nair, CK; Nair, N; Townley, RG, 1984) |
| "The effects of the calcium antagonists nicardipine and nisoldipine on left ventricular (LV) metabolism were analyzed in 32 patients with angina pectoris." | 7.67 | Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. ( Charlier, AA; Pouleur, H; Rousseau, MF; Van den Berghe, G; Van Hoof, F; Vincent, MF, 1984) |
| "The immediate effects of sublingual nifedipine (20 mg) were evaluated in 18 men with stable, exercise-related angina pectoris and angiographically confirmed coronary artery obstructions, stratified at the time of left ventricular (LV) angiography according to the degree of LV dysfunction supine at rest (Group 1: n = 9, left ventricular end-diastolic pressure [LVEDP] less than 20 mm Hg; Group 2: n = 9, LVEDP greater than 20 mm Hg)." | 7.67 | Hemodynamic effects of nifedipine during upright exercise in stable angina pectoris and either normal or severely impaired left ventricular function. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "Marked improvement in the respiratory status of two patients with chronic obstructive lung disease was observed during treatment with nifedipine for angina pectoris." | 7.67 | Exacerbation of asthmatic symptoms after cessation of nifedipine therapy. ( Eliraz, A; Fink, A; Wishnitzer, R, 1984) |
| "In a randomised double-blind study, the effects on red cell deformability of a single sublingual dose of nifedipine were compared with placebo in eight patients with stable angina pectoris." | 7.67 | The acute effects of nifedipine on red cell deformability in angina pectoris. ( Nicholson, HP; Roath, S; Waller, DG, 1984) |
| " The haemodynamic effects of sublingual nifedipine (20 mg) and intravenous metoprolol (10 mg) singly and in combination were therefore studied in 20 patients with severe angina pectoris associated with angiographically documented coronary artery disease." | 7.67 | The effect on left ventricular performance of nifedipine and metoprolol singly and together in exercise-induced angina pectoris. ( Ahuja, RC; Forsyth, D; Hussain, M; Nelson, GI; Silke, B; Taylor, SH, 1984) |
| "Nifedipine, a "calcium channel blocker", is increasingly employed in the treatment of angina pectoris." | 7.67 | Nifedipine plasma concentration in patients treated for angina pectoris. ( Levy, M; Stern, Z; Zylber-Katz, E, 1984) |
| " The haemodynamic effects of equivalent hypotensive doses of nifedipine and verapamil were therefore compared in 20 patients with severe angina pectoris associated with angiographically documented coronary artery disease." | 7.67 | The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH; Verma, SP, 1984) |
| " In selected population of 113 patients with effort angina and proven coronary artery disease, the coronary cineangiographic pattern after 2 year therapy with nifedipine (Group 1, 39 patients), propranolol (Group 2, 36 patients), or isosorbide dinitrate (control group, 38 patients) was compared to the pre-treatment pattern." | 7.67 | [Angiographic course of coronary atherosclerosis in angina pectoris. Its relation to 2 years' treatment with propranolol, nifedipine and nitrates]. ( De Cesare, N; Fabbiocchi, F; Guazzi, M; Guazzi, MD; Loaldi, A; Montorsi, P; Polese, A; Ravagnani, P, 1989) |
| "The effect of oral administration of nifedipine (Adalat) on whole blood viscosity in patients with angina pectoris was investigated." | 7.67 | Changes in blood viscosity following nifedipine administration and its relation to the contents of adenosine triphosphate and 2,3-diphosphoglyceric acid in red blood cells in patients with angina pectoris. ( Fujinami, T; Kako, T; Kohketsu, M; Yoneda, S, 1989) |
| "Combined nitrate/beta-blocker/nifedipine therapy is commonly used to treat refractory angina pectoris." | 7.67 | Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris. ( Boden, WE; Bough, EW; Korr, KS, 1985) |
| "Variations induced by nifedipine (10 mg sublingually) in the residual lumen diameter of significant (greater than 50%) coronary lesions were assessed angiographically in 58 patients with effort angina (group 1) and in 19 patients with Prinzmetal angina (group 2)." | 7.67 | Different vasomotor action of nifedipine on dynamic coronary obstructions and therapeutic response in effort and prinzmetal angina. ( Bartorelli, A; de Cesare, N; Fabbiocchi, F; Guazzi, MD; Loaldi, A; Montorsi, P; Polese, A, 1989) |
| "The short-term effects of sublingual nifedipine (20 mg) on cardiac output and its distribution at rest and during exercise were evaluated by measurement of iliofemoral blood flow and cardiac output in 10 men with stable angina pectoris controlled by metoprolol." | 7.67 | Regional distribution of cardiac output at rest and during exercise in patients with exertional angina pectoris before and after nifedipine therapy. ( Fletcher, PJ; Freedman, B; Harris, PJ; Kelly, DT; Thomson, A, 1988) |
| "To assess the dosing equivalency and the early and late antianginal efficacy of a gastrointestinal therapeutic system for once-daily, continuous-release nifedipine (N-GITS), 10 patients with stable angina pectoris, who were previously receiving chronic treatment with nifedipine, completed a 12-week trial comparing N-GITS with standard nifedipine." | 7.67 | Comparative dosing and efficacy of continuous-release nifedipine versus standard nifedipine for angina pectoris: clinical response, exercise performance, and plasma nifedipine levels. ( Alpert, DA; Parker, VE; Vetrovec, GW, 1988) |
| "A study was performed to compare isosorbide dinitrate and nifedipine as adjunctive therapy in 14 patients with coronary artery disease and stable angina pectoris taking maximal beta-blocking drugs." | 7.67 | Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris. ( Antman, EM; Holman, BL; Nesto, RW; White, HD; Wynne, J, 1987) |
| "The mechanism of the antianginal actions of nilvadipine was investigated in 11 patients with effort angina pectoris." | 7.67 | Effects of a new second generation calcium channel blocker, nilvadipine (FR34235), on exercise-induced hemodynamic changes in stable angina pectoris. ( Kamihara, S; Koide, M; Miyahara, T; Noda, S; Sotobata, I; Tsunekawa, A; Yokota, M, 1987) |
| "To determine the comparative effectiveness and hemodynamic effects of long-term oral treatment with propranolol alone and combined with nifedipine in patients with stable angina pectoris, 20 patients with coronary disease were studied by equilibrium radionuclide ventriculography." | 7.67 | Clinical and hemodynamic effects of combined propranolol and nifedipine therapy versus propranolol alone in patients with angina pectoris. ( Berenfeld, D; Braun, S; Laniado, S; Terdiman, R, 1985) |
| "In 16 patients with unstable angina pectoris 2 mg of nifedipine were infused intravenously for 1 hour." | 7.67 | [Changes in diastolic ventricular properties by intravenous nifedipine infusion in patients with unstable angina pectoris]. ( Karsch, KR; Mauser, M; Seipel, L; Wagner, S, 1985) |
| "The effects of different doses of nifedipine on frequency of angina and objective measurements of myocardial ischaemia during exercise were studied in 10 patients with stable angina pectoris." | 7.66 | Treatment of angina pectoris with nifedipine: importance of dose titration. ( Deanfield, J; Fox, K; Wright, C, 1983) |
| "In conclusion, we observed first that nifedipine is highly efficacious in preventing the coronary vasospasm of Prinzmetal's variant angina." | 7.66 | Nifedipine therapy for coronary vasospasm. ( Antman, EM; Muller, JE; Stone, PH, 1983) |
| "To examine the antianginal effects of felodipine, a new calcium antagonist, 8 patients with coronary artery disease and exertional angina pectoris were studied." | 7.66 | Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris. ( De Coster, PM; Detry, JM; Renkin, J, 1983) |
| "We report clinical experience with the coronary vasodilator nifedipine in 127 patients with symptoms of myocardial ischemia associated with electrocardiographic or angiographic evidence, or both, of coronary-artery spasm." | 7.66 | Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. ( Achuff, S; Antman, E; Braunwald, E; Geltman, E; Goldberg, S; Heupler, F; Kerin, NZ; Liang, CS; MacAlpin, R; Muller, J; Neff, RK; Reichek, N; Rubenfire, M; Tabatznik, B, 1980) |
| "The antianginal effectivity of niludipine (Bay a 7168), a new calcium antagonistic drug, was investigated in angina pectoris patients, selected for admission to the trials by pre-determined strict criteria." | 7.66 | Treatment of angina pectoris patients with niludipine a new calcium antagonistic drug. ( Fujita, K; Furukawa, K; Imako, K; Itsumi, H; Kurata, N; Maeda, K; Oshiro, T; Shiota, K; Tanaka, C; Tsukano, Y; Yagi, Y, 1981) |
| "Angina pectoris patients were divided into two groups of unstable angina and stable angina, platelet aggregation was measured at rest and after treadmill exercise tolerance, and then the effects before and after the administration of nifedipine (Adalat) were examined." | 7.66 | Effect of the calcium antagonistic agent nifedipine on platelet aggregation response to exercise in patients with angina pectoris. ( Arakawa, K; Hiroki, T; Inoue, T; Yoshida, T, 1982) |
| "The efficacy of nifedipine in relieving recurrent ischemic episodes following acute myocardial infarction was studied in 11 patients a mean of 9." | 7.66 | Nifedipine therapy for recurrent ischemic pain following myocardial infarction. ( Muller, JE; Stone, PH, 1982) |
| "16 patients suffering from hypertension and angina pectoris (class II according to the NYHA) are treated with 100 mg atenolol once daily for three weeks." | 7.66 | [Effects of therapy with a association of nifedipine and atenolol in patients with systemic arterial hypertension and angina pectoris]. ( Attisano, N; Grenci, G; Martelli, G; Sarica, G; Schirripa, V, 1982) |
| "This study investigates the use of propranolol and nifedipine in the treatment of angina pectoris." | 7.66 | The use of propranolol and nifedipine in the medical management of angina pectoris. ( Fox, KM; Jonathan, A; Selwyn, AP, 1981) |
| "The therapeutic action of Nifedipine (Ni) and some of its haemodynamic effects have been studied in 24 male patients suffering from chronic, severe angina pectoris (Class II and III according to the NYHA) by means of right heart catheterization and repeated quantitative bicycle ergometer exercise test before and after 10 mg." | 7.66 | [Action of nifedipine on effort tolerance and on the left ventricular function during exercise in patients suffering from angina pectoris (author's transl)]. ( Valenti, P, 1980) |
| "Nifedipine is a non-nitrate vasodilator which has proved effective, in oral form, in Europe, Japan, and the USA for treatment of Prinzmetal Angina." | 7.66 | Nifedipine in the treatment of life threatening Prinzmetal angina. ( Campbell, TJ; Hickie, JB; Michell, G; O'Rouke, MF, 1979) |
| "Nifedipine was administered in a dose of 30 mg orally to 14 patients with coronary heart disease and clinical evidence of left heart failure." | 7.66 | [The effect of nifedipine on the pulmonary artery pressure in patients with coronary heart disease (author's transl)]. ( Beck, OA; Hochrein, H, 1978) |
| "It is reported that nifedipine, a newly developed antianginal agent, was dramatically effective to suppress the repeatedly occurring ventricular fibrillation in 2 cases of variant form of angina pectoris." | 7.65 | Suppression of repeatedly occurring ventricular fibrillation with nifedipine in variant form of angina pectoris. ( Hashimoto, H; Honda, Y; Kimura, E; Mizuno, K; Tanaka, K, 1977) |
| "The hemodynamic effects of nifedipine and propranolol administered intravenously were studied in 17 patients with angina pectoris." | 7.65 | Effects of Adalat (nifedipine) on left ventricular hemodynamics in angina pectoris: comparative study with propranolol. ( Hamamato, H; Kanazawa, M; Kurita, A; Mabuchi, G; Ogawa, T, 1976) |
| "Nifedipine was administered to 20 patients (8 in group 1, and 12 in group 2)." | 6.67 | Transient myocardial ischemia during nifedipine therapy in stable angina pectoris, and its relation to coronary collateral flow and comparison with metoprolol. ( Andersen, PE; Egstrup, K, 1993) |
| " Both nifedipine alone (15-60 mg) and in combination with dilazep (50 mg) three times a day produced a significant reduction in angina attacks, consumption of nitroglycerin tablets and increased exercise tolerance." | 6.67 | Controlled clinical trial of nifedipine alone and in combination with dilazep in patients with angina pectoris. ( Biswas, NR; Pandhi, P; Sharma, PL; Wahi, PL, 1991) |
| "Amlodipine has significant anti-anginal efficacy." | 6.67 | A double-blind dose-response study of amlodipine in patients with stable angina pectoris. ( Alfiero, R; Cocco, G, 1991) |
| "Nifedipine was administered in amounts of 60 mg/day for three weeks, diltiazem 270 mg/day also for three weeks." | 6.67 | [Comparison of the effects of nifedipine and diltiazem in patients with stable angina pectoris of various severity and pathomorphology of the coronary arteries]. ( Koukalová, H; Meluzín, J; Novák, M, 1991) |
| "Nifedipine was ineffective, particularly in patients with angina predominantly on effort and with a moderate to severe reduction in exercise tolerance." | 6.67 | Transient myocardial ischemia during daily life in rest and exertional angina pectoris and comparison of effectiveness of metoprolol versus nifedipine. ( Ardissino, D; Egstrup, K; Feruglio, GA; Giordano, MP; Marraccini, P; Roncarolo, P; Rosenfeld, M; Savonitto, S; Slavich, G; Wahlqvist, I, 1991) |
| " To determine the mechanism of action of nifedipine and its dose-response relation, 14 patients with stable angina were treated with nifedipine 10, 20 and 30 mg 4 times daily as single-agent therapy in a double-blind, randomized, placebo-controlled crossover trial." | 6.67 | Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectoris. ( Gervino, E; Jarisch, WR; Rice, KR; Stone, PH, 1990) |
| "In atenolol-treated patients with severe effort angina pectoris, nifedipine 20 mg tid improved exercise capacity, while nisoldipine 20 mg once daily did not have a similar effect." | 6.67 | Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol. ( Kantor, M; Pedersen, TR, 1990) |
| " However, 2 h after dosing there was a significant prolongation during stress testing in the time to onset of both 1 mm ST depression on the ECG (by 28%) and to angina (by 37%) compared with atenolol alone, but no benefit was apparent by 12 h after dosing." | 6.66 | Slow release nifedipine plus atenolol in chronic stable angina pectoris. ( Challenor, VF; George, CF; Renwick, AG; Waller, DG, 1989) |
| " Thus, nifedipine GITS represents a sound pharmacologic approach to the management of ischemic disease; and with once-daily dosing and a favorable side-effect profile this agent affords the potential for better patient compliance and efficacy without concern about the development of tolerance." | 6.66 | Once-daily therapy for angina pectoris with nifedipine gastrointestinal therapeutic system. Dosing and clinical efficacy. ( Vetrovec, GW, 1989) |
| " Treatment was titrated to produce at least a 30% increase in treadmill exercise duration over placebo baseline and then maintained at that dosage for an additional 3 weeks." | 6.66 | Comparison of atenolol and nifedipine in chronic stable angina pectoris. ( Kostis, JB; Narahara, KA; Shapiro, W; Thandroyen, F; Zohman, LR, 1989) |
| "For effective treatment of coronary heart disease with calcium antagonists, knowledge of both the dose-response relationship of a remedy and equipotent dosage for comparison of different drugs is necessary." | 6.66 | [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease]. ( Fleischer, K; Forster, A; Hopf, R; Kaltenbach, M; Mohler, C; Schulz, PC, 1989) |
| " Dose-response comparisons against nifedipine in 21 patients and against isosorbide dinitrate in 14 patients demonstrate that PN 200-110 has a similar antianginal efficacy profile to both drugs." | 6.66 | Efficacy of a new calcium antagonist PN 200-110 (isradipine) in angina pectoris. ( Allen, J; Jackson, NC; Pool, PE; Taylor, SH, 1987) |
| "Treatment with metoprolol (100 mg twice daily), nifedipine (10 mg 3 times daily) and both drugs combined were compared for effect on clinical variables, bicycle ergometer exercise tolerance and adverse effects in a randomized double-blind, crossover study in patients with stable effort angina (n = 62)." | 6.66 | Metoprolol, nifedipine, and the combination in stable effort angina pectoris. ( Arstila, M; Bae, EA; Härkönen, R; Keyriläinen, O; Rytkönen, U; Schjelderup-Mathiesen, PM; Uusitalo, A; Wendelin, H, 1986) |
| "Propranolol treatment decreased exercise cardiac output by 14% (p = 0." | 6.66 | Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise. ( Cobb, FR; Coleman, RE; Higginbotham, MB; Morris, KG, 1986) |
| "Nifedipine 3 X 20 mg/day was compared to IS 5-MN 3 X 20 mg/day and IS 5-MN 50 mg once daily for 1 week each." | 6.66 | Influence of isosorbide 5-mononitrate 20 mg, sustained-release 50 mg and sustained-release nifedipine 20 mg on ischaemic ST-segment changes during Holter monitoring. A double-blind cross-over study in patients with spontaneous angina pectoris. ( von Arnim, T, 1987) |
| "The propranolol group had a lower cumulative probability of experiencing recurrent resting angina than the placebo group (p = ." | 6.66 | Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial. ( Achuff, SC; Baughman, KL; Brinker, JA; Chandra, NC; Gottlieb, SO; Mellits, ED; Ouyang, P; Shapiro, EP; Traill, TA; Weisfeldt, ML, 1986) |
| " The average daily dosage of nicardipine for optimal angina relief was 89 mg (range 40 to 160)." | 6.66 | Nicardipine for angina pectoris at rest and coronary arterial spasm. ( Feldman, RL; Gelman, JS; Pepine, CJ; Scott, E, 1985) |
| " In 2 patients, verapamil caused weakness, lightheadedness, and severe sinus bradycardia (40 to 48 beats/min), and the dosage was reduced (blindly) to 240 mg/day, with the alleviation of bradycardia and associated symptoms." | 6.66 | Propranolol-verapamil versus propranolol-nifedipine in severe angina pectoris of effort: a randomized, double-blind, crossover study. ( Corbett, JR; Croft, CH; Fulton, KL; Hillis, LD; Winniford, MD, 1985) |
| "Nifedipine is a new antianginal drug, the calcium-antagonistic inhibitory action on excitation-contraction coupling apparently being so pronounced that, in therapeutic dosage, all other pharmacological properties are negligible." | 6.65 | Effect of nifedipine on exercise tolerance in angina pectoris. ( Kidner, PH; McIlwraith, GR; Oram, S, 1980) |
| "Calcium antagonists are used in the treatment of hypertension and angina." | 6.44 | The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension. ( Coca, A; Sierra, C, 2008) |
| "Nifedipine is a dihydropyridine calcium channel antagonist with predominantly vasodilatory activity." | 6.43 | Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris. ( Croom, KF; Wellington, K, 2006) |
| "The drug is equally effective in treating hypertension in elderly and younger patients and does not appear to adversely affect glucose or lipid metabolism." | 6.39 | Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina. ( Brogden, RN; McTavish, D, 1995) |
| "Nisoldipine is an orally administered calcium entry blocking drug structurally related to nifedipine." | 6.37 | Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders. ( Friedel, HA; Sorkin, EM, 1988) |
| " In a double-blind study of ten patients with stable angina pectoris treated with nifedipine, propranolol, and atenolol, smoking was found to have direct and adverse effects on the heart and to interfere with the efficacy of all three antianginal drugs, but with that of nifedipine the most." | 6.16 | Smoking, catecholamines, and the ischemic myocardium. ( Fox, KM, 1988) |
| "Preliminary experimental and clinical data suggest that nifedipine can abort early acute myocardial infarction (AMI) or decrease infarct size by reversal of coronary artery spasm, improved coronary flow to the ischemic zone, reduction in myocardial oxygen demand or protection of ischemic cells." | 6.15 | Nifedipine in acute myocardial infarction. ( Pearle, DL, 1984) |
| "Patients with unstable angina pectoris who remain symptomatic at rest after hospitalization are at increased risk of death or myocardial infarction." | 5.27 | Adjunctive nifedipine therapy in high-risk, medically refractory, unstable angina pectoris. ( Blaustein, AS; Heller, GV; Kolman, BS, 1983) |
| "Some Ca2+-antagonists are used for the treatment of angina pectoris." | 5.27 | Clinical efficacy of niludipine in the treatment of angina pectoris. ( Fujita, K; Igarashi, T; Ogasawara, S; Oyama, Y; Shibata, J; Tateda, K; Tomita, T; Yamazaki, M; Yasuda, H; Yokota, H, 1984) |
| "When nicardipine was administered after propranolol, the indices of inotropic state were unaffected." | 5.27 | Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris. ( Charlier, AA; Cheron, P; Pouleur, H; Rousseau, MF; van den Berghe, G; Vincent, MF, 1985) |
| " Although the safety profile of nifedipine has been generally regarded as favorable, a few reports of clinically significant adverse effects in specific patient groups have appeared in the literature." | 5.26 | Nifedipine therapy in angina pectoris: evaluation of safety and side effects. ( Terry, RW, 1982) |
| "A retrospective analysis of the database from A Coronary Disease Trial Investigating Outcome with Nifedipine (ACTION) evaluated the effectiveness of nifedipine gastrointestinal therapeutic system (GITS) (i) in combination with renin angiotensin system (RAS) blockers and (ii) in patients with isolated systolic hypertension (ISH)." | 5.15 | Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the 'ACTION' database in patients with angina. ( Elliott, HL; Meredith, PA, 2011) |
| "The stroke and heart failure risk reduction by nifedipine GITS in patients with stable angina can be attributed partly to its BP lowering effect, whereas effects on coronary procedures are likely to be related almost entirely to its antianginal effects." | 5.12 | Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions. ( de Brouwer, S; Kirwan, BA; Lubsen, J; Poole-Wilson, PA; Vokó, Z, 2007) |
| "Data from a trial comparing long-acting nifedipine gastrointestinal therapeutic system to placebo in 7,665 patients with stable angina pectoris was analyzed." | 5.12 | Resource utilization implications of treatment were able to be assessed from appropriately reported clinical trial data. ( de Brouwer, S; Dunselman, PH; Kirwan, BA; Lubsen, J; Poole-Wilson, PA; van Dalen, FJ; Vokó, Z, 2007) |
| "Little data is available concerning the prognostic implications of renal function abnormalities, their evolution over time and the effects of nifedipine on such abnormalities in patients with stable angina pectoris." | 5.12 | Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome. ( Danchin, N; de Brouwer, S; Fox, KA; Kirwan, BA; Lubsen, J; Poole-Wilson, PA; Ruilope, LM; Segura, J; Wagener, G, 2007) |
| "These results indicate that nifedipine more effectively prevented admission for angina pectoris by inhibiting the progression of coronary artery disease in patients with a history of MI." | 5.12 | Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy). ( Haze, K; Hirayama, A; Hosoda, S; Kawai, C; Kodama, K; Nonogi, H; Shinoda, E; Sumiyoshi, T; Yui, Y, 2007) |
| "The salutary effects of the addition of nifedipine GITS to the basic regimen of patients with concurrent stable symptomatic coronary artery disease and hypertension emphasize the need for blood pressure control." | 5.11 | Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial. ( de Brouwer, S; Kirwan, BA; Lubsen, J; Poole-Wilson, PA; Wagener, G, 2005) |
| "The effects of nifedipine on inflammation and endothelial function in the coronary circulation were studied in patients who had angina pectoris (n = 17)." | 5.11 | Effect of nifedipine on C-reactive protein levels in the coronary sinus and on coronary blood flow in response to acetylcholine in patients with stable angina pectoris having percutaneous coronary intervention. ( Dohi, Y; Goto, T; Hayashi, K; Ikeda, K; Nakazawa, A; Sato, K; Sugiura, T; Sugiyama, M; Takase, H; Toriyama, T; Ueda, R, 2005) |
| "Four hundred seventy-five patients with angina pectoris were randomized to double-blind treatment with PPR (physiological pattern release) verapamil hydrochloride, amlodipine besylate, amlodipineatenolol combination, or placebo." | 5.09 | Medical therapy, symptoms, and the distress the cause: relation to quality of life in patients with angina pectoris and/or hypertension. ( Anderson, R; Hollenberg, NK; Williams, GH, 2000) |
| "This double-blind study compared the efficacy and safety of once daily amlodipine (5-10 mg/day) vs twice daily nifedipine (40-80 mg/day) in 244 patients with chronic stable angina pectoris." | 5.09 | [Amlodipine versus nifedipine retard. A randomized double-blind comparative study on long-term efficacy and safety of amlodipine and nifedipine retard in the monotherapy of chronic stable angina pectoris]. ( Kupper, W; Sauerbrey-Wullkopf, N, 2001) |
| "Although the combined administration of atenolol and nifedipine has been shown to be effective in the treatment of angina pectoris the optimum dosage level of the combination has not yet been established." | 5.08 | A cross-over study comparing the efficacy of a combination of atenolol and nifedipine at different doses in angina pectoris. ( Jennings, K; Metcalfe, MJ, 1995) |
| "We examined the antianginal and anti-ischemic effects of oral zatebradine, a direct sinus node inhibitor that has no blood pressure-lowering or negative inotropic effects in patients with chronic stable angina pectoris taking extended-release nifedipine." | 5.08 | Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study ( Baiker, WM; Frishman, WH; Pepine, CJ; Weiss, RJ, 1995) |
| "The present study was designed to investigate which characteristics of anginal symptoms or exercise test results could predict the favorable anti-ischemic effect of the beta-adrenergic blocking agent metoprolol and the calcium antagonist nifedipine in patients with stable angina pectoris." | 5.08 | Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study. ( Ardissino, D; Bae, EA; Egstrup, K; Marraccini, P; Merlini, PA; Omland, T; Rasmussen, K; Savonitto, S; Schjelderup-Mathiesen, PM; Wahlqvist, I, 1995) |
| "The Total Ischemic Burden Bisoprolol Study (TIBBS) was a randomized double-blind controlled study with two parallel groups; 330 patients from 30 centers in seven European countries with stable angina pectoris, a positive exercise test and more than two transient ischemic episodes during 48 h of Holter monitoring (central evaluation) were included." | 5.08 | Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS Investigators. ( von Arnim, T, 1995) |
| "This study was designed to investigate whether combination therapy with metoprolol and nifedipine provides a greater anti-ischemic effect than does monotherapy in individual patients with stable angina pectoris." | 5.08 | Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. ( Ardissiono, D; Bae, EA; Egstrup, K; Marraccini, P; Merlini, PA; Omland, T; Rasmussen, K; Rehnqvist, N; Savonitto, S; Schjelderup-Mathiesen, PM; Wahlqvist, I, 1996) |
| " To evaluate the efficacy and safety of this formulation and to compare this with the beta-blocker atenolol, we conducted a double-blind, randomised, multi-centre study in 129 male patients with documented exercise induced angina pectoris." | 5.08 | Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN). ( Bernink, PJ; Claessens, RJ; de Vries, RJ; Dunselman, PH; Kingma, JH; Lok, DJ; Pasteuning, WH; van den Heuvel, AF, 1996) |
| "This study showed that use of short-acting nifedipine and diltiazem in this postmyocardial infarction population was associated with a 24% higher cardiac event rate, but this strong adverse trend did not reach statistical significance." | 5.08 | Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. ( Hama, J; Ishikawa, K; Kanamasa, K; Katori, R; Kimura, A; Nakai, S; Ogawa, I; Oyaizu, M; Takenaka, T; Yabushita, H; Yamamoto, K; Yamamoto, T, 1997) |
| "Fifty-nine cases with angina pectoris (AP) in coronary heart disease were divided randomly into two groups, 37 cases of Hehuantang group (HT) treated with Hehuantang, 22 cases of patient treated with nifedipine tablet was taken as control group (CG)." | 5.08 | [A clinical study of hehuantang in treating coronary heart disease]. ( Cai, PY; Shen, BY; Xu, BT, 1996) |
| "The safety and tolerability of mibefradil, a selective T-type calcium channel antagonist, were evaluated in 3,430 patients with essential hypertension and chronic stable angina pectoris treated in 15 double-blind placebo and active-controlled clinical trials and 2 open-label, long-term safety studies." | 5.08 | Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonist. ( Charlon, V; Kobrin, I; Lindberg, E; Pordy, R, 1997) |
| "The purpose of the study was to compare the antianginal and hypotensive efficacy and tolerability of 8 weeks of treatment with amlodipine taken once daily and nifedipine taken twice daily in patients with stable exertional angina pectoris and mild-to-moderate hypertension." | 5.08 | [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension]. ( Hlawaty, M; Kubler, G; Negrusz-Kawecka, M; Olszowska, M; Salamon, P; Tracz, W; Witkowska, M, 1997) |
| "MIBEFRADIL IN THE TREATMENT OF HYPERTENSION: The antihypertensive efficacy of mibefradil, a new selective transient (T)-channel calcium antagonist, was studied in eight randomized, double-blind, parallel-design trials: four placebo-controlled and four active drug-controlled versus other calcium antagonists." | 5.08 | Differential properties of mibefradil in hypertension and angina. ( Kobrin, I, 1997) |
| "This double-blind, randomised multicentre study compares nifedipine gastrointestinal therapeutic system (GITS) with atenolol in 129 male patients, with exercise-induced angina pectoris." | 5.08 | Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN). ( de Vries, RJ; Dunselman, PH, 1997) |
| "We compared the effects of abrupt cessation of nifedipine and isosorbide dinitrate therapy in patients with stable angina pectoris." | 5.08 | Withdrawal effects of antianginal therapy: comparison of isosorbide dinitrate and nifedipine. ( Koutishenko, N; Metelitsa, VI, 1998) |
| "To present the design of ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS), an ongoing multicentre clinical outcome trial with nifedipine GITS (Gastro-Intestinal Therapeutic System) in patients with stable angina pectoris." | 5.08 | Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System. ( Baumann, J; Kirwan, BA; Lubsen, J; Parker, AB; Pocock, SJ; Poole-Wilson, PA; van Dalen, FJ, 1998) |
| " Patients of stable angina pectoris treated with Radix Codonopsitis Pilosulae (50 cases) or Nifedipine (20 cases) were observed as well." | 5.08 | [Clinical study on relationship among Heart-Qi Deficiency, left ventricular function and myocardial ischemia in patients with coronary heart disease]. ( Lu, X; Wang, S; Zhao, M, 1998) |
| " Fifteen male patients with stable angina pectoris treated with atenolol were studied after undergoing routine cardiac catheterisation." | 5.07 | A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease. ( Dawkins, KD; Donaldson, KM; Waller, DG, 1993) |
| "Twenty-four patients with chronic stable exertional angina pectoris were randomized in a double-blind, placebo-controlled, crossover trial to assess the efficacy and durability of a newly developed, sustained-release formulation of nifedipine (nifedipine CC) in a single 40-mg oral dose." | 5.07 | Duration and extent of antianginal effects of a sustained-release formulation of nifedipine in angina. ( Inagaki, H; Izawa, H; Matsunami, T; Saito, F; Sotobata, I; Yokota, M; Yoshida, J, 1994) |
| "To determine the relative efficacy of nifedipine gastrointestinal therapeutic system (GITS) and diltiazem, 20 patients with angina pectoris and coronary artery disease were studied in a double-blinded, placebo-controlled randomized crossover trial." | 5.07 | Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris. ( Jacoby, RM; Nesto, RW; Phillips, RT; Siu, SC, 1993) |
| "The effects of single doses of felodipine (5 and 10 mg) and nifedipine (10 and 20 mg) on chronic stable effort angina pectoris were assessed in a placebo-controlled, double-blind, crossover study of 24 patients receiving beta blockers and short-acting nitroglycerin." | 5.07 | Effects of felodipine versus nifedipine on exercise tolerance in stable angina pectoris. ( Aberg, A; Ekelund, LG; Ulvenstam, G; Walldius, G, 1994) |
| "Compared with placebo, adding betaxolol 20 mg every day to nifedipine (up to 60 mg/day in divided doses) or diltiazem (up to 360 mg/day in divided doses) for a 3-week treatment period in 135 patients with stable angina pectoris significantly (p < 0." | 5.07 | Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris. ( Friedman, R; Glasser, SP; Smith, LK; Talibi, T; Weir, EK, 1994) |
| " We studied the short effects of oral administration of nifedipine (10 mg) and propranolol (80 mg) alone and in combination in 15 elderly patients with chronic exertional angina pectoris in a double-blind, randomized, cross-over study." | 5.07 | [Acute effects of propranolol and its association with nifedipine in aged patients with effort stable angina. Randomized double-blind crossover study, under placebo control]. ( Cicatiello, AM; De Rosa, ML; Di Palma, A; Iannuzzi, L; Lirato, C; Pandolfi, E; Parlati, S; Santamaria, F; Sestito, M, 1993) |
| "These data suggest that (1) dobutamine stress can be used to induce cardiac ischemia in elderly patients with coronary artery disease, (2) nifedipine-GITS provides symptomatic angina relief in elderly patients, (3) peripheral edema is frequent in elderly patients on nifedipine-GITS, and (4) ultrafast computed cine-tomography testing can be used to assess ventricular performance, but current methodology may not detect perfusion or wall motion abnormalities during angina." | 5.07 | Early experience with dobutamine stress testing and cardiac cine-tomographic imaging in the elderly: antianginal effects of nifedipine-GITS. ( Abbott, J; Caputo, G; Schwartz, JB, 1993) |
| "The effects of the addition of slow-release nifedipine 20 mg twice daily and nisoldipine 10 mg twice daily to atenolol monotherapy were compared in a double-blind placebo-controlled study of 24 patients with chronic stable angina pectoris." | 5.07 | A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia. ( Dawkins, KD; Donaldson, KM; Waller, DG, 1993) |
| "An interim analysis of patient compliance is reported in 234 hypertension outpatients who were entered into a large-scale, open, crossover, comparative study between a new-generation calcium antagonist, amlodipine (5 mg, once daily), and nifedipine SR (20 mg, twice daily)." | 5.07 | Patient compliance and therapeutic coverage: amlodipine versus nifedipine SR in the treatment of hypertension and angina: interim results. Steering Committee and Cardiologists and General Practitioners involved in the Belgium Multicentre Study on Patient ( Detry, JM, 1994) |
| "Patients with stable, effort-induced angina pectoris and a typical combination of anginal pain and ischemic ST depression in exercise tolerance tests were randomized to treatment for 8 weeks with nicorandil (a newly developed antianginal and anti-ischemic drug) or nifedipine." | 5.07 | Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study. ( Diderholm, E; Frithz, G; Gudbrandsson, T; Hedbäck, B; Höglund, C; Moelstad, P; Perk, J; Sverrisson, JT; Ulvenstam, G, 1992) |
| "In a randomized, cross-over, double-blind study, the effects of nifedipine were compared with those of diltiazem in 20 patients with severe stable angina pectoris and multivessel coronary artery disease treated with nitrates and beta-blockers." | 5.07 | Effects of nifedipine and diltiazem on myocardial ischemia in patients with severe stable angina pectoris treated with nitrates and beta-blockers. ( Meluzín, J; Simek, P; Stĕtka, F; Zeman, K, 1992) |
| "To monitor the tolerance and long-term efficacy of a low-dose fixed combination of 50 mg atenolol and 20 mg nifedipine (slow release formulation) in patients with stable angina pectoris, 157 patients received treatment twice daily in a multi-centre, open-label fashion for periods up to 12 months following a four week run-in period on atenolol 50 mg twice daily." | 5.07 | Tolerance and long-term efficacy of a fixed combination of atenolol and nifedipine in the treatment of angina pectoris. Stuart Clinical Research Group. ( Oliver, IM; Russell, WA; Saul, PA, 1992) |
| "The effects of verapamil, nifedipine, propranolol, and combinations of nifedipine+propranolol and nifedipine+verapamil were studied in 60 patients with stable angina pectoris." | 5.07 | [Effect of various antianginal agents on the frequency and duration of myocardial ischemic episodes in patients with stable angina pectoris]. ( Lysenko, AF; Voronkov, LG, 1992) |
| "Amlodipine, a potent long-acting dihydropyridine calcium antagonist, was compared with placebo in a parallel, randomized, double-blind study in 134 patients with chronic stable angina pectoris maintained on beta-adrenergic blocking agents." | 5.07 | Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study. ( Awan, NA; Bamrah, VS; Barry, W; Bennett, T; Canosa, FL; DiBianco, R; Glasser, SP; Kawanishi, DT; Schoomaker, FW; Singh, JB, 1992) |
| "In patients with chronic stable exertional angina pectoris, the antianginal and anti-ischemic efficacies and the safety of 25 mg carvedilol b." | 5.07 | Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina. ( Derr, I; Eberhardt, R; Ehmer, B; van der Does, R, 1992) |
| "Once-daily administration of amlodipine is a highly effective treatment for patients with angina pectoris." | 5.07 | Amlodipine in post-infarction angina. ( Taylor, SH, 1992) |
| "Epanolol (200 mg once daily) was compared with nifedipine (20 mg twice daily) in a multicentre, double-blind, randomised, crossover study in which 571 patients with stable angina pectoris were entered." | 5.07 | A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial. ( Berry, SC; Blake, P; Godley, M; Ratcliffe, M; Readman, A, 1991) |
| "In a double blind crossover five-week trial with a randomized onset in 12 patients with normal blood pressure, stable angina pectoris and more severe left ventricular dysfunction (ejection fraction less than or equal to 40%) the effect of placebo nifedipine and diltiazem on left ventricular function and tolerance of exercise was compared." | 5.07 | [The effect of nifedipine and diltiazem on left ventricular function in patients with stable angina pectoris and severe left ventricular dysfunction]. ( Groch, L; Meluzín, J; Nechvátal, L; Novák, M; Spinarová, L, 1991) |
| "Altogether 12 patients with stable angina pectoris of effort were examined for the efficacy of nicardipine as compared to nifedipine and placebo by means of pharmacodynamic studies using treadmill." | 5.06 | [The comparative efficacy of nicardipine and nifedipine in stenocardia patients]. ( Martsevich, SIu; Metelitsa, VI; Simkhaev, LS; Slastnikova, ID, 1990) |
| "The use of metoprolol combined with nifedipine and diltiazem was studied and compared in 32 patients suffering from coronary disease associated with angina pectoris of effort." | 5.06 | [The use of metoprolol with calcium antagonists of different mechanisms of action (diltiazem and nifedipine) in patients with stenocardia of effort]. ( Guliev, AB; Lupanov, VP; Sidorenko, BA, 1990) |
| "Since not all patients tolerate beta-blockers, the efficacy of nifedipine and isosorbide dinitrate was evaluated alone and in combination in patients with stable angina pectoris." | 5.06 | Nifedipine and isosorbide dinitrate alone and in combination for patients with chronic stable angina: a double-blind crossover study. ( Olson, LC; Vlay, SC, 1990) |
| "In a double blind crossed ten-week study with a randomized beginning the authors compared in 25 patients with chronic stable angina pectoris (II-III according to NYHA classification) and with normal blood pressure the effect of placebo, nifedipine, diltiazem and in 16 of the patients (who completed treatment with the combined drugs) also a combination of nifedipine and diltiazem." | 5.06 | [Effectiveness of nifedipine, diltiazem and their combination in the treatment of chronic stable angina pectoris]. ( Koukalová, H; Lupínek, Z; Meluzín, J, 1990) |
| "Nicardipine and nifedipine are structurally similar dihydropyridine calcium channel blockers with demonstrated efficacy in the treatment of stable angina pectoris." | 5.06 | Randomized double-blind comparison of side effects of nicardipine and nifedipine in angina pectoris. The Nicardipine Investigators Group. ( DeWood, MA; Wolbach, RA, 1990) |
| "The antianginal efficacies of nifedipine (40 to 120 mg/day) and diltiazem (120 to 360 mg/day) were studied in 21 normotensive patients with chronic stable angina pectoris, using a randomized, double-blind, crossover design." | 5.06 | Comparison of antianginal efficacies and exercise hemodynamic effects of nifedipine and diltiazem in stable angina pectoris. ( Liang, CS; Murphy, GW; Wallace, WA; Wellington, KL, 1989) |
| "The antianginal effects of propranolol 160 mg/day, diltiazem 240 mg/day, nicardipine 80 mg/day, nifedipine 40 to 80 mg/day and verapamil 320 mg/day were compared in 12 patients with chronic stable angina pectoris using a symptom-limited exercise test." | 5.06 | Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris. ( Azzollini, F; Cereda, A; Pelosi, G; Picca, M, 1989) |
| "The hemodynamic effects and antianginal efficacy of 10 mg amlodipine administered intravenously were assessed for 45 minutes in 18 subjects with stable angina pectoris." | 5.06 | Pharmacodynamics of amlodipine: hemodynamic effects and antianginal efficacy after atrial pacing. ( Grant, P; Gupta, S; Hillis, WS; Hogg, KJ; Hornung, RS; Singh, SP, 1989) |
| "The Nifedipine-Total Ischemia Awareness Program was designed to evaluate the prevalence, prognostic implications and effect of therapy on painful and painless myocardial ischemic episodes in a nationwide study of patients with angina pectoris." | 5.06 | The Nifedipine-Total Ischemia Awareness Program: a national survey of painful and painless myocardial ischemia including results of antiischemic therapy. ( Cohn, PF; Gerber, FR; Nesto, R; Vetrovec, GW, 1989) |
| "The primary aim of this multicentre, randomised, double-blind, crossover study in 529 patients with stable angina pectoris was to compare the tolerability of epanolol, a novel antianginal agent, administered as a single oral daily dose of 200mg, with an oral retard formulation of twice-daily nifedipine 20mg and to determine patient preference (VISA 2)." | 5.06 | Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris. ( Readman, AS, 1989) |
| "Although conventional treatment of angina pectoris with nifedipine capsules involves frequent daily dosing, a new vehicle for the once-daily delivery of this potent but insoluble calcium channel blocking agent has been developed." | 5.06 | Usefulness of nifedipine for myocardial ischemia and the nifedipine gastrointestinal therapeutic system. ( Bittar, N, 1989) |
| "The possibility of the development of tolerance to anti-ischemic effects of nifedipine (NF) during chronic administration for 2 months was studied in 15 patients with stable angina pectoris of effort." | 5.06 | [The development of nifedipine tolerance during its regular dosage in patients with stable exertional stenocardia]. ( Martsevich, SIu; Metelitsa, VI; Piotrovskiĭ, VK; Rumiantsev, DO; Slastnikova, ID, 1989) |
| "The clinical utility of nifedipine and diltiazem blood levels in patients with angina pectoris receiving monotherapy (N = 14) and combination treatment (N = 9) were assessed in a placebo run-in, double blind, randomized, crossover study." | 5.06 | Clinical utility of nifedipine and diltiazem plasma levels in patients with angina pectoris receiving monotherapy and combination treatment. ( Frishman, WH; Goldberger, J, 1989) |
| "6 years (range 50 to 75), with stable angina pectoris were administered propranolol until beta blockade was evident." | 5.06 | Comparative study of the effect of nifedipine versus diltiazem on exercise performance, serum propranolol levels, and ST-segment abnormalities in patients with chronic stable angina taking propranolol. ( Krikler, DM; Krikler, S; Robinson, K, 1989) |
| "This multicenter study assessed the efficacy of a new formulation of nifedipine in 54 patients with stable angina pectoris receiving beta-blocker therapy." | 5.06 | Efficacy of nifedipine gastrointestinal therapeutic system in combination with beta blockers in the management of exertional angina. A multicenter study of 54 patients. ( Bittar, N; Corder, CN; Eich, R; McGrew, FA; Paulk, EA; Zellner, S, 1987) |
| "The haemodynamic dose-response effects of a new long-acting slow-calcium channel blocking agent, amlodipine were evaluated in 20 patients with angiographically confirmed coronary heart disease." | 5.06 | A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease. ( Frais, MA; Jackson, NC; Reynolds, G; Sharma, SK; Silke, B; Taylor, SH; Verma, SP, 1986) |
| "The utility of using an endurance test as well as a maximal exercise test to assess the effect of amlodipine, a dihydropyridine calcium antagonist, was evaluated in 16 patients with angina pectoris." | 5.06 | Endurance testing for evaluation of antianginal therapy with amlodipine, a calcium channel blocking agent. ( Harris, M; Hossack, KF; Kinnard, DR, 1988) |
| "This study evaluated the safety, antianginal and antiischemic effects of amlodipine, a dihydropyridine calcium antagonist, in patients with chronic stable angina pectoris." | 5.06 | Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris. ( Glasser, SP; West, TW, 1988) |
| " Nineteen patients with chronic stable angina pectoris were studied using a prospective, randomized, Latin-square crossover protocol in an effort to determine the differential effects of nifedipine-propranolol combination therapy, diltiazem-propranolol combination therapy and high dose diltiazem monotherapy on exercise treadmill performance." | 5.06 | Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high dose diltiazem monotherapy for stable angina pectoris. ( Morse, JR, 1988) |
| "Labetalol, a combined alpha- and beta-receptor antagonist, was compared with nifedipine in a placebo-controlled, randomized double-blind cross over study (four week treatment periods) of 11 normotensive patients with stable exertional angina pectoris." | 5.06 | Labetalol in the treatment of stable exertional angina pectoris: a comparison with nifedipine. ( Crake, T; Fox, K; Mulcahy, D; Wright, C, 1988) |
| "The antianginal effects of nifedipine 20 mg three times a day and atenolol 100 mg once a day singly and in combination were investigated in 16 patients with angina pectoris." | 5.06 | Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. ( Dargie, HJ; Elliott, AT; Findlay, IN; Ford, M; Gillen, G; MacLeod, K, 1986) |
| "The antianginal efficacy of nitroglycerin (NTG), given in a new transdermal therapeutic system (TTS), was compared with that of nifedipine and verapamil, both in slow-release (SR) formulation, in a randomized, double-blind, placebo-controlled study, carried out in 8 patients with stable exercise-induced angina pectoris." | 5.06 | Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil. ( De Ponti, C; Gibelli, G; Mazzocchi, F; Negrini, M; Pollavini, P; Prina, L, 1986) |
| "Atenolol and nifedipine have been shown to be effective single agents in angina pectoris, but reports suggest that additional benefits may be conferred by combining the 2 drugs." | 5.06 | Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report. ( Foale, RA; Sandberg, M, 1988) |
| "To compare the clinical efficacy and dose equivalency of standard nifedipine versus a new gastrointestinal therapeutic system (GITS) formulation of nifedipine, 98 patients with chronic stable angina pectoris participated in a 14-week, multicenter, open-label, crossover trial." | 5.06 | Nifedipine gastrointestinal therapeutic system in stable angina pectoris. Results of a multicenter open-label crossover comparison with standard nifedipine. ( Cole, S; Parker, VE; Procacci, PM; Tabatznik, B; Terry, R; Vetrovec, GW, 1987) |
| "The two dihydropyridine calcium antagonists, nicardipine and nifedipine, were compared in 12 patients with both stable angina pectoris and systemic hypertension using a double-blind, crossover protocol." | 5.06 | A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. ( Bonandi, L; Dei Cas, L; Feroldi, P; Metra, M; Nodari, S; Nordio, G; Raddino, R; Visioli, O, 1988) |
| "To study the acute effects of ISDN, nifedipine, propranolol and placebo on cardiac function in patients with myocardial ischemia and to characterize their hemodynamic effects by PANOVA, we repetitively performed exercise radionuclide angiography (RNA) following random assignment of each drug in 20 patients with effort angina pectoris." | 5.06 | The effects of antianginal drugs on left ventricular function in patients with effort angina pectoris. Comparison among isosorbide dinitrate, nifedipine and propranolol by PANOVA. ( Takeuchi, J; Taniguchi, K; Umezawa, S, 1988) |
| "The efficacy and safety of oral nifedipine and diltiazem were compared in 20 patients with stable angina pectoris with use of a placebo run-in, randomized, double-blind titration to maximal effect crossover protocol." | 5.06 | Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment. ( Allen, L; Charlap, S; Cinnamon, J; Frishman, W; Kimmel, B; Strom, J; Teicher, M, 1988) |
| "In order to evaluate the therapeutic effects of metoprolol, nifedipine, and their combination, 11 patients with secondary angina pectoris and with thallium tomographic findings indicating coronary artery disease were studied before and after these three treatment regimes in a single-blind cross-over study." | 5.06 | Hemodynamic effects of metoprolol and nifedipine in angina pectoris measured by isotope technique. ( Boström, PA, 1988) |
| "The relative efficacy of nifedipine and slow-release nifedipine (Adalat Retard) in the treatment of stable exertional angina pectoris was evaluated in a double blind randomised crossover study in eight patients on no concomitant antianginal treatment and in 10 patients who were additionally on atenolol." | 5.06 | Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol. ( Crake, T; Fox, KM; Mockus, L; Quyyumi, AA; Wright, C, 1987) |
| "Seventeen post-myocardial infarction patients experiencing angina on effort performed 6 different exercise tests until they reached symptom-limited maximal level, 3 after placebo and 3 after oral administration of 10 mg of the Calcium antagonist, nifedipine, in a randomized, double blind, cross-over controlled study." | 5.06 | Assessment of exercise tolerance of cardiac patients by bicycle, treadmill and treadmill plus isometric exercise with and without nifedipine. ( Hämäläinen, H; Kallio, V; Pietilä, J; Vuori, I, 1987) |
| "To examine the effects of chronic oral therapy with verapamil, 120 mg three times a day, and nifedipine, 20 mg four times daily, on left ventricular ejection fraction and regional wall motion at rest and exercise, 10 patients with chronic stable angina pectoris underwent serial rest and exercise radionuclide angiography." | 5.06 | Improved left ventricular performance during exercise with verapamil or nifedipine in patients with chronic stable angina. ( Cairns, JA; Gill, JB; McEwan, MP, 1987) |
| "The results of bicycle ergometry (BE) following administration of placebo, 80 mg propranolol (anaprilin), 30 mg nifedipine (corinfar) and a combination of 60 mg propranolol and 20 mg nifedipine were reviewed in coronary patients with angina pectoris of functional classes (FC) II-IV." | 5.06 | [Comparative evaluation of the results of the bicycle ergometry test in patients with stress stenocardia after treatment with propranolol and nifedipine]. ( Abasova, LI; Gel'fgat, EB, 1986) |
| "Nifedipine, diltiazem and verapamil are three effective calcium-antagonists in the treatment of angina pectoris." | 5.06 | [Comparative evaluation using an ergometric test of the efficacy of the 3 major calcium antagonists on exertion stable angina]. ( Acanfora, D; Artiaco, D; Cicatiello, M; Covelluzzi, F; De Caprio, L; De Rosa, ML; Papa, M; Rengo, F; Santangelo, L, 1987) |
| "The short-term effect of oral nifedipine on effort tolerance was tested in 10 patients with effort angina pectoris and a positive effort test (GXT)." | 5.06 | Short-term effect of nifedipine on effort tolerance in patients with angina pectoris. ( Flugelman, MY; Gotsman, MS; Halon, DA; Shefer, A; Witt, H, 1986) |
| "To explore beneficial and harmful effects of various combinations of antianginal drugs, we compared antianginal and cardiorespiratory effects of nifedipine and isosorbide dinitrate in low and high doses in combination with nadolol, a long acting beta-adrenoceptor blocker in a double-blind study in 19 patients with stable angina pectoris." | 5.05 | A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation. ( Mir, MA; Tirlapur, VG, 1983) |
| "The action of nifedipine given first intravenously and then orally was studied in nine patients undergoing investigation for angina pectoris who were already receiving atenolol (100-200 mg/daily) and who had been shown to be fully beta blocked (reduction in maximal heart rate by greater than 25%)." | 5.05 | Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol. ( Krikler, DM; Razis, P; Rowland, E; Sugrue, D, 1983) |
| "The duration of effect of single oral doses of 10 and 20 mg of nifedipine was studied in 10 patients with angiographically proven coronary artery disease and with stable exercise-induced angina pectoris." | 5.05 | Efficacy, duration and mechanism of action of nifedipine in stable exercise-induced angina pectoris. ( Ardissino, D; Bobba, P; De Servi, S; Mussini, A; Previtali, M; Salerno, JA; Specchia, G, 1983) |
| "To characterize the potential of nifedipine in the therapy of unstable angina pectoris we implemented a blinded, randomly assigned, titrated schedule of conventional therapy (propranolol, if not contraindicated, and isosorbide dinitrate) or nifedipine for 14 days in 126 patients hospitalized in a coronary care unit for ischemic chest pain of less than 45 min duration." | 5.05 | Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. ( Morrison, J; Muller, JE; Pearle, DL; Rosner, B; Rude, RE; Schneider, JF; Serfas, DH; Sobel, BE; Stone, PH; Turi, ZG, 1984) |
| "Reports of acute ischemic events after withdrawal of calcium antagonist therapy in outpatients and during bypass surgery in patients with prior angina at rest prompted the examination of the effect of nifedipine withdrawal in 81 patients who had completed a prospective, double-blind randomized trial of nifedipine versus placebo for rest angina." | 5.05 | Acute nifedipine withdrawal: consequences of preoperative and late cessation of therapy in patients with prior unstable angina. ( Achuff, SC; Baughman, KL; Gerstenblith, G; Gottlieb, SO; Mellits, ED; Ouyang, P; Traill, TA; Weisfeldt, ML, 1984) |
| "In 12 male patients with angiographically confirmed coronary heart disease and stable angina the antianginal effects of 50 mg Gallopamil have been studied in comparison with 10 mg Nifedipine and placebo." | 5.05 | [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo]. ( Drews, H; Hopf, R; Kaltenbach, M, 1984) |
| "Thirty patients with chronic stable angina pectoris were randomized in a double-blind prospective placebo-controlled crossover trial to assess the efficacy of nifedipine (30 to 60 mg/day orally) in controlling symptoms and objective signs of myocardial ischemia using a symptom-limited treadmill exercise test." | 5.05 | Nifedipine in chronic stable angina: a double-blind placebo-controlled crossover trial. ( Liang, CS; Sherman, LG, 1983) |
| "The effect of nifedipine 20 mg three times daily and atenolol 100 mg once daily, singly and in combination on left ventricular ejection fraction, was investigated in 14 patients with chronic effort related angina pectoris." | 5.05 | The effects of nifedipine, atenolol and that combination on left ventricular function. ( Dargie, HJ; Findlay, IN, 1983) |
| "5 and 10mg intravenous nicardipine were measured in 20 male patients with uncomplicated angina pectoris due to angiographically confirmed coronary artery disease." | 5.05 | Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris. ( Hafizullah, M; Jackson, NC; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "The effectiveness of verapamil in the management of patients with unstable angina pectoris associated with obstructive coronary artery disease was evaluated in 2 double-blind placebo-controlled randomized clinical trials." | 5.05 | Verapamil therapy for unstable angina pectoris: review of double-blind placebo-controlled randomized clinical trials. ( Conti, CR; Mehta, J, 1982) |
| "The effectiveness and safety of verapamil, nifedipine, and placebo in patients with chronic stable angina pectoris were evaluated and compared in two double-blind randomized crossover trials." | 5.05 | Rationale for the choice of calcium antagonists in chronic stable angina. An objective double-blind placebo-controlled comparison of nifedipine and verapamil. ( Bowles, MJ; Davies, AB; Khurmi, NS; Raftery, EB; Subramanian, VB, 1982) |
| "In a double-blind clinical trial the antianginal effects of nifedipine (30 and 60 mg/day) and propranolol 240 and 480 mg/day) and a combination of both drugs were compared with those of placebo in 16 patients with severe exertional angina pectoris." | 5.05 | Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination. ( Dargie, H; Krikler, D; Krikler, S; Lynch, P, 1980) |
| "To assess the effects of verapamil and nifedipine on left ventricular function at rest and during exercise in patients with Prinzmetal's variant angina pectoris, 10 patients (6 men and 4 women with a mean age of 52 years) with variant angina were each treated for 2 months periods with placebo, verapamil (400 +/- 80 mg/day, mean +/- standard deviation [SD]) and nifedipine (82 +/- 31 mg/day)." | 5.05 | Effect of verapamil and nifedipine on left ventricular function at rest and during exercise in patients with Prinzmetal's variant angina pectoris. ( Corbett, J; Dehmer, GJ; Hillis, LD; Johnson, SM; Lewis, SE; Mauritson, DR; Willerson, JT, 1981) |
| "To evaluate the hemodynamic effects of nifedipine on anginal patients during exercise in the upright position, a placebo (P) and 20 mg of nifedipine were administered in a double-blind random sequence to ten patients presenting with exertional angina and a healed myocardial infarction." | 5.05 | Acute effects of chewable nifedipine on hemodynamic responses to upright exercise in patients with prior myocardial infarction and effort angina. ( Angelino, PF; Baduini, G; Marra, S; Paolillo, V; Spadaccini, F, 1983) |
| "Twenty patients suffering from angina pectoris with co-existing fixed or labile airways obstruction, were administered fortnightly treatment periods of nifedipine or matching placebo over an 8-week period." | 5.05 | Efficacy of nifedipine in the treatment of angina pectoris and chronic airways obstruction. ( Chatterjee, SS; Jaiprakash, SS; MacDonald, G; Sahay, JN, 1980) |
| "Nifedipine was administered to 21 patients with angina pectoris which was refractory to conventional medication." | 5.05 | Nifedipine in medically refractory angina pectoris. ( O'Rourke, MF; Sammel, NL, 1981) |
| "1 A double-blind cross over study was carried out to assess the effects of the combination of nifedipine and propranolol in 25 patients with chronic stable angina pectoris at beta-adrenoceptor blockade." | 5.05 | The combination of nifedipine and propranolol in the management of patients with angina pectoris. ( Beattie, JM; Hutton, I; Murray, RG; Tweddel, AC, 1981) |
| "In order to assess the therapeutical efficacy of atenolol in stable angina pectoris of effort, we studied 40 patients with a positive exercise stress test." | 5.05 | [Therapeutical comparison between atenolol and nifedipine in effort angina (author's transl)]. ( Battaglia, R; Gruppillo, P; Maistrello, I; Masoni, A; Masoni, C, 1981) |
| "This study examines the effects of increasing doses of nifedipine on exercise-induced ST-segment depression in patients with severe typical stable angina pectoris." | 5.05 | The dose-response effects of nifedipine of ST-segment changes in exercise testing: preliminary studies. ( Deanfield, J; Fox, KM; Jonathan, A; Selwyn, A, 1981) |
| "The acute effects of nifedipine withdrawal were studied in 81 patients with angina at rest who had completed a prospective, double-blind, randomized trial of nifedipine versus placebo." | 5.05 | Safety of acute calcium antagonist withdrawal: studies in patients with unstable angina withdrawn from nifedipine. ( Gerstenblith, G; Gottlieb, SO, 1985) |
| "The clinical and hemodynamic effects of propranolol, propranolol-verapamil (P-V), propranolol-nifedipine (P-N) and propranolol-diltiazem (P-D) were studied in 19 patients with chronic exertional angina pectoris." | 5.05 | Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study. ( Humen, DP; Johnston, DL; Kostuk, WJ; Lesoway, R, 1985) |
| "Nicardipine, 30 and 40 mg thrice daily, was administered to 66 patients with stable angina pectoris in a multicentre, randomised, double-blind, cross-over trial." | 5.05 | Nicardipine for stable angina pectoris. ( Freedman, D; Hermanovich, J; Lewinter, MM; Scheidt, S; Venkataraman, K, 1985) |
| "This study evaluated 1 year the efficacy of therapy with nicardipine in patients with chronic stable angina pectoris." | 5.05 | Short- and long-term treatment of stable effort angina with nicardipine, a new calcium channel blocker: a double-blind, placebo-controlled, randomised, repeated cross-over study. ( Freedman, D; Gheorghiade, M; Schwemer, G; St Clair, C; St Clair, J, 1985) |
| "In a randomized, double-blind, placebo-controlled crossover trial, diltiazem and nifedipine were compared in 10 patients with stable angina pectoris and mild to moderate hypertension (supine diastolic blood pressure greater than or equal to 90 mm Hg)." | 5.05 | Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension. ( Allen, L; Charlap, S; Dorsa, F; Frishman, WH; Goldberger, J; Kimmel, B; Stroh, J; Strom, J, 1985) |
| "To evaluate the effects of calcium entry blocking agents on cardiac sympathetic tone during angina pectoris, arterial and coronary sinus (CS) norepinephrine (NE) and epinephrine (E) concentrations and CS blood flow were determined at rest and during pacing-induced angina, both before and after verapamil in nine patients and after nifedipine in nine patients, all of whom had fixed obstructive coronary artery disease." | 5.05 | Myocardial catecholamine balance during angina: effects of calcium entry blockers, verapamil and nifedipine. ( Chatterjee, K; Curran, D; Kramer, P; Namekawa, M; Parmley, WW; Rouleau, JL; Swedberg, K, 1985) |
| "A single blind randomized parallel study designed to assess the anti-anginal efficacy of pindolol and nifedipine was carried out in 42 ambulatory coronary patients with stable angina pectoris." | 5.04 | Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. ( Amrein, R; Castagnoli, E; Chu, D; Cocco, G; Strozzi, C, 1979) |
| "3 years, with stable angina pectoris earlier treated with beta-blockers, were investigated with standardized exercise tests to evaluate the action of nifedipine alone and in combination with a beta-blocker." | 5.04 | Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study. ( Ekelund, LG; Orö, L, 1979) |
| "During a double-blind cross-over study of 3 weeks duration 42 hypertensive outpatients with prevailingly mild angina pectoris received 30 mg daily of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonic acid dimethylester (nifedipine, Bay a 1040, Adalat) daily or placebo, respectively." | 5.04 | [On the clinical evaluation of therapy with nifedipine in association with various anithypertensive drugs (author's transl)]. ( Kaufmann, W; Laaser, U; Meurer, KA, 1977) |
| "To test if nifedipine, 10 mg sublingually, could increase exercise tolerance, ten patients with angina pectoris each performed two types of bicycle exercise test, one with a stepwise increase in load and the other with a continuously increasing load." | 5.04 | Effect of nifedipine on exercise tolerance in patients with angina pectoris. ( Atterhög, JH; Ekelund, LG; Melin, AL, 1975) |
| "Developed by Bayer in Germany, nifedipine was shown to be effective in the treatment of patients with angina pectoris by Japanese investigators." | 4.83 | [Clinical experience with nifedipine in the treatment of angina pectoris in Japan]. ( Hosoda, S, 2006) |
| "Nifedipine was synthesized by Bayer Germany in 1966 and considered for clinical use as a coronary vasodilator in patients with angina pectoris." | 4.83 | [Nifedipine: a novel vasodilator]. ( Taira, N, 2006) |
| "Nifedipine, as most calcium-antagonist drugs, is widely used for the treatment of angina pectoris and primary hypertension." | 4.80 | [Edema and skin ulcers of the lower limbs as a collateral effect of nifedipine. A clinical case report]. ( Luca, S; Romeo, S, 1999) |
| "In patients with coronary disease, the use of short-acting nifedipine in moderate to high doses causes an increase in total mortality." | 4.79 | Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. ( Furberg, CD; Meyer, JV; Psaty, BM, 1995) |
| "Nifedipine and atenolol are first choice drugs in the treatment of arterial hypertension and angina pectoris." | 4.78 | [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris]. ( Verdecchia, P, 1993) |
| " Although nifedipine is highly effective against vasospastic angina, its use in threatened myocardial infarction or severe unstable angina is not supported by recent studies, unless combined with a beta-blocker." | 4.77 | Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials. ( Opie, LH, 1988) |
| " As the first dihydropyridine available for use in the United States, nifedipine controls angina and hypertension with minimal depression of cardiac function." | 4.77 | Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications. ( Katz, AM; Leach, NM, 1987) |
| " Verapamil is extremely effective in patients with supraventricular tachyarrhythmias, hypertrophic cardiomyopathy, and the various anginal syndromes, but it appears to be ineffective or possibly even deleterious in those with pulmonary hypertension, congestive heart failure of any cause, and Raynaud's phenomenon or disease." | 4.77 | Calcium antagonists in patients with cardiovascular disease. Current perspectives. ( Hillis, LD; Winniford, MD, 1985) |
| " Nifedipine and diltiazem are effective in the relief of angina, and verapamil is used in the treatment of supraventricular tachyarrhythmias." | 4.77 | Calcium channel blocking agents: physiologic basis of nursing intervention. ( Touloukian, JE, 1985) |
| " The pharmacokinetics of verapamil and of one of its metabolites, norverapamil, is changed after multiple oral dosing as has been described in patients with supraventricular tachyarrhythmias, angina pectoris or in patients with essential hypertension." | 3.76 | Pharmacokinetics of calcium channel blocking agents. ( Anderson, P, 1986) |
| "To examine the association between hospitalization for acute coronary syndromes and treatment with amlodipine or extended-release nifedipine in patients 65 years of age and older." | 3.74 | Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: a population-based study. ( Bucci, C; Juurlink, DN; Mamdani, MM; Tu, JV, 2008) |
| " Benidipine treatment was associated with higher cardiovascular- and cardiac event-free rates than diltiazem treatment, and higher stroke- and ESRD-free rates than nifedipine." | 3.74 | Prognostic effects of calcium channel blockers on cardiac events, stroke and end-stage renal disease in patients with angina pectoris. Retrospective comparative study of benidipine, diltiazem and nifedipine. ( Arioka, I; Dohi, S; Sakai, K, 2008) |
| "Nifedipine GITS was not effective in slowing down the progression of calcium in advanced atherosclerotic plaques in patients with stable angina pectoris." | 3.74 | Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy. ( de Brouwer, S; Kirwan, BA; Motro, M; Poole-Wilson, PA; Shemesh, J, 2007) |
| "The prototype 1,4-dihydropyridine (1,4-DHP) nifedipine, indicated for the management of hypertension and angina pectoris, has drawbacks of rapid onset of vasodilating action and a short half-life." | 3.72 | Metabolism of the dihydropyridine calcium channel blockers mebudipine and dibudipine by isolated rat hepatocytes. ( Bohlooli, S; Grant, MH; Mahmoudian, M; Skellern, GG; Tettey, JN, 2004) |
| "The effects of SMP-300, an orally active, potent, and selective Na+/H+ exchange inhibitor, were evaluated and compared with those of nifedipine, propranolol, and nicorandil on three experimental angina models and on myocardial infarction in rats." | 3.71 | Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats. ( Matsui, K; Ohashi, N; Sasabe, M; Yamamoto, S, 2002) |
| "The effect of abrupt discontinuation of nifedipine (N) on exercise tolerance and myocardial ischemia was studied in 7 patients with stable angina pectoris of effort (AP)." | 3.69 | [The nifedipine withdrawal syndrome in patients with stable stenocardia of effort]. ( Kutishenko, NP; Martsevich, SIu; Metelitsa, VI, 1995) |
| "Effects of CD-832 on isoproterenol (ISO)-induced myocardial ischemia were studied in dogs with partial coronary stenosis of the left circumflex coronary artery and findings were compared with those for nifedipine or diltiazem." | 3.69 | Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis. ( Araki, H; Higuchi, S; Kishi-Tanikawa, S; Takahashi, K; Takahashi, T; Tsuchida, K, 1996) |
| "We investigated the effect of abrupt cessation of nifedipine after regular administration (20 mg, four times daily) for 5 weeks in seven patients with stable angina pectoris." | 3.68 | Withdrawal phenomenon after abrupt cessation of nifedipine in stable angina pectoris. ( Koutishenko, N; Martsevich, SY; Metelitsa, VI, 1993) |
| " Angina pectoris was induced by methacholine or isoproterenol, and the change in the ST-segments in the electrocardiogram (ECG) was used as the parameter to indicate angina pectoris." | 3.68 | Effect of KRN2391, a novel vasodilator, on various experimental anginal models in rats. ( Fukata, Y; Fukushima, H; Harada, K; Kaneta, S; Miwa, A; Ogawa, N, 1993) |
| "The nifedipine gastrointestinal therapeutic system (GITS) was recently approved for use in the treatment of angina and hypertension." | 3.68 | P&T Committee review of nifedipine GITS: new modality for angina and hypertension. ( Horn, J; Krakoff, L; Vetrovec, G; Weintraub, M, 1990) |
| "Gingival hyperplasia is an adverse reaction of nifedipine therapy." | 3.68 | Nifedipine-induced gingival hyperplasia. ( Barak, S; Ben Yehuda, A; Katz, J; Rotstein, I, 1992) |
| "The intracardiac hemodynamics was studied in 33 patients with exertional angina pectoris undergoing an acute drug test with verapamil (n-15) and nifedipine (n-18) by using radionuclide ventriculography both at rest and during exercise." | 3.68 | [Anti-anginal effects of calcium antagonists and intra-cardiac hemodynamics]. ( Malov, AG; Mazur, NA; Rubanovich, AI; Sergienko, VB; Sumarokov, AB; Zeĭnalov, FI, 1991) |
| "Nifedipine-induced gingival hypertrophy is a rare side effect reported by the producers of this drug but, surely, not well known in all its aspects." | 3.68 | [Nifedipine and gingival hypertrophy]. ( Borgia, MC; Calpicchio, A; De Paola, G; Di Folco, G, 1991) |
| "The anti-anginal efficacy of amlodipine was investigated in patients with angina pectoris by means of atrial pacing during cardiac catheterization." | 3.68 | Anti-anginal efficacy of intravenous amlodipine assessed by means of atrial pacing. ( Grant, P; Gupta, S; Hillis, WS; Hogg, KJ; Hornung, RS; Singh, SP, 1991) |
| "Patients with stable angina pectoris received an intravenous bolus injection of 10 mg amlodipine followed by a second 10-mg bolus, 30 min later, if no haemodynamic compromise occurred." | 3.68 | Haemodynamic and electrophysiological effects of amlodipine, a new long-acting calcium antagonist. ( Dailey, S; Epstein, A; Kay, G; Plumb, V; Vetrovec, GW, 1991) |
| "In 18 patients (12 females) presenting with effort-induced chest pain and normal coronary angiograms (syndrome X), 10 mg sublingual nifedipine increased the lumen of major coronary arteries (quantitative angiography) by 13% +/- 10 (p less than 0." | 3.68 | [Acute coronary vasomotor effects of nifedipine and its therapeutic efficacy in syndrome X]. ( Annoni, L; Cozzi, S; De Cesare, N; Fabbiocchi, F; Guazzi, MD; Loaldi, A; Montorsi, P; Polese, A, 1990) |
| " The possibility of development of tolerance to the anti-ischaemic and anti-anginal effects of nifedipine during sustained administration for 2 months was studied in 15 patients with stable angina pectoris by means of repeated exercise tests on a treadmill." | 3.68 | Development of tolerance to nifedipine in patients with stable angina pectoris. ( Egorov, LV; Martsevich, SY; Metelitsa, VI; Piotrovskii, VK; Rumiantsev, DO; Slastnikova, ID; Vygodin, VA, 1990) |
| "This prospective study was undertaken to evaluate the safety of nifedipine, a calcium channel blocking agent, on 60 subjects with asthma, chronic obstructive pulmonary disease (COPD), angina, and normal subjects." | 3.67 | Safety of nifedipine in subjects with bronchial asthma and COPD. ( Bewtra, A; Nair, CK; Nair, N; Townley, RG, 1984) |
| "We describe two patients in whom spontaneous angina following acute myocardial infarction (postinfarction angina caused by coronary artery spasm) and worsening angina were successfully eliminated after clinical dosage of oral diltiazem, while marked sinus node suppression developed and temporary pacing was performed." | 3.67 | Elimination of unstable angina by diltiazem under temporary pacing. ( Imamura, T; Ishikawa, T; Koiwaya, Y; Tanaka, K, 1984) |
| "The effects of the calcium antagonists nicardipine and nisoldipine on left ventricular (LV) metabolism were analyzed in 32 patients with angina pectoris." | 3.67 | Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. ( Charlier, AA; Pouleur, H; Rousseau, MF; Van den Berghe, G; Van Hoof, F; Vincent, MF, 1984) |
| "The immediate effects of sublingual nifedipine (20 mg) were evaluated in 18 men with stable, exercise-related angina pectoris and angiographically confirmed coronary artery obstructions, stratified at the time of left ventricular (LV) angiography according to the degree of LV dysfunction supine at rest (Group 1: n = 9, left ventricular end-diastolic pressure [LVEDP] less than 20 mm Hg; Group 2: n = 9, LVEDP greater than 20 mm Hg)." | 3.67 | Hemodynamic effects of nifedipine during upright exercise in stable angina pectoris and either normal or severely impaired left ventricular function. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "Marked improvement in the respiratory status of two patients with chronic obstructive lung disease was observed during treatment with nifedipine for angina pectoris." | 3.67 | Exacerbation of asthmatic symptoms after cessation of nifedipine therapy. ( Eliraz, A; Fink, A; Wishnitzer, R, 1984) |
| "In a randomised double-blind study, the effects on red cell deformability of a single sublingual dose of nifedipine were compared with placebo in eight patients with stable angina pectoris." | 3.67 | The acute effects of nifedipine on red cell deformability in angina pectoris. ( Nicholson, HP; Roath, S; Waller, DG, 1984) |
| " The haemodynamic effects of sublingual nifedipine (20 mg) and intravenous metoprolol (10 mg) singly and in combination were therefore studied in 20 patients with severe angina pectoris associated with angiographically documented coronary artery disease." | 3.67 | The effect on left ventricular performance of nifedipine and metoprolol singly and together in exercise-induced angina pectoris. ( Ahuja, RC; Forsyth, D; Hussain, M; Nelson, GI; Silke, B; Taylor, SH, 1984) |
| "Nifedipine, a "calcium channel blocker", is increasingly employed in the treatment of angina pectoris." | 3.67 | Nifedipine plasma concentration in patients treated for angina pectoris. ( Levy, M; Stern, Z; Zylber-Katz, E, 1984) |
| "A case of unstable angina pectoris precipitated by the administration of nifedipine, a complication which has not been well documented, is reported." | 3.67 | Unstable angina precipitated by nifedipine. A case report. ( Manga, P; Vythilingum, S, 1984) |
| " The haemodynamic effects of equivalent hypotensive doses of nifedipine and verapamil were therefore compared in 20 patients with severe angina pectoris associated with angiographically documented coronary artery disease." | 3.67 | The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "The daily ECG monitoring was used in 20 patients with stable functional class II-III angina pectoris to study the antianginal and anti-ischemic effects of verapamil and nifedipine during the cross use of the drugs." | 3.67 | [Evaluation of the efficacy of a course of verapamil and nifedipine in patients with stable stenocardia by daily monitoring of the electrocardiogram]. ( Bochkareva, EV; Kokurina, EV; Metelitsa, VI; Urumbaev, RK; Vodop'ianova, RS, 1989) |
| " In selected population of 113 patients with effort angina and proven coronary artery disease, the coronary cineangiographic pattern after 2 year therapy with nifedipine (Group 1, 39 patients), propranolol (Group 2, 36 patients), or isosorbide dinitrate (control group, 38 patients) was compared to the pre-treatment pattern." | 3.67 | [Angiographic course of coronary atherosclerosis in angina pectoris. Its relation to 2 years' treatment with propranolol, nifedipine and nitrates]. ( De Cesare, N; Fabbiocchi, F; Guazzi, M; Guazzi, MD; Loaldi, A; Montorsi, P; Polese, A; Ravagnani, P, 1989) |
| "The effect of oral administration of nifedipine (Adalat) on whole blood viscosity in patients with angina pectoris was investigated." | 3.67 | Changes in blood viscosity following nifedipine administration and its relation to the contents of adenosine triphosphate and 2,3-diphosphoglyceric acid in red blood cells in patients with angina pectoris. ( Fujinami, T; Kako, T; Kohketsu, M; Yoneda, S, 1989) |
| "Combined nitrate/beta-blocker/nifedipine therapy is commonly used to treat refractory angina pectoris." | 3.67 | Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris. ( Boden, WE; Bough, EW; Korr, KS, 1985) |
| " Nifedipine, a calcium antagonist, was added to the current medical therapy consisting of maximal doses of beta blockers and nitrates in a group of 18 patients who had had one revascularization procedure and subsequently had class 3 and 4 angina pectoris." | 3.67 | Angina after aortocoronary bypass grafting: combined medical therapy including nifedipine. ( Assey, ME; Hanger, KH, 1985) |
| "Variations induced by nifedipine (10 mg sublingually) in the residual lumen diameter of significant (greater than 50%) coronary lesions were assessed angiographically in 58 patients with effort angina (group 1) and in 19 patients with Prinzmetal angina (group 2)." | 3.67 | Different vasomotor action of nifedipine on dynamic coronary obstructions and therapeutic response in effort and prinzmetal angina. ( Bartorelli, A; de Cesare, N; Fabbiocchi, F; Guazzi, MD; Loaldi, A; Montorsi, P; Polese, A, 1989) |
| " Among 15 patients with coronary artery disease who had been treated with nisoldipine, onset of severe unstable angina was observed in 2 and evolution of acute myocardial infarction in 1 patient after abrupt withdrawal of nisoldipine therapy." | 3.67 | Calcium-blocker withdrawal phenomenon: increase in affinity of alpha 2 adrenoceptors for agonist as a potential mechanism. ( Lopez, LM; Mehta, J, 1986) |
| "Nifedipine influence on a clinical course of angina pectoris, some indices of hemodynamics, glucose and insulin was studied in 39 male patients suffering from coronary heart disease (CHD) with different glucose tolerance." | 3.67 | [Effect of corinfar on the course of angina pectoris and indices of carbohydrate metabolism in relation to the type of glucose tolerance]. ( Katsenovich, RA; Kostko, SZ; Trigulova, RKh, 1987) |
| "The short-term effects of sublingual nifedipine (20 mg) on cardiac output and its distribution at rest and during exercise were evaluated by measurement of iliofemoral blood flow and cardiac output in 10 men with stable angina pectoris controlled by metoprolol." | 3.67 | Regional distribution of cardiac output at rest and during exercise in patients with exertional angina pectoris before and after nifedipine therapy. ( Fletcher, PJ; Freedman, B; Harris, PJ; Kelly, DT; Thomson, A, 1988) |
| "To assess the dosing equivalency and the early and late antianginal efficacy of a gastrointestinal therapeutic system for once-daily, continuous-release nifedipine (N-GITS), 10 patients with stable angina pectoris, who were previously receiving chronic treatment with nifedipine, completed a 12-week trial comparing N-GITS with standard nifedipine." | 3.67 | Comparative dosing and efficacy of continuous-release nifedipine versus standard nifedipine for angina pectoris: clinical response, exercise performance, and plasma nifedipine levels. ( Alpert, DA; Parker, VE; Vetrovec, GW, 1988) |
| "A study was performed to compare isosorbide dinitrate and nifedipine as adjunctive therapy in 14 patients with coronary artery disease and stable angina pectoris taking maximal beta-blocking drugs." | 3.67 | Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris. ( Antman, EM; Holman, BL; Nesto, RW; White, HD; Wynne, J, 1987) |
| "The mechanism of the antianginal actions of nilvadipine was investigated in 11 patients with effort angina pectoris." | 3.67 | Effects of a new second generation calcium channel blocker, nilvadipine (FR34235), on exercise-induced hemodynamic changes in stable angina pectoris. ( Kamihara, S; Koide, M; Miyahara, T; Noda, S; Sotobata, I; Tsunekawa, A; Yokota, M, 1987) |
| "A new oral sustained release formulation containing 20 mg nifedipine (Coral retard) was administered twice daily to 30 patients suffering from coronary diseases and/or hypertension, in order to assess its clinical effectiveness." | 3.67 | Clinical efficacy and bioavailability of a sustained release nifedipine formulation. ( Piovella, C, 1987) |
| "Pharmacokinetic, haemodynamic and radionuclide studies explored the acute pharmacokinetic and pharmacodynamic actions of nicardipine in patients with coronary heart disease." | 3.67 | Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease. ( Finlayson, JR; Frais, MA; Graham, DJ; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1986) |
| "A 84-year-old man was given nifedipine for control of angina pectoris." | 3.67 | Nifedipine-associated acute psychosis. ( Kahn, JK, 1986) |
| "To determine the comparative effectiveness and hemodynamic effects of long-term oral treatment with propranolol alone and combined with nifedipine in patients with stable angina pectoris, 20 patients with coronary disease were studied by equilibrium radionuclide ventriculography." | 3.67 | Clinical and hemodynamic effects of combined propranolol and nifedipine therapy versus propranolol alone in patients with angina pectoris. ( Berenfeld, D; Braun, S; Laniado, S; Terdiman, R, 1985) |
| " All patients had class II or III stable angina pectoris and were receiving at least 160 to 240 mg/day of propranolol or equivalent doses of beta-blocker therapy." | 3.67 | Acute electrophysiologic, hemodynamic and left ventricular effects of nifedipine and beta-blocker interactions. Maintenance of global and regional left ventricular wall motion. ( Parker, VE; Vetrovec, GW, 1985) |
| "Long-acting nifedipine tablets were given to 47 severely and moderately hypertensive patients with renal insufficiency, cardiovascular, cerebrovascular, and peripheral vascular disease, diabetes mellitus, asthma, and systemic lupus erythematosus." | 3.67 | Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases. ( Bursztyn, M; Grossman, E; Rosenthal, T, 1985) |
| "In 16 patients with unstable angina pectoris 2 mg of nifedipine were infused intravenously for 1 hour." | 3.67 | [Changes in diastolic ventricular properties by intravenous nifedipine infusion in patients with unstable angina pectoris]. ( Karsch, KR; Mauser, M; Seipel, L; Wagner, S, 1985) |
| "The calcium-channel blocker, nifedipine, was used as additional oral therapy to beta-adrenergic receptor blockade by the cardioselective agent, atenolol, in the therapy of 31 patients with hypertension." | 3.66 | Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol. ( Jee, L; Opie, LH; White, D, 1982) |
| " Our previous results have now been reviewed, and they show that according to both subjective and objective criteria, nifedipine adds benefits to the action of propranolol in the management of chronic stable angina pectoris." | 3.66 | Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris. ( Harris, L; Krikler, DM; Rowland, E, 1982) |
| "The effects of different doses of nifedipine on frequency of angina and objective measurements of myocardial ischaemia during exercise were studied in 10 patients with stable angina pectoris." | 3.66 | Treatment of angina pectoris with nifedipine: importance of dose titration. ( Deanfield, J; Fox, K; Wright, C, 1983) |
| "In conclusion, we observed first that nifedipine is highly efficacious in preventing the coronary vasospasm of Prinzmetal's variant angina." | 3.66 | Nifedipine therapy for coronary vasospasm. ( Antman, EM; Muller, JE; Stone, PH, 1983) |
| "To examine the antianginal effects of felodipine, a new calcium antagonist, 8 patients with coronary artery disease and exertional angina pectoris were studied." | 3.66 | Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris. ( De Coster, PM; Detry, JM; Renkin, J, 1983) |
| "To determine the mechanisms responsible for beneficial effects of nifedipine in pacing-induced angina pectoris, 20 patients undergoing diagnostic cardiac catheterization were studied." | 3.66 | Salutary effect of nifedipine in pacing-induced angina: relation to afterload reduction. ( Ludbrook, PA; Sobel, BE; Tiefenbrunn, AJ, 1983) |
| "We report clinical experience with the coronary vasodilator nifedipine in 127 patients with symptoms of myocardial ischemia associated with electrocardiographic or angiographic evidence, or both, of coronary-artery spasm." | 3.66 | Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. ( Achuff, S; Antman, E; Braunwald, E; Geltman, E; Goldberg, S; Heupler, F; Kerin, NZ; Liang, CS; MacAlpin, R; Muller, J; Neff, RK; Reichek, N; Rubenfire, M; Tabatznik, B, 1980) |
| " During hospitalization all patients were treated with calcium antagonists (Nifedipine 10/20 mg every six hours) and/or nitrates (2% nitroglycerin ointment 2 inches every six/four hours) with one death (occurring after coronary arteriography) and eleven non-fatal myocardial infarctions." | 3.66 | [Angina at rest. Clinical, electrocardiographic and angiographic observations in 107 patients]. ( Ardissino, D; Bobba, P; Bramucci, E; Casali, PM; De Servi, S; Falcone, C; Martinelli, L; Minzioni, G; Mussini, A; Specchia, G; Viganò, M, 1980) |
| "The antianginal effectivity of niludipine (Bay a 7168), a new calcium antagonistic drug, was investigated in angina pectoris patients, selected for admission to the trials by pre-determined strict criteria." | 3.66 | Treatment of angina pectoris patients with niludipine a new calcium antagonistic drug. ( Fujita, K; Furukawa, K; Imako, K; Itsumi, H; Kurata, N; Maeda, K; Oshiro, T; Shiota, K; Tanaka, C; Tsukano, Y; Yagi, Y, 1981) |
| "To elucidate the mechanisms of action of nifedipine in angina pectoris, 14 patients were studied before and after sublingual administration of 10 mg nifedipine." | 3.66 | Mechanisms of angina relief after nifedipine: a hemodynamic and myocardial metabolic study. ( Emanuelsson, H; Holmberg, S, 1983) |
| "Angina pectoris patients were divided into two groups of unstable angina and stable angina, platelet aggregation was measured at rest and after treadmill exercise tolerance, and then the effects before and after the administration of nifedipine (Adalat) were examined." | 3.66 | Effect of the calcium antagonistic agent nifedipine on platelet aggregation response to exercise in patients with angina pectoris. ( Arakawa, K; Hiroki, T; Inoue, T; Yoshida, T, 1982) |
| "The efficacy of nifedipine in relieving recurrent ischemic episodes following acute myocardial infarction was studied in 11 patients a mean of 9." | 3.66 | Nifedipine therapy for recurrent ischemic pain following myocardial infarction. ( Muller, JE; Stone, PH, 1982) |
| "16 patients suffering from hypertension and angina pectoris (class II according to the NYHA) are treated with 100 mg atenolol once daily for three weeks." | 3.66 | [Effects of therapy with a association of nifedipine and atenolol in patients with systemic arterial hypertension and angina pectoris]. ( Attisano, N; Grenci, G; Martelli, G; Sarica, G; Schirripa, V, 1982) |
| "This study investigates the use of propranolol and nifedipine in the treatment of angina pectoris." | 3.66 | The use of propranolol and nifedipine in the medical management of angina pectoris. ( Fox, KM; Jonathan, A; Selwyn, AP, 1981) |
| "The effectiveness of nifedipine in treating angina pectoris at rest was evaluated in 14 patients with frequent ischemic episodes associated with S-T segment elevation or depression." | 3.66 | Treatment of angina at rest with nifedipine: a short-term controlled study. ( Bobba, P; Chimienti, M; Medici, A; Previtali, M; Ray, M; Salerno, JA; Specchia, G; Tavazzi, L, 1980) |
| "The therapeutic action of Nifedipine (Ni) and some of its haemodynamic effects have been studied in 24 male patients suffering from chronic, severe angina pectoris (Class II and III according to the NYHA) by means of right heart catheterization and repeated quantitative bicycle ergometer exercise test before and after 10 mg." | 3.66 | [Action of nifedipine on effort tolerance and on the left ventricular function during exercise in patients suffering from angina pectoris (author's transl)]. ( Valenti, P, 1980) |
| "The anti-anginal activity of nifedipine was studied after a dosage of 10 and 20 mg in nine patients suffering from a typical, stable effort angina pectoris." | 3.66 | [Effectiveness and duration of action of nifedipine in effort angina (author's transl)]. ( Arosio, G; Ciampalini, G; Di Girolamo, A; Ettori, F; Fappani, A; Oneglia, C, 1980) |
| "The hemodynamic effects of nitroglycerin and nifedipin and the application of both substances during a long term training program in patients with angina pectoris, myocardial infarction, and myocardial dysfunction (=48) were studied." | 3.66 | [Use of nifedipine and nitroglycerin during exercise therapy in patients with myocardial infarct. Clinical and hemodynamic studies]. ( Schenk, KE, 1978) |
| "Nifedipine is a non-nitrate vasodilator which has proved effective, in oral form, in Europe, Japan, and the USA for treatment of Prinzmetal Angina." | 3.66 | Nifedipine in the treatment of life threatening Prinzmetal angina. ( Campbell, TJ; Hickie, JB; Michell, G; O'Rouke, MF, 1979) |
| "The clinical response to therapy with the calcium-blocking agent nifedipine was assessed in 12 patients with variant angina pectoris who were 44 to 67 years old." | 3.66 | Nifedipine in the treatment of Prinzmetal's (variant) angina. ( Goldberg, S; Hirshfeld, JW; Kastor, JA; Muller, J; Reichek, N; Wilson, J, 1979) |
| "Nifedipine was administered in a dose of 30 mg orally to 14 patients with coronary heart disease and clinical evidence of left heart failure." | 3.66 | [The effect of nifedipine on the pulmonary artery pressure in patients with coronary heart disease (author's transl)]. ( Beck, OA; Hochrein, H, 1978) |
| "It is reported that nifedipine, a newly developed antianginal agent, was dramatically effective to suppress the repeatedly occurring ventricular fibrillation in 2 cases of variant form of angina pectoris." | 3.65 | Suppression of repeatedly occurring ventricular fibrillation with nifedipine in variant form of angina pectoris. ( Hashimoto, H; Honda, Y; Kimura, E; Mizuno, K; Tanaka, K, 1977) |
| "The hemodynamic effects of nifedipine and propranolol administered intravenously were studied in 17 patients with angina pectoris." | 3.65 | Effects of Adalat (nifedipine) on left ventricular hemodynamics in angina pectoris: comparative study with propranolol. ( Hamamato, H; Kanazawa, M; Kurita, A; Mabuchi, G; Ogawa, T, 1976) |
| "The development of heart failure is uncommon in patients with stable angina, and even less so in the absence of an obvious precipitating factor." | 2.73 | The development of heart failure in patients with stable angina pectoris. ( de Brouwer, S; Erik Otterstad, J; Kirwan, BA; Lubsen, J; Poole-Wilson, PA; Sutton, GC; Vokó, Z, 2007) |
| "Nifedipine gastrointestinal therapeutic system (GITS) is a once-daily formulation of nifedipine that provides stable plasma concentrations over the entire 24 h dosing interval." | 2.69 | Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina. ( Baird, MG; Bélanger, L; Erne, P; Klinke, P; Kostuk, WJ; Lotan, C; Marmor, A; Motro, M; Palant, A; Sclarowski, S; Stolero, D; Toal, CB; Turpie, A; Weiss, A; Zilberman, A, 1999) |
| "The treatment with nifedipine GITS 30-60 mg/day (monotherapy or combination) lasted for 6 months." | 2.69 | [Treatment of chronic stable angina: follow-up study with nifedipine gastrointestinal therapeutic system. SENIOR Study Group]. ( de Lombera Romero, F; Fuertes García, A; González Juanatey, JR; Luengo Fernández, E; Palencia Pérez, MA; Sagués Cabarro, F; Vargas García, R; Wilke Delgado, M, 2000) |
| " Twenty patients with chronic stable angina were recruited to a double-blind, double-dummy crossover study of controlled-release diltiazem (diltiazem CR) versus sustained-release nifedipine (nifedipine SR) and underwent clinical assessment, symptom and adverse event reporting, and repeated treadmill exercise tests over a 10- to 11-week period." | 2.69 | Improved efficacy and safety of controlled-release diltiazem compared to nifedipine may be related to its negative chronotropic effect. ( Basu, SK; Kinsey, CD; Lahiri, A; Miller, AJ, 2000) |
| "Nifedipine GITS was significantly better than isosorbide dinitrate (P < or = 0." | 2.68 | A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina. ( Bailey, AE; Curry, PV; Steare, SE; Walker, JM, 1996) |
| " About 8% of patients had a low compliance rate, irrespective of the dosage regimen." | 2.67 | [Time of drug intake in hypertension and angina pectoris. A controlled monitoring study]. ( Erne, P; Heynen, G; Saxenhofer, H; Waeber, B, 1994) |
| " After a 4 week run-in period on atenolol, patients were randomly allocated to receive either atenolol alone or its combination with nifedipine and then crossed over to the alternative treatment for a further 4 weeks." | 2.67 | Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina. ( Adnams, C; Commerford, P; Meyer, TE, 1993) |
| "Nifedipine was administered to 20 patients (8 in group 1, and 12 in group 2)." | 2.67 | Transient myocardial ischemia during nifedipine therapy in stable angina pectoris, and its relation to coronary collateral flow and comparison with metoprolol. ( Andersen, PE; Egstrup, K, 1993) |
| "Treatment with propranolol and nifedipine resulted in reduction of episodes and duration of painful and painless ischemia; approximately 77% of patients were free of all ischemic episodes." | 2.67 | Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination. ( Kawanishi, DT; Morrison, EC; Rahimtoola, SH; Reid, CL, 1992) |
| "nifedipine were investigated in this double-blind, randomized, group-comparative, multicenter study over 2 weeks, in 251 patients with stable reproducible exercise-induced angina." | 2.67 | [Randomized, double-blind comparison of isosorbide-5-mononitrate and delayed-action nifedipine in patients with stable exertional angina. Multicenter Study Group]. ( Bulitta, M; Hilbich, K; Krepp, P; Neuhaus, R; Patyna, WD; Puespoek, J; Rittinghausen, R; Ueberbacher, HJ, 1991) |
| " Both nifedipine alone (15-60 mg) and in combination with dilazep (50 mg) three times a day produced a significant reduction in angina attacks, consumption of nitroglycerin tablets and increased exercise tolerance." | 2.67 | Controlled clinical trial of nifedipine alone and in combination with dilazep in patients with angina pectoris. ( Biswas, NR; Pandhi, P; Sharma, PL; Wahi, PL, 1991) |
| "Amlodipine has significant anti-anginal efficacy." | 2.67 | A double-blind dose-response study of amlodipine in patients with stable angina pectoris. ( Alfiero, R; Cocco, G, 1991) |
| "Nifedipine was administered in amounts of 60 mg/day for three weeks, diltiazem 270 mg/day also for three weeks." | 2.67 | [Comparison of the effects of nifedipine and diltiazem in patients with stable angina pectoris of various severity and pathomorphology of the coronary arteries]. ( Koukalová, H; Meluzín, J; Novák, M, 1991) |
| " Antianginal efficacy was assessed by a dynamic exercise test at the end of the dosage intervals, i." | 2.67 | Evaluation of the antianginal effect of nifedipine: influence of formulation dependent pharmacokinetics. ( Emanuelsson, H; Herlitz, J; Karlson, BW; Nilsson, JE; Olsson, G, 1991) |
| "Carvedilol 25 mg b." | 2.67 | Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r. ( Derr, I; Eberhardt, R; Ehmer, B; Rudorf, J; Uberbacher, HJ; van der Does, R, 1991) |
| "Nifedipine was ineffective, particularly in patients with angina predominantly on effort and with a moderate to severe reduction in exercise tolerance." | 2.67 | Transient myocardial ischemia during daily life in rest and exertional angina pectoris and comparison of effectiveness of metoprolol versus nifedipine. ( Ardissino, D; Egstrup, K; Feruglio, GA; Giordano, MP; Marraccini, P; Roncarolo, P; Rosenfeld, M; Savonitto, S; Slavich, G; Wahlqvist, I, 1991) |
| "Diltiazem was significantly better than Nifedipine with respect to the development of angina during exercise testing (1 patient compared with 7 patients) and to maximum load (118." | 2.67 | [Comparative study of effects of diltiazem, nifedipine and their combination on exercise stable angina]. ( Bonnet, JL; Bory, M; Djiane, P; Gillet, T; Habib, G; Sebag, CL, 1991) |
| "Trimetazidine has been shown to have an antianginal effect, increasing exercise capability without producing any significant change of heart rate or systolic blood pressure." | 2.67 | Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study. ( Dalla-Volta, S; Della-Valentina, P; Desideri, A; Maraglino, G; Viena, P, 1990) |
| " Six patients had negative results; out of the remaining six, three exhibited a significant increase in the dosage required for provoking ischemia." | 2.67 | Intravenous nifedipine prevents ergonovine-induced myocardial ischemia in patients with stable effort angina. ( Brunelli, C; Caponnetto, S; Caudullo, M; Ghigliotti, G; Iannetti, M; Spallarossa, P, 1990) |
| "Isradipine has favourable effects comparable with those of nifedipine in patients with chronic stable angina and can be safely administered in these patients." | 2.67 | Effects of the calcium antagonist, isradipine, and nifedipine on resting and exercise haemodynamics and the neurohumoral system in patients with stable chronic angina. ( Burger, KJ; Kornecki, P; Mitrovic, V; Rieckmann, C; Schlepper, M; Welzel, D, 1990) |
| " To determine the mechanism of action of nifedipine and its dose-response relation, 14 patients with stable angina were treated with nifedipine 10, 20 and 30 mg 4 times daily as single-agent therapy in a double-blind, randomized, placebo-controlled crossover trial." | 2.67 | Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectoris. ( Gervino, E; Jarisch, WR; Rice, KR; Stone, PH, 1990) |
| "In atenolol-treated patients with severe effort angina pectoris, nifedipine 20 mg tid improved exercise capacity, while nisoldipine 20 mg once daily did not have a similar effect." | 2.67 | Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol. ( Kantor, M; Pedersen, TR, 1990) |
| " At the end of the 2-week control period, exercise performance was assessed with treadmill exercise testing and measurement of oxygen consumption during the final third of the dosing interval." | 2.66 | Comparison of nitroglycerin patches and nifedipine. ( Burdick, DC; Eldridge, JE; Hossack, KF; Jones, RH, 1987) |
| " However, 2 h after dosing there was a significant prolongation during stress testing in the time to onset of both 1 mm ST depression on the ECG (by 28%) and to angina (by 37%) compared with atenolol alone, but no benefit was apparent by 12 h after dosing." | 2.66 | Slow release nifedipine plus atenolol in chronic stable angina pectoris. ( Challenor, VF; George, CF; Renwick, AG; Waller, DG, 1989) |
| "Propranolol treatment decreased exercise cardiac output by 14 percent (p = 0." | 2.66 | Chronic stable angina monotherapy. Nifedipine versus propranolol. ( Cobb, FR; Coleman, RE; Higginbotham, MB; Morris, KG, 1989) |
| " Thus, nifedipine GITS represents a sound pharmacologic approach to the management of ischemic disease; and with once-daily dosing and a favorable side-effect profile this agent affords the potential for better patient compliance and efficacy without concern about the development of tolerance." | 2.66 | Once-daily therapy for angina pectoris with nifedipine gastrointestinal therapeutic system. Dosing and clinical efficacy. ( Vetrovec, GW, 1989) |
| " Treatment was titrated to produce at least a 30% increase in treadmill exercise duration over placebo baseline and then maintained at that dosage for an additional 3 weeks." | 2.66 | Comparison of atenolol and nifedipine in chronic stable angina pectoris. ( Kostis, JB; Narahara, KA; Shapiro, W; Thandroyen, F; Zohman, LR, 1989) |
| "For effective treatment of coronary heart disease with calcium antagonists, knowledge of both the dose-response relationship of a remedy and equipotent dosage for comparison of different drugs is necessary." | 2.66 | [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease]. ( Fleischer, K; Forster, A; Hopf, R; Kaltenbach, M; Mohler, C; Schulz, PC, 1989) |
| "A double-blind, placebo-controlled study was performed to assess whether a new calcium antagonist, nisoldipine, in doses of either 5 mg or 10 mg daily, in combination with beta-adrenergic-blocking drugs (combination therapy) was more effective than beta-adrenergic-blocking drugs alone (single therapy) in the treatment of chronic stable angina." | 2.66 | Efficacy of nisoldipine combined with beta-adrenergic-blocking drugs in the treatment of chronic stable angina. ( Banim, SO; Creamer, JE; O'Keefe, JC, 1987) |
| " Dose-response comparisons against nifedipine in 21 patients and against isosorbide dinitrate in 14 patients demonstrate that PN 200-110 has a similar antianginal efficacy profile to both drugs." | 2.66 | Efficacy of a new calcium antagonist PN 200-110 (isradipine) in angina pectoris. ( Allen, J; Jackson, NC; Pool, PE; Taylor, SH, 1987) |
| " Patients received 5 mg nifedipine three times a day rising to 20 mg three times a day in three dosage increments over six weeks or 2." | 2.66 | Comparison of isradipine and nifedipine in chronic stable angina. ( Handler, CE; Najm, Y; Rosenthal, E; Tsagadopoulos, D, 1988) |
| " The drugs were infused intravenously within 30 min in a dosage which led to a comparable afterload reduction (nifedipine [N] 2 mg, isradipine [I] 0." | 2.66 | [Isradipine (PN 200-110), a new dihydropyridine calcium antagonist with slight negative inotropic properties in comparison with nifedipine]. ( Karsch, KR; Mauser, M; Voelker, W, 1988) |
| " A reduction in prescribed dosage was required in 37% of nifedipine-treated compared with 6% of diltiazem-treated patients." | 2.66 | A randomized double-blind comparison of diltiazem and nifedipine in stable angina. ( Dempsey, EE; Grace, M; Klinke, WP; Kvill, L, 1988) |
| "Treatment with metoprolol (100 mg twice daily), nifedipine (10 mg 3 times daily) and both drugs combined were compared for effect on clinical variables, bicycle ergometer exercise tolerance and adverse effects in a randomized double-blind, crossover study in patients with stable effort angina (n = 62)." | 2.66 | Metoprolol, nifedipine, and the combination in stable effort angina pectoris. ( Arstila, M; Bae, EA; Härkönen, R; Keyriläinen, O; Rytkönen, U; Schjelderup-Mathiesen, PM; Uusitalo, A; Wendelin, H, 1986) |
| "Propranolol treatment decreased exercise cardiac output by 14% (p = 0." | 2.66 | Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise. ( Cobb, FR; Coleman, RE; Higginbotham, MB; Morris, KG, 1986) |
| " Nifedipine pharmacokinetics after a single oral dose and sustained dosing (three times daily for five days) were not significantly different." | 2.66 | Haemodynamic effects of combined oral nifedipine and sublingual nitroglycerin in patients with chronic stable angina. ( Boje, KM; Fung, HL; Parker, JO; Yoshitomi, K, 1987) |
| "Nitrendipine is a newly-developed calcium channel blocker derived from the dehydropyridine series which, according to experimental studies, affects marked dilation of the peripheral and coronary vessels." | 2.66 | [Antihypertensive and anti-ischemic effect of nitrendipine. Double-blind, randomized, crossover and placebo controlled acute study]. ( Blasini, R; Brügmann, U; Reiniger, G; Rudolph, W, 1985) |
| "Nifedipine was not better than placebo." | 2.66 | Atenolol and/or nifedipine in effort angina: which is the treatment of choice for exercise coronary protection? ( Caiazzo, MR; Carella, G; Chiariello, M; Condorelli, M; Cotecchia, MR; de Arcangelis, E; Di Maro, T; Romano, M, 1988) |
| "Nifedipine 3 X 20 mg/day was compared to IS 5-MN 3 X 20 mg/day and IS 5-MN 50 mg once daily for 1 week each." | 2.66 | Influence of isosorbide 5-mononitrate 20 mg, sustained-release 50 mg and sustained-release nifedipine 20 mg on ischaemic ST-segment changes during Holter monitoring. A double-blind cross-over study in patients with spontaneous angina pectoris. ( von Arnim, T, 1987) |
| "Treatment with Nifedipine significantly increased heart rate at rest (p less than 0." | 2.66 | [Comparative evaluation of 3 calcium antagonist drugs in patients with stable angina of effort. Double-blind placebo-controlled randomized study]. ( Buonamici, P; Buzzigoli, A; Fazzini, PF; Pucci, PD; Santoro, GM; Sarro, F, 1987) |
| "The propranolol group had a lower cumulative probability of experiencing recurrent resting angina than the placebo group (p = ." | 2.66 | Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial. ( Achuff, SC; Baughman, KL; Brinker, JA; Chandra, NC; Gottlieb, SO; Mellits, ED; Ouyang, P; Shapiro, EP; Traill, TA; Weisfeldt, ML, 1986) |
| "Nisoldipine is an effective antianginal agent which performs well in comparison to nifedipine." | 2.66 | Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina. ( Chaitman, BR; Crean, PA; Lam, J; Waters, DD, 1987) |
| " The absence of reflex tachycardia found in previous chronic oral dosing studies with this drug appears to take some days to develop in humans." | 2.66 | PY 108-068--acute effects of a single oral dose in chronic stable angina. ( de Buitleir, M; Krikler, DM; Krikler, S, 1986) |
| "Thus, remediable coronary vasospasm is not likely to be a major cause of post infarction ischemia in patients with nontransmural infarction." | 2.66 | Chest pain after nontransmural infarction: the absence of remediable coronary vasospasm. ( Biello, DR; Eisenberg, PR; Geltman, EM; Jaffe, AS; Lee, RG, 1985) |
| " The average daily dosage of nicardipine for optimal angina relief was 89 mg (range 40 to 160)." | 2.66 | Nicardipine for angina pectoris at rest and coronary arterial spasm. ( Feldman, RL; Gelman, JS; Pepine, CJ; Scott, E, 1985) |
| " In 2 patients, verapamil caused weakness, lightheadedness, and severe sinus bradycardia (40 to 48 beats/min), and the dosage was reduced (blindly) to 240 mg/day, with the alleviation of bradycardia and associated symptoms." | 2.66 | Propranolol-verapamil versus propranolol-nifedipine in severe angina pectoris of effort: a randomized, double-blind, crossover study. ( Corbett, JR; Croft, CH; Fulton, KL; Hillis, LD; Winniford, MD, 1985) |
| "Nifedipine is a calcium antagonist with established anti-vasospastic action in man and, possibly cardioprotective effects during ischaemia." | 2.65 | Acute myocardial ischaemia: what information can be expected in the near future from ongoing clinical trials with nifedipine? ( Hugenholtz, PG; Lubsen, J, 1983) |
| "Twelve patients with variant angina combined with angina of effort were examined." | 2.65 | [Comparative study of the effectiveness of korinfar, izoptin and obzidan in patients with variant stenocardia combined with effort stenocardia]. ( Borisova, GA; Peres Peres, A; Shevchenko, OP; Sidorenko, BA, 1984) |
| "Nicardipine is an effective antianginal agent with an optimal dose of 90 to 120 mg/day." | 2.65 | Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina. ( Bala Subramanian, V; Bowles, MJ; Khurmi, NS; Raftery, EB, 1984) |
| "In 28 patients with unstable angina pectoris biplane coronary angiography was performed in the acute stage." | 2.65 | [Dynamics of critical stenosis in patients with unstable angina pectoris]. ( Karsch, KR; Niemczyk, P; Seipel, L; Voelker, W, 1984) |
| " In this dosage nifedipine did not show any significant change in exercise duration and the variables obtained using computer assisted exercise testing when compared to placebo." | 2.65 | Evaluation of verapamil and high dose nifedipine in patients with chronic stable angina with objective methods. ( Bowles, MJ; Davies, AB; Khurmi, NS; Raftery, EB; Subramanian, VB, 1984) |
| "Amiodarone is a potent coronary vasodilator; it has alpha and beta receptor-antagonist activity and is well-known for its marked antiarrhythmic efficacy." | 2.65 | The value of amiodarone for the treatment of unstable angina. ( Bertholet, M; Demoulin, JC; Hastir, F; Kulbertus, HE; Renier, J, 1983) |
| "Propranolol therapy was continued and either placebo, nifedipine (20 mg), isosorbide dinitrate (20 mg) or both drugs were given randomly 1 1/2 hours before exercise in a double-blind trial." | 2.65 | "Maximal" drug therapy is not necessarily optimal in chronic angina pectoris. ( Chesler, E; Pierpont, GL; Tolins, M; Weir, EK, 1984) |
| "Nifedipine was discontinued in 2, and the dose was decreased in 3 of the 14 patients because of adverse effects." | 2.65 | Long-term responses to nifedipine in patients with coronary spasm who have an initial favorable response. ( Conti, CR; Feldman, RL; Hill, CK; Hill, JA; Pepine, CJ, 1983) |
| "Failure of medical treatment (defined as sudden death, myocardial infarction, or bypass surgery within four months) occurred in 43 of 70 patients given placebo and in 30 of 68 given nifedipine." | 2.65 | Nifedipine in unstable angina: a double-blind, randomized trial. ( Achuff, SC; Baughman, KL; Becker, LC; Bulkley, BH; Flaherty, JT; Gerstenblith, G; Kallman, CH; Llewellyn, M; Mellits, ED; Ouyang, P; Weisfeldt, ML; Weiss, JL, 1982) |
| "nifedipine (N) was evaluated in 50 outpatients with effort angina; 26 were treated with dilazep 300 mg/die and 24 with nifedipine 30 mg/die." | 2.65 | [Dilazep vs. nifedipine in patients with stable effort angina. A double blind randomized study (author's transl)]. ( Giusti, C; Regoli, F, 1981) |
| "Nifedipine is a new antianginal drug, the calcium-antagonistic inhibitory action on excitation-contraction coupling apparently being so pronounced that, in therapeutic dosage, all other pharmacological properties are negligible." | 2.65 | Effect of nifedipine on exercise tolerance in angina pectoris. ( Kidner, PH; McIlwraith, GR; Oram, S, 1980) |
| "Nifedipine treatment reduced the weekly number of anginal attacks as well as the weekly number of nitroglycerin tablets consumed by the pts, increased maximum workload tolerated and reduced the S-T segment depression for the same workload, meanwhile heart rate and blood pressure did not change significantly either at rest or during exercise." | 2.64 | [Effects of nifedipine in the treatment of effort stable angina: a double blind study (author's transl)]. ( Bonaduce, D; Carlomagno, A; Condorelli, M; De Caprio, L; Petretta, M; Rengo, F; Scarafile, P, 1978) |
| "Calcium antagonists are used in the treatment of hypertension and angina." | 2.44 | The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension. ( Coca, A; Sierra, C, 2008) |
| "Nifedipine is a dihydropyridine calcium channel antagonist with predominantly vasodilatory activity." | 2.43 | Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris. ( Croom, KF; Wellington, K, 2006) |
| "The drug is equally effective in treating hypertension in elderly and younger patients and does not appear to adversely affect glucose or lipid metabolism." | 2.39 | Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina. ( Brogden, RN; McTavish, D, 1995) |
| "Amlodipine is a dihydropyridine calcium antagonist drug with distinctive pharmacokinetic characteristics which appear to be attributable to a high degree of ionisation." | 2.38 | Clinical pharmacokinetics of amlodipine. ( Elliott, HL; Meredith, PA, 1992) |
| "Amlodipine is a dihydropyridine calcium antagonist that has unique pharmacokinetic properties." | 2.38 | The efficacy of amlodipine in the management of ischaemic heart disease. ( McGibney, D, 1991) |
| "Amlodipine was found to increase exercise capacity significantly and reduce electrocardiographic evidence of myocardial ischaemia after treadmill exercise testing 24 h after administration compared with placebo in patients suffering from angina pectoris." | 2.38 | A review of amlodipine in myocardial ischaemia. ( Taylor, SH, 1991) |
| "Amlodipine, a dihydropyridine calcium antagonist, was synthesized in an attempt to develop a compound with a pharmacokinetic profile characteristic of this class, which would also have an increased oral bioavailability and extended clearance time." | 2.38 | The pharmacokinetic profile of amlodipine. ( Abernethy, DR, 1989) |
| " At clinically high dosage levels, the incidence of peripheral edema was comparable for both nifedipine and diltiazem, although low-dose nifedipine resulted in a significantly greater incidence of edema compared with low-dose diltiazem." | 2.38 | High-dose monotherapy and combination therapy with calcium channel blockers for angina. A comprehensive review of the literature. ( Temkin, LP, 1989) |
| "Amlodipine has also been found to be effective in reducing the anginal attack rate in patients with vasospastic angina." | 2.38 | The efficacy of amlodipine in myocardial ischemia. ( Taylor, SH, 1989) |
| " Diltiazem with a beta-blocker is usually well-tolerated, with a low incidence of adverse effects, similar to the experience with diltiazem monotherapy." | 2.37 | Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects. ( Parisi, AF; Strauss, WE, 1988) |
| "Nisoldipine is an orally administered calcium entry blocking drug structurally related to nifedipine." | 2.37 | Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders. ( Friedel, HA; Sorkin, EM, 1988) |
| " The dosage and choice of drugs are based on pharmaco-kinetic and dynamic data in animals and man." | 2.36 | Clinical pharmacology of beta-adrenoceptor antagonism in angina pectoris: an overview. ( Oh, VM, 1980) |
| "Treatment with nifedipine can safely be combined with administration of a beta receptor blocking agent." | 2.36 | Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. ( Henry, PD, 1980) |
| "Clinical experience in the treatment of hypertension with this class of agents is confined to verapamil, nifedipine, and diltiazem." | 2.36 | Calcium antagonists. Clinical use in the treatment of systemic hypertension. ( Frishman, WH; Ocken, S; Spivack, C, 1983) |
| "Amiodarone is an extremely potent drug which is effective for both supraventricular as well as ventricular arrhythmias." | 2.36 | New antiarrhythmic drugs. ( Hess, DS; Scheinman, MM, 1983) |
| "The case of an 83-year-old man with colon cancer who developed chest pain during 5-FU infusion is presented." | 1.38 | A case of severe coronary spasm associated with 5-fluorouracil chemotherapy. ( Cho, WH; Choi, SK; Kim, SB; Kim, SM; Kwak, CH; Lee, B; Sir, JJ, 2012) |
| "Does nifedipine treatment alone decrease the progression of renal disease with overt proteinuria? If these answers are yes, are these beneficial effects of nifedipine superior to that of other DHPs with equihypotensive properties? Does nifedipine treatment also reduce oxidative stress markers? Are these unique effects of nifedipine correlated with its anti-oxidative properties? These prospective studies will provide further valuable information whether nifedipine may be a preferred DHP to achieve BP goals in hypertensive patients with systolic dysfunction or overt proteinuria." | 1.34 | Revival of nifedipine, a dihydropyridine-based calcium blocker. ( Nakamura, K; Yamagishi, S, 2007) |
| "We describe the safety profile of nifedipine GITS as assessed from adverse events reported in the ACTION trial in which 7,665 patients with stable, symptomatic coronary artery disease were randomly assigned nifedipine GITS or placebo and followed for a mean of 4." | 1.33 | Safety of nifedipine GITS in stable angina: the ACTION trial. ( de Brouwer, S; Kirwan, BA; Lubsen, J; Poole-Wilson, PA; van Dalen, FJ; Vokó, Z, 2006) |
| "Gingival overgrowth was noticed in 29% of the patients." | 1.30 | The clinical effects of nifedipine on periodontal status. ( Caglayan, F; Caglayan, G; Eratalay, K; Tavassoli, S; Yamalik, N, 1998) |
| "Nifedipine was also effective in these models, but propranolol was not." | 1.29 | Antianginal effects of YM-16151-4 in various experimental angina models. ( Asano, M; Shibasaki, K; Takenaka, T; Uchida, W, 1993) |
| " This oesophageal disorder may be considered a side effect caused by prolonged therapy with nitroderivatives and Ca-antagonists." | 1.28 | "Oesophageal angina" in patients with angina pectoris: a possible side effect of chronic therapy with nitroderivates and Ca-antagonists. ( Bacchelli, S; Barbara, L; Bortolotti, M; Brunelli, F; Degli Esposti, D; Del Campo, L; Labriola, E; Sarti, P, 1992) |
| "Amlodipine is a new calcium antagonist of the 1." | 1.28 | [Amlodipine: pharmacokinetic and pharmacodynamic profile of a calcium antagonist with prolonged effect]. ( Heynen, G, 1992) |
| "Pretreatment with nifedipine (3 x 10(-8) M) prevented the rise in LVEDP induced by pacing tachycardia." | 1.28 | Effects of nifedipine on diastolic abnormalities in low-flow and pacing-induced ischemia in isolated rat hearts. ( Iizuka, M; Ikenouchi, H; Momomura, S; Serizawa, T; Sugimoto, T, 1991) |
| "We studied seven patients with Prinzmetal's angina and three patients with unstable angina pectoris type III (according to the criteria of Conti) during and after a spontaneous attack of angina pectoris by two-dimensional echocardiography." | 1.28 | [Echocardiography detection of reversible regional disorders of contraction in patients with unstable angina pectoris and Prinzmetal angina during an attack]. ( Geibel, A; Hofmann, T; Just, H; Kasper, W; Meinertz, T; Wollschläger, H, 1989) |
| "Nifedipine was effective in reducing the frequency and duration of SMI in our patients." | 1.28 | [Clinical characteristics of silent myocardial ischemia and the effect of nifedipine treatment]. ( Huang, L; Xin, Q; Zhu, SJ, 1989) |
| "Nifedipine is a strong calcium antagonist; it blocks the excitation-contraction coupling, yet at therapeutic dosage levels it has few side effects." | 1.27 | What is preferable in unstable angina, beta-blockade or calcium-inhibition? ( Hugenholtz, PG; Serruys, PW; Simoons, ML, 1983) |
| "Patients with unstable angina pectoris who remain symptomatic at rest after hospitalization are at increased risk of death or myocardial infarction." | 1.27 | Adjunctive nifedipine therapy in high-risk, medically refractory, unstable angina pectoris. ( Blaustein, AS; Heller, GV; Kolman, BS, 1983) |
| " Using a randomized, double-blind, placebo-controlled protocol, the effects of nadolol alone and nadolol in combination with isosorbide dinitrate and nifedipine were compared, in low and high doses, on antianginal efficacy, respiratory functions and arterial blood oxygen saturation (SaO2) in 19 patients with stable angina pectoris." | 1.27 | Cardiorespiratory effects of isosorbide dinitrate and nifedipine in combination with nadolol: a double-blind comparative study of beneficial and adverse antianginal drug interactions. ( Mir, MA; Tirlapur, VG, 1984) |
| " These results suggest that the chronic administration of calcium antagonists, at the usual therapeutic doses, does not effect the process of stimulus-secretion coupling of anterior pituitary hormones, ruling out any impairment of the related target glands which have been expected on the basis of previous studies." | 1.27 | Lack of inhibition of anterior pituitary hormone release during chronic treatment with calcium antagonists. ( Bigi, F; D'Armiento, M; de Cristofaro, AM; Greco, V; Pontecorvi, A; Reda, G, 1984) |
| "Verapamil was found to be a more effective antianginal drug than nifedipine." | 1.27 | [Comparative effectiveness of finoptin, corinfar and their combination in patients with angina pectoris]. ( Mazur, NA; Romakov, AIu; Sagirov, AM; Sumarokov, AB, 1984) |
| "Nicardipine is a potent vasodilator, which produced a marked reduction of systemic vascular resistance and left ventricular end-diastolic pressure during exercise." | 1.27 | Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease. ( Jaarsma, W; Kan, G; Lie, KI; Visser, CA, 1984) |
| "Some Ca2+-antagonists are used for the treatment of angina pectoris." | 1.27 | Clinical efficacy of niludipine in the treatment of angina pectoris. ( Fujita, K; Igarashi, T; Ogasawara, S; Oyama, Y; Shibata, J; Tateda, K; Tomita, T; Yamazaki, M; Yasuda, H; Yokota, H, 1984) |
| "They also have great potential for the treatment of hypertension, cerebrovascular disorders, and Raynaud's phenomenon." | 1.27 | Calcium channel blocking drugs. Part II: Clinical applications. ( Brill, DM; Fozzard, HA, 1985) |
| "When nicardipine was administered after propranolol, the indices of inotropic state were unaffected." | 1.27 | Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris. ( Charlier, AA; Cheron, P; Pouleur, H; Rousseau, MF; van den Berghe, G; Vincent, MF, 1985) |
| "Nicardipine is a powerful arteriodilator without detectable negative inotropic effects and prolongs the time to pacing induced angina." | 1.27 | Effect of nicardipine on left ventricular function and on angina induced by atrial pacing in patients with coronary artery disease. ( Lipkin, DP; Poole-Wilson, PA, 1985) |
| " When nicorandil in a dosage of 20 to 40 mg/day was added to the regimen, the mean number of attacks dropped significantly (P less than 0." | 1.27 | Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate. ( Araki, H; Hayata, N; Matsuguchi, T; Nakamura, M, 1987) |
| "Confusion and sleep disorders constitute 8 cases." | 1.27 | Nifedipine--a survey of adverse effects. Four years' reporting in Sweden. ( Myrhed, M; Wiholm, BE, 1986) |
| "Nifedipine was associated with a decrease in systolic blood pressure (from 156 +/- 14 to 138 +/-13 mmHg), an increase in heart rate (from 73 +/- 13 to 81 +/- 8." | 1.27 | [Increase in liver circulation with nifedipine]. ( Kuhnen, R; Lüderitz, B; Nitsch, J, 1986) |
| "Nifedipine is a potent coronary vasodilator in the resting state and an effective afterload-reducing agent." | 1.27 | Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise. ( Antman, E; Ganz, P; Holman, BL; Koslowski, J; Nesto, RW; White, HD; Wynne, J, 1985) |
| "Nicardipine was administered as a 2 mg bolus (i." | 1.27 | Effects of nicardipine on left ventricular function and energetics in man. ( Feldman, RL; Hill, JA; Lambert, CR; Pepine, CJ, 1986) |
| "Nifedipine was given bucally in a dose (10 or 20 mg) that decreased aortic pressure 5 mm Hg or more." | 1.27 | Effect of nifedipine on coronary hemodynamics in patients with left anterior descending coronary occlusion. ( Conti, CR; Feldman, RL; Hill, JA; Pepine, CJ, 1985) |
| " Although the safety profile of nifedipine has been generally regarded as favorable, a few reports of clinically significant adverse effects in specific patient groups have appeared in the literature." | 1.26 | Nifedipine therapy in angina pectoris: evaluation of safety and side effects. ( Terry, RW, 1982) |
| "Coronary spasm is due to strong contraction of coronary vascular smooth muscle cells which is triggered by an increase of intracellular calcium ions; hyperventilation plus TRIS-buffer infusion induces coronary spasm by decreasing hydrogen ions which antagonize the action of calcium ions." | 1.26 | Pathophysiology and treatment of coronary arterial spasm. ( Yasue, H, 1980) |
| "Nitroglycerin was well suited for treatment of acute attacks." | 1.26 | Prinzmetal's variant angina. ( Efsen, F; Sandøe, E; Vilhelmsen, R, 1981) |
| "Niludipine was at 93." | 1.26 | Clinical effectiveness of niludipine in patients with ischemic heart disease. ( Ban, M; Hashimoto, H; Imura, K; Ito, T; Kanayama, H; Kotaka, K; Miyazaki, Y; Mochizuki, M; Nizoe, K; Ogawa, K; Okumura, K; Sakai, K; Shikano, M; Sone, T; Uno, T; Watanabe, J, 1982) |
| "Nifedipine was dramatically effective in suppressing repeatedly occurring ventricular fibrillation." | 1.26 | Variant form of angina pectoris: its clinical features and treatment. The 185th Luis Guerrero Memorial Lecture given at the 6th Paul Dudley White Session, University of Santo Tomas, Manila, The Philippines, January 24, 1979. ( Kimura, E, 1980) |
| " When used in standard recommended oral dosage nifedipine has no significant effect on glucose tolerance." | 1.26 | Effect of nifedipine on glucose tolerance and insulin secretion in diabetic and non-diabetic patients. ( Donnelly, T; Harrower, AD, 1980) |
| "In 10 patients with stress stenocardia pharmacodynamics of Isoptin was studied with the aid of identical physical loads on the treadmill repeated with an hour's interval for 5-6 hours." | 1.26 | [Calcium antagonists in stress angina pectoris (pharmacodynamic study)]. ( Metelitsa, VI; Nikolenko, SA; Savvateev, KL; Shinbaeva, NA, 1982) |
| "Nifedipine was effective in all 5 cases with coronary stenosis of more than 75." | 1.26 | Effects of calcium antagonists, especially nifedipine, on variant angina, resting angina, and unstable angina. ( Hayakawa, H; Kimura, E; Kishida, H; Kusama, Y; Otsu, F; Takayama, M, 1982) |
| "Thus nifedipine appears to be an efficacious agent in the treatment of refractory rest angina in patients with obstructive coronary artery disease." | 1.26 | Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease. ( Banka, VS; Bodenheimer, MM; Feldman, M; Helfant, RH; Moses, JW; Wertheimer, JH, 1981) |
| "Nifedipine (0." | 1.26 | Treatment of Prinzmetal's variant angina. Role of medical treatment with nifedipine and surgical coronary revascularization combined with plexectomy. ( Bertrand, ME; Lablanche, JM; Tilmant, PY, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 673 (72.37) | 18.7374 |
| 1990's | 208 (22.37) | 18.2507 |
| 2000's | 40 (4.30) | 29.6817 |
| 2010's | 9 (0.97) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meredith, PA | 4 |
| Lloyd, SM | 2 |
| Ford, I | 4 |
| Elliott, HL | 4 |
| Cao, X | 1 |
| Nakamura, Y | 1 |
| Wada, T | 1 |
| Izumi-Nakaseko, H | 1 |
| Ando, K | 1 |
| Zhu, B | 1 |
| Xu, B | 1 |
| Takahara, A | 1 |
| Saitoh, M | 1 |
| Sugiyama, A | 1 |
| Bucci, C | 1 |
| Mamdani, MM | 1 |
| Juurlink, DN | 1 |
| Tu, JV | 1 |
| Sierra, C | 1 |
| Coca, A | 1 |
| Vokó, Z | 6 |
| Danchin, N | 2 |
| de Brouwer, S | 9 |
| Kirwan, BA | 11 |
| Poole-Wilson, PA | 14 |
| Lubsen, J | 21 |
| Arioka, I | 1 |
| Dohi, S | 2 |
| Sakai, K | 2 |
| Oikawa, Y | 1 |
| Matsuno, S | 1 |
| Yajima, J | 1 |
| Nakamura, M | 2 |
| Ono, T | 1 |
| Ishiwata, S | 1 |
| Fujimoto, Y | 1 |
| Aizawa, T | 1 |
| Nishigaki, K | 2 |
| Inoue, Y | 1 |
| Yamanouchi, Y | 1 |
| Fukumoto, Y | 1 |
| Yasuda, S | 1 |
| Sueda, S | 1 |
| Urata, H | 1 |
| Shimokawa, H | 1 |
| Minatoguchi, S | 2 |
| Higuma, T | 1 |
| Oikawa, K | 1 |
| Kato, T | 4 |
| Mori, Y | 1 |
| Kudo, T | 1 |
| Yamamoto, T | 2 |
| Hoshi, Y | 1 |
| Kameda, K | 1 |
| Suto, N | 1 |
| Fujita, N | 1 |
| Inokubo, Y | 1 |
| Konta, A | 1 |
| Osanai, T | 1 |
| Okumura, K | 2 |
| Kim, SM | 1 |
| Kwak, CH | 1 |
| Lee, B | 1 |
| Kim, SB | 1 |
| Sir, JJ | 1 |
| Cho, WH | 1 |
| Choi, SK | 1 |
| Cheung, BM | 1 |
| Kumana, CR | 1 |
| Kawano, H | 1 |
| Ashizawa, N | 1 |
| Toda, G | 1 |
| Seto, S | 1 |
| Yano, K | 1 |
| Donaldson, KM | 2 |
| Dawkins, KD | 2 |
| Waller, DG | 6 |
| Meng, J | 1 |
| Romero, M | 1 |
| Sánchez, I | 1 |
| Pujol, MD | 1 |
| Bochkareva, EV | 6 |
| Kokurina, EV | 8 |
| Voronina, VP | 1 |
| Kucheriavaia, NG | 1 |
| Butina, EK | 1 |
| Bohlooli, S | 1 |
| Mahmoudian, M | 1 |
| Skellern, GG | 1 |
| Grant, MH | 1 |
| Tettey, JN | 1 |
| Liakishev, AA | 2 |
| Wagener, G | 2 |
| Takase, H | 1 |
| Toriyama, T | 1 |
| Sugiyama, M | 1 |
| Nakazawa, A | 1 |
| Hayashi, K | 1 |
| Goto, T | 1 |
| Sugiura, T | 1 |
| Ikeda, K | 1 |
| Sato, K | 1 |
| Ueda, R | 1 |
| Dohi, Y | 1 |
| Clayton, TC | 1 |
| Pocock, SJ | 2 |
| Fox, KA | 2 |
| McMurray, JJ | 1 |
| van Dalen, FJ | 3 |
| Croom, KF | 1 |
| Wellington, K | 2 |
| Kosicka, T | 1 |
| Kara-Perz, H | 1 |
| Głuszek, J | 1 |
| Perz, S | 1 |
| Motro, M | 3 |
| Shemesh, J | 2 |
| Yamagishi, S | 1 |
| Nakamura, K | 1 |
| Sutton, GC | 2 |
| Erik Otterstad, J | 1 |
| Ikeda, J | 1 |
| Matsubara, M | 1 |
| Yao, K | 1 |
| Dart, AM | 1 |
| Otterstad, JE | 1 |
| Parker, JD | 2 |
| Eisen, A | 1 |
| Tenenbaum, A | 1 |
| Koren-Morag, N | 1 |
| Tanne, D | 1 |
| Golan, A | 1 |
| Fisman, EZ | 1 |
| Schwammenthal, E | 1 |
| Adler, Y | 1 |
| Litovchik, I | 1 |
| Krakover, R | 1 |
| Blatt, A | 1 |
| Vered, Z | 1 |
| Dunselman, PH | 3 |
| Ruilope, LM | 1 |
| Segura, J | 1 |
| Yui, Y | 1 |
| Shinoda, E | 1 |
| Kodama, K | 1 |
| Hirayama, A | 1 |
| Nonogi, H | 1 |
| Haze, K | 1 |
| Sumiyoshi, T | 2 |
| Hosoda, S | 6 |
| Kawai, C | 1 |
| Io, K | 1 |
| Ojio, S | 1 |
| Tanaka, T | 2 |
| Segawa, T | 1 |
| Matsuo, H | 1 |
| Watanabe, S | 1 |
| Hattori, A | 1 |
| Ueno, K | 1 |
| Ono, H | 1 |
| Hiei, K | 1 |
| Sato, H | 1 |
| Morita, N | 1 |
| Noda, T | 1 |
| Kawasaki, M | 1 |
| Takemura, G | 1 |
| Fujiwara, H | 1 |
| Taira, N | 1 |
| Rutsch, W | 1 |
| Schmutzler, H | 1 |
| Stone, KS | 1 |
| Scordo, KA | 1 |
| Opie, LH | 6 |
| Temkin, LP | 2 |
| Kimura, E | 6 |
| Kishida, H | 2 |
| Koide, T | 1 |
| Kakihana, M | 1 |
| Takabatake, Y | 1 |
| Iizuka, M | 2 |
| Uchida, Y | 1 |
| Ozeki, K | 1 |
| Morooka, S | 1 |
| Kato, A | 1 |
| Tanaka, S | 3 |
| Oya, T | 1 |
| Momomura, S | 2 |
| Murao, S | 1 |
| Leisch, F | 2 |
| Schützenberger, W | 1 |
| Bergmann, H | 1 |
| Herbinger, W | 1 |
| Oh, VM | 1 |
| Demoulin, JC | 2 |
| Bertholet, M | 2 |
| Chevigne, M | 1 |
| Legrand, V | 1 |
| Renier, J | 2 |
| Soumagne, D | 1 |
| Soyeur, D | 1 |
| Limet, R | 1 |
| Kulbertus, H | 1 |
| Kangilaski, J | 1 |
| McBride, G | 1 |
| Zelis, R | 4 |
| Daly, K | 1 |
| Bergman, G | 1 |
| Rothman, M | 1 |
| Atkinson, L | 1 |
| Jackson, G | 3 |
| Jewitt, DE | 1 |
| Franklin, GS | 1 |
| Brown, JW | 1 |
| Freedman, ML | 1 |
| Weser, C | 1 |
| Jee, L | 1 |
| White, D | 2 |
| Stone, PH | 11 |
| Turi, ZG | 4 |
| Muller, JE | 8 |
| Terry, RW | 1 |
| Krikler, DM | 8 |
| Harris, L | 2 |
| Rowland, E | 3 |
| Packer, M | 2 |
| Frishman, WH | 10 |
| Segal, BL | 1 |
| Kotler, MN | 1 |
| Iskandrian, AS | 1 |
| Winniford, MD | 5 |
| Hillis, LD | 7 |
| Ekelund, LG | 4 |
| Banka, VS | 2 |
| Bodenheimer, MM | 2 |
| Helfant, RH | 3 |
| Sánchez Cascos, A | 1 |
| Espín, A | 1 |
| Ramírez, M | 1 |
| De Rábago, P | 1 |
| Hugenholtz, PG | 10 |
| Serruys, PW | 6 |
| Simoons, ML | 6 |
| Meyer, J | 1 |
| Tirlapur, VG | 2 |
| Mir, MA | 2 |
| Vanhaleweyk, GL | 1 |
| Miller, A | 1 |
| Blaustein, AS | 1 |
| Heller, GV | 1 |
| Kolman, BS | 1 |
| Swedberg, K | 3 |
| Ebner, F | 2 |
| Kuz'ko, NV | 1 |
| Yabe, Y | 1 |
| Hollman, J | 1 |
| Austin, GE | 1 |
| Gruentzig, AR | 1 |
| Douglas, JS | 1 |
| King, SB | 1 |
| Ellrodt, G | 1 |
| Chew, CY | 1 |
| Singh, BN | 2 |
| Henry, PD | 1 |
| Horwitz, DL | 1 |
| Karlsberg, RP | 1 |
| Flaim, SF | 2 |
| Willerson, JT | 3 |
| Braunwald, E | 4 |
| Johnston, WE | 1 |
| Lowenstein, E | 1 |
| Bianchi, CP | 1 |
| Hayashi, H | 4 |
| Kisamori, K | 1 |
| Kaneko, M | 1 |
| Masumura, Y | 1 |
| Kamikawa, T | 1 |
| Kobayashi, A | 1 |
| Suzuki, Y | 1 |
| Yamazaki, N | 1 |
| Yamaguchi, T | 1 |
| Harada, Y | 1 |
| Casson, WR | 1 |
| Jones, RM | 1 |
| Parsons, RS | 1 |
| Covinsky, JO | 1 |
| Hamburger, SC | 1 |
| Spivack, C | 2 |
| Ocken, S | 2 |
| Sobol', IuS | 1 |
| Desiatnichenko, VM | 1 |
| Romakov, AIu | 2 |
| Mazur, NA | 4 |
| Manger Cats, V | 1 |
| Lie, KI | 7 |
| Radomski, L | 1 |
| Brody, MJ | 1 |
| Verdouw, PD | 1 |
| de Jong, JW | 2 |
| Geltman, E | 3 |
| Jaffe, AS | 3 |
| Razis, P | 1 |
| Sugrue, D | 1 |
| Di Pasquale, G | 4 |
| Lusa, AM | 3 |
| Manini, GL | 4 |
| Dominici, P | 3 |
| Pinelli, G | 5 |
| Pepine, CJ | 11 |
| Feldman, RL | 8 |
| Hill, JA | 8 |
| Conti, CR | 8 |
| Mehta, J | 3 |
| Hill, C | 1 |
| Scott, E | 2 |
| Schulz, W | 4 |
| Jost, S | 2 |
| Kaltenbach, M | 9 |
| Kober, G | 5 |
| Chaitman, BR | 5 |
| Wagniart, P | 1 |
| Pasternac, A | 1 |
| Brevers, G | 1 |
| Scholl, JM | 1 |
| Lam, J | 3 |
| Methe, M | 1 |
| Ferguson, RJ | 1 |
| Bourassa, MG | 3 |
| Ardissino, D | 7 |
| De Servi, S | 7 |
| Salerno, JA | 4 |
| Specchia, G | 9 |
| Previtali, M | 4 |
| Mussini, A | 5 |
| Bobba, P | 5 |
| Pearle, DL | 2 |
| Schneider, JF | 1 |
| Serfas, DH | 1 |
| Morrison, J | 1 |
| Rude, RE | 1 |
| Rosner, B | 1 |
| Sobel, BE | 6 |
| Deanfield, J | 5 |
| Wright, C | 6 |
| Krikler, S | 7 |
| Ribeiro, P | 1 |
| Fox, K | 4 |
| Breland, BD | 1 |
| Boland, MJ | 1 |
| Ol'binskaia, LI | 1 |
| Vartanova, OA | 1 |
| Giannini, SD | 1 |
| Forti, N | 1 |
| Campanari, JC | 1 |
| Di Rienzo, F | 1 |
| Adler, R | 1 |
| Ziliotto, EE | 1 |
| Kern, P | 1 |
| Gottlieb, SO | 4 |
| Ouyang, P | 4 |
| Achuff, SC | 3 |
| Baughman, KL | 3 |
| Traill, TA | 2 |
| Mellits, ED | 4 |
| Weisfeldt, ML | 4 |
| Gerstenblith, G | 4 |
| Brinker, JA | 2 |
| Shevchenko, OP | 1 |
| Peres Peres, A | 1 |
| Borisova, GA | 1 |
| Sidorenko, BA | 5 |
| Katsenovich, RA | 3 |
| Kostko, SZ | 4 |
| Arifdzhanova, UA | 2 |
| Khashimov, KhA | 1 |
| Vakhidova, MA | 2 |
| Khurmi, NS | 7 |
| Bowles, MJ | 6 |
| Bala Subramanian, V | 3 |
| Raftery, EB | 6 |
| Hopf, R | 3 |
| Drews, H | 1 |
| Seu, V | 2 |
| Abrile, PG | 1 |
| Boero, E | 2 |
| Magaia, O | 2 |
| Mocini, A | 2 |
| Castrignano, A | 1 |
| Maffei, P | 1 |
| Perugini, P | 1 |
| Livi, A | 1 |
| Sherman, LG | 1 |
| Liang, CS | 5 |
| Maclean, D | 1 |
| Feely, J | 1 |
| Scheinman, MM | 1 |
| Hess, DS | 1 |
| Cohen, DJ | 1 |
| Foley, RW | 1 |
| Ryan, JM | 1 |
| Carù, B | 7 |
| De Ponti, C | 9 |
| De Biase, AM | 3 |
| Antman, EM | 3 |
| Mysliwiec, M | 1 |
| Rydzewski, A | 1 |
| Bulhak, W | 1 |
| Idle, JR | 1 |
| Sever, PS | 1 |
| Findlay, IN | 2 |
| Dargie, HJ | 6 |
| Pitlik, S | 1 |
| Manor, RS | 1 |
| Lipshitz, I | 1 |
| Perry, G | 1 |
| Rosenfeld, J | 1 |
| D'Armiento, M | 1 |
| Pontecorvi, A | 1 |
| Bigi, F | 1 |
| de Cristofaro, AM | 1 |
| Reda, G | 1 |
| Greco, V | 1 |
| Brügmann, U | 5 |
| Blasini, R | 5 |
| Rudolph, W | 5 |
| Rankin, JS | 1 |
| Newton, JR | 1 |
| Califf, RM | 1 |
| Jones, RH | 2 |
| Wechsler, AS | 1 |
| Oldham, HN | 1 |
| Wolfe, WG | 1 |
| Lowe, JE | 1 |
| Wester, HA | 1 |
| Mouselimis, N | 1 |
| Karsch, KR | 3 |
| Niemczyk, P | 1 |
| Voelker, W | 2 |
| Seipel, L | 2 |
| Michels, R | 1 |
| Pfisterer, M | 2 |
| Fridrich, R | 1 |
| Burkart, F | 2 |
| Hope, RR | 1 |
| Lazzara, R | 1 |
| Kramer, PH | 1 |
| Chatterjee, K | 2 |
| Schwartz, A | 2 |
| Rouleau, JL | 2 |
| Curran, D | 2 |
| Blevins, L | 1 |
| Parmley, WW | 3 |
| Carraway, RD | 1 |
| Nair, N | 1 |
| Townley, RG | 1 |
| Bewtra, A | 1 |
| Nair, CK | 1 |
| Hess, OM | 2 |
| Krayenbühl, HP | 1 |
| Bashour, TT | 1 |
| Kabbani, SS | 1 |
| Brewster, HP | 1 |
| Wald, SH | 1 |
| Hanna, ES | 1 |
| Cheng, TO | 1 |
| Hansen, ME | 1 |
| Ishikawa, T | 1 |
| Imamura, T | 1 |
| Koiwaya, Y | 1 |
| Tanaka, K | 3 |
| Coluccini, M | 2 |
| Bassein, L | 2 |
| Siebert, J | 2 |
| Skarzyński, P | 2 |
| Rousseau, MF | 3 |
| Vincent, MF | 2 |
| Van Hoof, F | 2 |
| Van den Berghe, G | 3 |
| Charlier, AA | 2 |
| Pouleur, H | 3 |
| Sagirov, AM | 2 |
| Sumarokov, AB | 3 |
| Jackson, NC | 5 |
| Silke, B | 13 |
| Verma, SP | 12 |
| Reynolds, G | 7 |
| Hafizullah, M | 3 |
| Taylor, SH | 17 |
| Lipkin, D | 1 |
| Visser, CA | 2 |
| Jaarsma, W | 1 |
| Kan, G | 1 |
| Yasuda, H | 1 |
| Tomita, T | 1 |
| Fujita, K | 2 |
| Shibata, J | 1 |
| Tateda, K | 1 |
| Yokota, H | 1 |
| Igarashi, T | 1 |
| Ogasawara, S | 2 |
| Yamazaki, M | 1 |
| Oyama, Y | 1 |
| Urbaniuk, KG | 1 |
| Mazurets, AF | 1 |
| Volgina, AS | 1 |
| Rossi, LP | 1 |
| Subramanian, VB | 4 |
| Davies, AB | 3 |
| Hastir, F | 1 |
| Kulbertus, HE | 1 |
| Detry, JM | 3 |
| De Coster, PM | 1 |
| Renkin, J | 1 |
| Falcone, C | 3 |
| Angoli, L | 3 |
| Gavazzi, A | 1 |
| Bramucci, E | 4 |
| Ferrario, M | 4 |
| Salerno, J | 1 |
| Montemartini, C | 2 |
| Spital, A | 1 |
| Scandling, JD | 1 |
| Galle, JS | 1 |
| Díaz, R | 1 |
| Corbalán, R | 3 |
| Marchant, E | 1 |
| Casanegra, P | 3 |
| Tweddel, AC | 2 |
| Johnsson, G | 1 |
| Pringle, TH | 1 |
| Murray, RG | 2 |
| Hutton, I | 2 |
| Tiefenbrunn, AJ | 4 |
| Ludbrook, PA | 4 |
| Witchitz, S | 2 |
| Kolsky, H | 1 |
| Moisson, P | 2 |
| Schanzenbächer, P | 3 |
| Deeg, P | 2 |
| Liebau, G | 2 |
| Kochsiek, K | 3 |
| Nelson, GI | 3 |
| Ahuja, RC | 3 |
| Hussain, M | 4 |
| Eliraz, A | 1 |
| Wishnitzer, R | 1 |
| Fink, A | 1 |
| Nicholson, HP | 1 |
| Roath, S | 1 |
| Forsyth, D | 1 |
| Tolins, M | 1 |
| Weir, EK | 2 |
| Chesler, E | 1 |
| Pierpont, GL | 1 |
| Stern, Z | 2 |
| Zylber-Katz, E | 1 |
| Levy, M | 2 |
| Ahmad, S | 1 |
| Ellingsen, O | 1 |
| Kjekshus, J | 1 |
| Emanuelsson, H | 3 |
| Hjalmarson, A | 1 |
| Holmberg, S | 2 |
| Waagstein, F | 1 |
| Manga, P | 1 |
| Vythilingum, S | 1 |
| Leon, MB | 2 |
| Bonow, RO | 2 |
| Kieval, J | 1 |
| Rosing, DR | 2 |
| Becker, HJ | 1 |
| Dowinsky, S | 1 |
| Pirelli, S | 2 |
| Cataldo, G | 2 |
| Salvadè, P | 3 |
| Piccolo, E | 3 |
| Cazzin, R | 3 |
| Sartori, F | 2 |
| Artusi, L | 2 |
| Pascotto, P | 3 |
| Lagioia, R | 4 |
| Mangini, S | 2 |
| De Toma, L | 3 |
| De Nicolò, M | 2 |
| Accettura, D | 3 |
| Ricci, A | 2 |
| Scrutinio, D | 4 |
| Rizzon, P | 4 |
| Antman, E | 2 |
| Muller, J | 2 |
| Goldberg, S | 2 |
| MacAlpin, R | 1 |
| Rubenfire, M | 1 |
| Tabatznik, B | 2 |
| Heupler, F | 1 |
| Achuff, S | 1 |
| Reichek, N | 2 |
| Kerin, NZ | 1 |
| Neff, RK | 1 |
| Yasue, H | 6 |
| Lynch, P | 1 |
| Dargie, H | 1 |
| Krikler, D | 1 |
| Gunther, S | 1 |
| Mudge, GH | 2 |
| Grossman, W | 1 |
| Waters, DD | 8 |
| Szlachcic, J | 3 |
| Theroux, P | 7 |
| Dauwe, F | 3 |
| Mizgala, HF | 4 |
| Kurita, A | 3 |
| Ogawa, T | 2 |
| Kanazawa, M | 2 |
| Hamamato, H | 2 |
| Mabuchi, G | 3 |
| Kikuchi, H | 1 |
| Atterhög, JH | 2 |
| Ekelund, LC | 1 |
| Melin, AL | 2 |
| Kenmure, AC | 2 |
| Scruton, JH | 2 |
| Mauri, F | 4 |
| Ciliberto, GR | 4 |
| Cocco, G | 4 |
| Strozzi, C | 2 |
| Chu, D | 2 |
| Amrein, R | 2 |
| Castagnoli, E | 2 |
| Endo, M | 2 |
| Kanda, I | 2 |
| Hirosawa, K | 2 |
| Konno, S | 2 |
| Mizuno, K | 3 |
| Honda, Y | 2 |
| Hashimoto, H | 3 |
| Omote, S | 2 |
| Takizawa, A | 4 |
| Nagao, M | 4 |
| Miwa, K | 2 |
| Williams, DO | 1 |
| Johnson, SM | 2 |
| Mauritson, DR | 2 |
| Corbett, J | 1 |
| Dehmer, GJ | 1 |
| Lewis, SE | 1 |
| Casali, PM | 1 |
| Martinelli, L | 1 |
| Minzioni, G | 1 |
| Viganò, M | 1 |
| Sandøe, E | 2 |
| Vilhelmsen, R | 2 |
| Efsen, F | 1 |
| Maeda, K | 1 |
| Tanaka, C | 1 |
| Yagi, Y | 1 |
| Oshiro, T | 1 |
| Itsumi, H | 1 |
| Furukawa, K | 1 |
| Imako, K | 1 |
| Kurata, N | 1 |
| Tsukano, Y | 1 |
| Shiota, K | 1 |
| Mueller, HS | 1 |
| Chahine, RA | 3 |
| Strasser, R | 1 |
| Klepzig, H | 1 |
| Cokkinos, DV | 1 |
| Patsouros, KD | 1 |
| Klotsotiras, G | 1 |
| Kanellaki, M | 1 |
| Patsilinakos, J | 1 |
| Pitcher, D | 1 |
| Sowton, E | 3 |
| Bailey, JS | 1 |
| Ogawa, K | 1 |
| Ito, T | 1 |
| Ban, M | 1 |
| Nizoe, K | 1 |
| Mochizuki, M | 1 |
| Watanabe, J | 1 |
| Kanayama, H | 1 |
| Sone, T | 1 |
| Imura, K | 1 |
| Uno, T | 1 |
| Shikano, M | 1 |
| Kotaka, K | 1 |
| Miyazaki, Y | 1 |
| Klein, W | 1 |
| Brandt, D | 1 |
| Fluch, N | 1 |
| Maurer, E | 1 |
| Engel, HJ | 1 |
| Wolf, R | 1 |
| Hundeshagen, H | 1 |
| Lichtlen, PR | 1 |
| Broustet, JP | 3 |
| Rumeau, P | 1 |
| Guern, P | 2 |
| Cherrier, JF | 1 |
| Pic, A | 1 |
| Bonnet, J | 1 |
| Jenkins, RM | 1 |
| Nagle, RE | 1 |
| Cherchi, A | 3 |
| Fonzo, R | 2 |
| Mercuro, G | 1 |
| Sau, F | 1 |
| Dipalma, JR | 1 |
| Zaret, GM | 1 |
| Allen, HB | 1 |
| Macdonald, G | 2 |
| Marra, S | 2 |
| Paolillo, V | 2 |
| Baduini, G | 1 |
| Spadaccini, F | 1 |
| Angelino, PF | 3 |
| Hill, CK | 1 |
| Bassan, MM | 1 |
| Weiler-Ravell, D | 2 |
| Shalev, O | 2 |
| Fox, KM | 9 |
| Selwyn, A | 2 |
| Eichelbaum, M | 1 |
| Hiroki, T | 1 |
| Inoue, T | 1 |
| Yoshida, T | 1 |
| Arakawa, K | 1 |
| Lumholtz, IB | 2 |
| Mortensen, SA | 1 |
| Vaisrub, S | 1 |
| Klaus, AP | 1 |
| Gorfinkel, HJ | 1 |
| Lemmo, JJ | 1 |
| Graham, BW | 1 |
| Michels, HR | 1 |
| Brower, RW | 2 |
| Heupler, FA | 1 |
| Zsotér, TT | 1 |
| Ippoliti, A | 1 |
| Donnelly, T | 1 |
| Harrower, AD | 1 |
| Check, WA | 1 |
| Jaiprakash, SS | 1 |
| Sahay, JN | 1 |
| Chatterjee, SS | 1 |
| Gonzalez, R | 1 |
| Chamorro, G | 2 |
| Muñoz, M | 1 |
| Rodriguez, JA | 1 |
| Ferrero, JA | 1 |
| Llacer, A | 1 |
| García-Fuster, MJ | 1 |
| Chorro, FJ | 1 |
| Insa, LD | 1 |
| Merino, J | 1 |
| Llopis, R | 1 |
| López-Merino, V | 1 |
| Hanson, JS | 1 |
| Christie, F | 1 |
| Lynch, PG | 1 |
| Sammel, NL | 1 |
| O'Rourke, MF | 1 |
| Beattie, JM | 1 |
| Parisi, AF | 3 |
| Strauss, WE | 2 |
| McIntyre, KM | 1 |
| Sasahara, AA | 1 |
| Schmidt, JF | 1 |
| Baadsgaard, O | 1 |
| Dawson, JR | 1 |
| Whitaker, NH | 1 |
| Lanocita, M | 1 |
| Bulkley, BH | 1 |
| Becker, LC | 1 |
| Weiss, JL | 1 |
| Flaherty, JT | 1 |
| Kallman, CH | 1 |
| Llewellyn, M | 1 |
| Goebel, G | 1 |
| Mannes, A | 1 |
| Dirschinger, J | 2 |
| Gruppillo, P | 1 |
| Battaglia, R | 1 |
| Masoni, C | 1 |
| Maistrello, I | 1 |
| Masoni, A | 1 |
| Regoli, F | 1 |
| Giusti, C | 1 |
| Malacoff, RF | 1 |
| Lorell, BH | 1 |
| Holman, BL | 3 |
| Idoine, J | 1 |
| Bifolck, L | 1 |
| Cohn, PF | 4 |
| Reed, FR | 1 |
| Low, RI | 1 |
| Takeda, P | 1 |
| Mason, DT | 1 |
| DeMaria, AN | 1 |
| Alves, LE | 1 |
| Rose, EP | 1 |
| Campbell, BC | 1 |
| Majid, PA | 1 |
| De Jong, J | 1 |
| Yokoyama, M | 1 |
| Koizumi, T | 1 |
| Fujitani, K | 1 |
| Mizutani, T | 1 |
| Fukuzaki, H | 1 |
| Nijsen-Karelse, M | 1 |
| Dion, RA | 1 |
| Jambroes, G | 1 |
| Tri, TB | 1 |
| Price, HL | 1 |
| Sobol, SM | 1 |
| Lee, J | 1 |
| Lubbe, WF | 1 |
| Bassan, M | 1 |
| Zacca, NM | 1 |
| Verani, MS | 1 |
| Miller, RR | 1 |
| Markham, RV | 1 |
| Firth, BG | 1 |
| Nicod, P | 2 |
| Isojima, K | 1 |
| Aozaki, N | 1 |
| Kondo, S | 1 |
| Hosono, K | 1 |
| Schirripa, V | 1 |
| Attisano, N | 1 |
| Sarica, G | 1 |
| Grenci, G | 1 |
| Martelli, G | 1 |
| Nikolenko, SA | 2 |
| Metelitsa, VI | 19 |
| Shinbaeva, NA | 2 |
| Savvateev, KL | 2 |
| Otsu, F | 1 |
| Kusama, Y | 1 |
| Takayama, M | 1 |
| Hayakawa, H | 1 |
| Valle Tudela, V | 1 |
| Alijarde Guimera, M | 1 |
| Cortadellas Angel, MJ | 1 |
| Ríus Garriga, J | 1 |
| Soler Soler, J | 1 |
| Badoini, G | 1 |
| Spadaccini, V | 1 |
| Bergorone, S | 1 |
| Oddenino, G | 1 |
| Boncompagni, F | 1 |
| Llovet, A | 1 |
| Sáenz de la Calzada, C | 2 |
| Díez, L | 1 |
| Guitián, R | 1 |
| Vidal, JM | 1 |
| Alba, F | 1 |
| Moses, JW | 1 |
| Wertheimer, JH | 1 |
| Feldman, M | 1 |
| Englert, R | 1 |
| Novo, S | 2 |
| Davì, G | 1 |
| Riolo, F | 1 |
| Pinto, A | 1 |
| Avellone, G | 1 |
| Fazio, M | 1 |
| Aquaro, G | 1 |
| Belli, R | 1 |
| Rey, L | 1 |
| Pavia, M | 1 |
| Idone, P | 1 |
| Wise, JR | 1 |
| Gowda, S | 1 |
| McKnight, RC | 1 |
| Graf, C | 1 |
| Frey, R | 1 |
| Dettli, R | 1 |
| Siegenthaler, W | 1 |
| Vygodin, VA | 4 |
| Jonathan, A | 2 |
| Selwyn, AP | 2 |
| Gupta, SC | 1 |
| Nair, KG | 1 |
| Bayer, R | 1 |
| Mannhold, R | 1 |
| Rodenkirchen, R | 1 |
| Nayler, WG | 1 |
| Montinaro, A | 1 |
| Lombardi, R | 1 |
| Bacca, F | 1 |
| Gozzelino, G | 1 |
| Fubini, A | 1 |
| Isaia, GG | 1 |
| Scagliotti, G | 1 |
| Gamna, G | 1 |
| Rovelli, EG | 1 |
| Parenti, GF | 1 |
| Carnovali, M | 1 |
| Lancelin, B | 1 |
| Blanchard, D | 1 |
| Aziza, JP | 1 |
| Guermonprez, JL | 1 |
| Maurice, P | 1 |
| Tavazzi, L | 2 |
| Ray, M | 2 |
| Medici, A | 2 |
| Chimienti, M | 2 |
| Pedersen, OL | 3 |
| Mikkelsen, E | 2 |
| Andersson, KE | 2 |
| McIlwraith, GR | 1 |
| Kidner, PH | 1 |
| Oram, S | 1 |
| Sol, JJ | 1 |
| Fergusson, DJ | 1 |
| Reeve, R | 1 |
| Balestra, G | 1 |
| Oldani, A | 1 |
| Fabbri, V | 1 |
| Mambelli, C | 1 |
| Morgagni, W | 1 |
| White, DA | 1 |
| Valenti, P | 1 |
| Offerhaus, L | 1 |
| Dunning, AJ | 1 |
| Bertrand, ME | 1 |
| Lablanche, JM | 1 |
| Tilmant, PY | 1 |
| Arosio, G | 2 |
| Ciampalini, G | 2 |
| Di Girolamo, A | 2 |
| Ettori, F | 1 |
| Fappani, A | 1 |
| Oneglia, C | 2 |
| Phaneuf, DC | 1 |
| Pelletier, G | 1 |
| Wout van den Toren, E | 1 |
| de Vries, RJ | 3 |
| Portegies, MC | 1 |
| Blanksma, PK | 1 |
| van Gilst, WH | 2 |
| Hillege, HJ | 1 |
| van Veldhuisen, DJ | 1 |
| Metcalfe, MJ | 1 |
| Jennings, K | 1 |
| Weiss, RJ | 2 |
| Baiker, WM | 1 |
| Messerli, FH | 1 |
| Furberg, CD | 1 |
| Psaty, BM | 1 |
| Meyer, JV | 1 |
| Martsevich, SIu | 8 |
| Kutishenko, NP | 2 |
| Uchida, W | 2 |
| Shibasaki, K | 2 |
| Asano, M | 2 |
| Takenaka, T | 3 |
| Brogden, RN | 3 |
| McTavish, D | 2 |
| Savonitto, S | 3 |
| Egstrup, K | 6 |
| Rasmussen, K | 2 |
| Bae, EA | 3 |
| Omland, T | 2 |
| Schjelderup-Mathiesen, PM | 3 |
| Marraccini, P | 3 |
| Merlini, PA | 2 |
| Wahlqvist, I | 3 |
| von Arnim, T | 5 |
| Verdecchia, P | 1 |
| Wright, RA | 1 |
| Perrie, AM | 1 |
| Stenhouse, F | 1 |
| Alberti, KG | 1 |
| Riemersma, RA | 1 |
| MacGregor, IR | 1 |
| Boon, NA | 1 |
| Yokota, M | 3 |
| Saito, F | 1 |
| Izawa, H | 1 |
| Matsunami, T | 1 |
| Yoshida, J | 1 |
| Inagaki, H | 1 |
| Sotobata, I | 2 |
| Erne, P | 2 |
| Saxenhofer, H | 1 |
| Waeber, B | 1 |
| Heynen, G | 2 |
| Hetzel, M | 2 |
| Wieshammer, S | 2 |
| Barnikel, U | 2 |
| Hetzel, J | 1 |
| Herb, S | 1 |
| Kochs, M | 2 |
| Hombach, V | 2 |
| Koolen, JJ | 1 |
| Van Wezel, HB | 1 |
| Piek, J | 1 |
| van Liebergen, R | 1 |
| Swaan, A | 1 |
| Kukushkin, SK | 1 |
| Geller, NL | 2 |
| Knatterud, GL | 2 |
| Davies, RF | 1 |
| Day, P | 1 |
| Deanfield, JE | 1 |
| Goldberg, AD | 1 |
| McMahon, RP | 2 |
| Meyer, TE | 1 |
| Adnams, C | 1 |
| Commerford, P | 1 |
| Siu, SC | 1 |
| Jacoby, RM | 1 |
| Phillips, RT | 2 |
| Nesto, RW | 7 |
| Martsevich, SY | 2 |
| Koutishenko, N | 2 |
| Ulvenstam, G | 2 |
| Walldius, G | 1 |
| Aberg, A | 1 |
| Knyshov, GV | 2 |
| Vykhovaniuk, IV | 2 |
| Tkhor, NV | 2 |
| Furkalo, SN | 2 |
| Korchinskaia, OI | 2 |
| Lee, DD | 1 |
| Rigonan, K | 1 |
| Dequattro, V | 1 |
| Foale, RA | 3 |
| Harada, K | 1 |
| Fukata, Y | 1 |
| Miwa, A | 1 |
| Kaneta, S | 1 |
| Fukushima, H | 1 |
| Ogawa, N | 1 |
| Wallace, WA | 2 |
| Wellington, KL | 2 |
| Chess, MA | 1 |
| Glasser, SP | 6 |
| Friedman, R | 1 |
| Talibi, T | 1 |
| Smith, LK | 1 |
| Ikram, H | 1 |
| Low, CJ | 1 |
| Shirlaw, TM | 1 |
| Foy, SG | 1 |
| Crozier, IG | 1 |
| Richards, AM | 1 |
| Horsburgh, RJ | 1 |
| Santamaria, F | 1 |
| Sestito, M | 1 |
| Lirato, C | 1 |
| Di Palma, A | 2 |
| De Rosa, ML | 2 |
| Iannuzzi, L | 1 |
| Pandolfi, E | 1 |
| Cicatiello, AM | 1 |
| Parlati, S | 1 |
| Aschermann, M | 1 |
| Bultas, J | 1 |
| Danzig, V | 1 |
| Mayer, O | 1 |
| Lorenc, Z | 1 |
| Vortel, J | 1 |
| Kvasnicka, J | 1 |
| Kishimoto, T | 1 |
| Okamiya, Y | 1 |
| Aoki, K | 1 |
| Ota, M | 1 |
| Hoshina, K | 1 |
| Takeshita, T | 1 |
| Shkarin, VV | 1 |
| Naumova, NA | 1 |
| Naumov, VG | 1 |
| Schwartz, JB | 1 |
| Caputo, G | 1 |
| Abbott, J | 1 |
| Andersen, PE | 1 |
| Gaffney, M | 1 |
| Taylor, C | 1 |
| Cusenza, E | 1 |
| Iriarte, M | 1 |
| Molinero, E | 2 |
| Sagastagoitia, JD | 2 |
| Arzubiaga, J | 2 |
| Aguirre, J | 1 |
| Salcedo, A | 2 |
| De Caprio, L | 4 |
| Acanfora, D | 3 |
| Odierna, L | 1 |
| Romaniello, C | 1 |
| Rengo, C | 1 |
| Giordano, A | 1 |
| Rengo, F | 4 |
| van Zwieten, PA | 1 |
| Pfaffendorf, M | 1 |
| Borzak, S | 1 |
| Fenton, T | 1 |
| Shook, TL | 2 |
| MacCallum, G | 1 |
| Young, PM | 1 |
| Ardissiono, D | 1 |
| Rehnqvist, N | 1 |
| Mori, T | 1 |
| Ishigai, Y | 1 |
| Fukuzawa, A | 1 |
| Chiba, K | 1 |
| Shibano, T | 1 |
| Boudoulas, H | 1 |
| Leier, CV | 1 |
| Barats, SS | 1 |
| Smolenskaia, OG | 1 |
| Klets, FKh | 1 |
| Zubareva, TV | 1 |
| Zakroeva, AG | 1 |
| Kots, IaI | 1 |
| Tenchurina, LR | 1 |
| Pratt, CM | 1 |
| Goldstein, S | 1 |
| Andrews, TC | 1 |
| Dyrda, I | 1 |
| Morgan, NA | 1 |
| Sopko, G | 1 |
| Mulcahy, D | 3 |
| Findlay, I | 1 |
| Walker, JM | 1 |
| Curry, PV | 1 |
| Bailey, AE | 1 |
| Steare, SE | 1 |
| Rayo Llerena, I | 1 |
| Marín Huerta, E | 1 |
| Mazzotta, G | 1 |
| Falcidieno, M | 1 |
| Ravera, E | 1 |
| Vecchio, C | 1 |
| Liu, KY | 1 |
| Zhang, Y | 1 |
| Feng, ZX | 1 |
| Starovoĭtova, SP | 1 |
| Sheianov, MV | 1 |
| Shchedrina, IS | 1 |
| Chukbar, VI | 1 |
| Pimenov, LT | 1 |
| Ezhov, AV | 1 |
| Churshin, AD | 1 |
| Takahashi, T | 1 |
| Takahashi, K | 1 |
| Kishi-Tanikawa, S | 1 |
| Tsuchida, K | 1 |
| Araki, H | 2 |
| Higuchi, S | 1 |
| Caubet, JF | 2 |
| Stason, WB | 2 |
| Bishop, DJ | 1 |
| Ross, SD | 2 |
| Di Somma, S | 1 |
| de Divitiis, M | 1 |
| Bertocchi, F | 1 |
| Carotenuto, A | 1 |
| Cudemo, G | 1 |
| Petitto, M | 1 |
| Napodano, M | 1 |
| de Divitiis, O | 1 |
| Leor, J | 1 |
| Battler, A | 1 |
| van den Heuvel, AF | 1 |
| Lok, DJ | 1 |
| Claessens, RJ | 1 |
| Bernink, PJ | 1 |
| Pasteuning, WH | 1 |
| Kingma, JH | 1 |
| Ishikawa, K | 1 |
| Nakai, S | 1 |
| Kanamasa, K | 1 |
| Hama, J | 1 |
| Ogawa, I | 1 |
| Oyaizu, M | 1 |
| Kimura, A | 1 |
| Yamamoto, K | 1 |
| Yabushita, H | 1 |
| Katori, R | 1 |
| Cai, PY | 1 |
| Xu, BT | 1 |
| Shen, BY | 1 |
| Nyberg, G | 1 |
| Zaslavskaia, RM | 1 |
| Kuklaeva, ZZ | 1 |
| Zhamankulov, KA | 1 |
| Teĭblium, MM | 1 |
| Kobrin, I | 2 |
| Charlon, V | 1 |
| Lindberg, E | 1 |
| Pordy, R | 1 |
| Arai, Y | 1 |
| Okazaki, T | 1 |
| Witkowska, M | 1 |
| Tracz, W | 1 |
| Kubler, G | 1 |
| Negrusz-Kawecka, M | 1 |
| Hlawaty, M | 1 |
| Olszowska, M | 1 |
| Salamon, P | 1 |
| Pitt, B | 1 |
| Ottervanger, JP | 1 |
| Wilson, JH | 1 |
| Stricker, BH | 1 |
| Tiberti, G | 1 |
| Bossi, M | 1 |
| Hirata, Y | 1 |
| Miyai, H | 1 |
| Mabuchi, Y | 1 |
| Aisaka, K | 1 |
| Zanolla, L | 1 |
| Franceschini, L | 1 |
| Rossi, L | 2 |
| Ochan, M | 1 |
| Amigoni, S | 1 |
| Zardini, P | 1 |
| Tavassoli, S | 1 |
| Yamalik, N | 1 |
| Caglayan, F | 1 |
| Caglayan, G | 1 |
| Eratalay, K | 1 |
| Tomiyama, H | 1 |
| Watanabe, G | 1 |
| Siojima, K | 1 |
| Nishikawa, E | 1 |
| Nakayama, T | 1 |
| Yamamoto, A | 1 |
| Ishikawa, Y | 1 |
| Yoshida, H | 1 |
| Doba, N | 1 |
| Baumann, J | 2 |
| Parker, AB | 1 |
| Kutishenko, PP | 1 |
| Alimova, EV | 1 |
| Slastnikova, ID | 9 |
| Kapoor, A | 1 |
| Goel, PK | 1 |
| Gupta, S | 3 |
| Schmid, CH | 1 |
| Niedzwiecki, D | 1 |
| Whiting, GW | 1 |
| Cory, D | 1 |
| Luo, D | 1 |
| Chalmers, TC | 1 |
| Boev, SS | 1 |
| Gómez Pajuelo, C | 2 |
| Gómez Sánchez, MA | 1 |
| Delgado Jiménez, JF | 1 |
| Tascón Pérez, JC | 1 |
| Rodríguez Torras, ML | 1 |
| Weber, F | 1 |
| Schneider, H | 1 |
| Urbaszek, W | 1 |
| Weintraub, M | 1 |
| Horn, J | 1 |
| Krakoff, L | 1 |
| Vetrovec, G | 1 |
| Luca, S | 1 |
| Romeo, S | 1 |
| Toal, CB | 1 |
| Baird, MG | 1 |
| Klinke, P | 1 |
| Sclarowski, S | 1 |
| Zilberman, A | 1 |
| Marmor, A | 2 |
| Kostuk, WJ | 3 |
| Lotan, C | 1 |
| Weiss, A | 1 |
| Palant, A | 2 |
| Stolero, D | 1 |
| Bélanger, L | 1 |
| Turpie, A | 1 |
| Fuertes García, A | 1 |
| Sagués Cabarro, F | 1 |
| González Juanatey, JR | 2 |
| de Lombera Romero, F | 1 |
| Luengo Fernández, E | 1 |
| Palencia Pérez, MA | 1 |
| Vargas García, R | 1 |
| Wilke Delgado, M | 1 |
| Hollenberg, NK | 1 |
| Williams, GH | 1 |
| Anderson, R | 1 |
| Zhiliaev, EV | 1 |
| Urzhumova, TV | 1 |
| Glazunov, AV | 1 |
| Sorokoletov, SM | 1 |
| Dzhanashiia, PKh | 1 |
| Houston, GD | 1 |
| Basu, SK | 1 |
| Kinsey, CD | 1 |
| Miller, AJ | 1 |
| Lahiri, A | 1 |
| Sauerbrey-Wullkopf, N | 1 |
| Kupper, W | 3 |
| Wang, X | 1 |
| Chen, K | 1 |
| Wang, W | 1 |
| Wang, S | 1 |
| Zhao, M | 1 |
| Lu, X | 1 |
| Schnellbacher, K | 1 |
| Bestehorn, HP | 1 |
| Roskamm, H | 1 |
| Tepliakov, AT | 1 |
| Rybal'chenko, EV | 1 |
| Garganeeva, AA | 1 |
| Chernov, VI | 1 |
| Yamamoto, S | 1 |
| Matsui, K | 1 |
| Sasabe, M | 1 |
| Ohashi, N | 1 |
| Heidenreich, PA | 1 |
| McDonald, KM | 1 |
| Hastie, T | 1 |
| Fadel, B | 1 |
| Hagan, V | 1 |
| Lee, BK | 1 |
| Hlatky, MA | 1 |
| Harada, T | 1 |
| Ohtaki, E | 1 |
| Toyama, S | 1 |
| Suzuki, K | 1 |
| Short, D | 1 |
| Santos Rodríguez, I | 1 |
| Sala Sánchez-Castillo, A | 1 |
| Delcán, JL | 1 |
| Pabón Osuna, P | 1 |
| Castaño Bazo, L | 1 |
| Ledesma García, C | 1 |
| Martín Luengo, C | 1 |
| de Castro del Pozo, S | 1 |
| Strano, A | 1 |
| Schenk, KE | 1 |
| Beeley, L | 1 |
| Talbot, J | 1 |
| Mérillon, JP | 1 |
| Morgant, C | 1 |
| Zygelman, M | 1 |
| Beaufils, P | 1 |
| Patart, O | 1 |
| Chapuy, JY | 1 |
| Gourgon, R | 1 |
| Oakley, GD | 1 |
| Griffo, R | 1 |
| Seriès, E | 1 |
| Laylavoix, F | 1 |
| Moskowitz, RM | 1 |
| Piccini, PA | 1 |
| Nacarelli, GV | 1 |
| Albanese, P | 1 |
| Castellaneta, G | 1 |
| Mastrocola, C | 1 |
| Baratta, L | 1 |
| Tubani, L | 1 |
| Vittori, G | 1 |
| Petrosillo, N | 1 |
| Avella, A | 1 |
| Folli, G | 1 |
| Olivieri, L | 1 |
| Radice, M | 2 |
| Mariotti, G | 1 |
| De Pasquale, B | 1 |
| Bossa, P | 1 |
| Campbell, TJ | 1 |
| Hickie, JB | 1 |
| Michell, G | 1 |
| O'Rouke, MF | 1 |
| Tamura, K | 1 |
| Ozawa, T | 2 |
| Murooka, H | 1 |
| Manca, C | 1 |
| Colla, B | 1 |
| Albertini, D | 1 |
| Dei Cas, L | 2 |
| Baldi, G | 1 |
| Visioli, O | 2 |
| Galli, MA | 2 |
| Tomov, L | 1 |
| Tomov, I | 1 |
| Todorova, M | 1 |
| Scardi, S | 3 |
| Borgioni, L | 3 |
| Alberti, E | 1 |
| Palmieri, M | 1 |
| Passarelli, A | 1 |
| Ruggeri, G | 1 |
| Zappalá, A | 1 |
| Baroni, F | 1 |
| Camerini, F | 3 |
| Frisvold, OJ | 1 |
| Skare, S | 1 |
| Chiavarelli, V | 1 |
| Vajola, FS | 1 |
| Romei, E | 1 |
| Jacovella, G | 1 |
| Martiny, W | 1 |
| Bottone, W | 1 |
| Matta, F | 1 |
| Minelli, M | 1 |
| Cerrone, G | 1 |
| Hvidt, S | 1 |
| Gudbjerg, LP | 1 |
| Kristensen, KH | 1 |
| Nielsen, I | 1 |
| Larsen, LP | 1 |
| Johansson, BW | 1 |
| Breithaupt, H | 1 |
| Walter, P | 1 |
| Orö, L | 1 |
| Pivotti, F | 1 |
| Pinamonti, B | 1 |
| Wildenhues, M | 1 |
| Steinke, L | 1 |
| Kiskery, L | 1 |
| Cafiero, M | 1 |
| Sensale, P | 1 |
| Buono, G | 1 |
| Gunther, SJ | 1 |
| Bonaduce, D | 1 |
| Carlomagno, A | 1 |
| Scarafile, P | 1 |
| Petretta, M | 1 |
| Condorelli, M | 2 |
| Germann, H | 1 |
| Ceremuzyński, L | 1 |
| Zalewski, A | 1 |
| Borkowska, J | 1 |
| Czarniak, S | 1 |
| Czerska, J | 1 |
| Sulikowska, A | 1 |
| Affaki, GS | 1 |
| Crittin, J | 1 |
| Bonan, R | 1 |
| Lown, B | 1 |
| Wilson, J | 1 |
| Hirshfeld, JW | 1 |
| Kastor, JA | 1 |
| Oliva, PB | 1 |
| Battye, R | 1 |
| Ordille, CM | 1 |
| Gola, E | 1 |
| Arena, G | 1 |
| Custurone, D | 1 |
| Tedesco, V | 1 |
| Lopresti, D | 1 |
| De Michelis, S | 1 |
| Abrile, P | 1 |
| Rosselli, P | 1 |
| D'Amore, F | 1 |
| Ferrera, U | 1 |
| Garassini, G | 1 |
| Schena, V | 1 |
| Longhini, C | 1 |
| Portaluppi, F | 1 |
| Toselli, T | 1 |
| Ravenna, F | 1 |
| Pedrielli, F | 1 |
| Laaser, U | 1 |
| Meurer, KA | 1 |
| Kaufmann, W | 1 |
| Fiorista, F | 1 |
| Rovelli, F | 1 |
| Beck, OA | 1 |
| Hochrein, H | 1 |
| Trevi, GP | 1 |
| Totaro, G | 1 |
| Raviele, A | 1 |
| Keidar, S | 1 |
| Grenadier, E | 1 |
| Medugno, G | 1 |
| Riavez, R | 1 |
| Schmitz, H | 1 |
| Schierl, W | 1 |
| Beck, O | 1 |
| Lydtin, H | 1 |
| Hernandez-Pieretti, O | 1 |
| Urbina-Quintana, A | 1 |
| de Hernandez, MI | 1 |
| de Rojas, E | 1 |
| Velasco, M | 1 |
| Hagel, FK | 1 |
| Mahlo, KL | 1 |
| Taurino, L | 1 |
| Storelli, A | 1 |
| Roma, F | 1 |
| Dünschede, HB | 1 |
| Grundei, P | 1 |
| Avogadro, BG | 1 |
| Cavanna, M | 1 |
| Liebau, H | 1 |
| Diderholm, E | 1 |
| Frithz, G | 1 |
| Gudbrandsson, T | 1 |
| Hedbäck, B | 1 |
| Höglund, C | 1 |
| Moelstad, P | 1 |
| Perk, J | 1 |
| Sverrisson, JT | 1 |
| Meluzín, J | 4 |
| Zeman, K | 1 |
| Stĕtka, F | 1 |
| Simek, P | 1 |
| Saul, PA | 1 |
| Oliver, IM | 1 |
| Russell, WA | 1 |
| Voronkov, LG | 5 |
| Lysenko, AF | 2 |
| Glezer, GA | 1 |
| Moskalenko, NP | 1 |
| Gaponenko, VA | 1 |
| Stoliarov, AS | 1 |
| Saitova, RA | 1 |
| Simbirina, TE | 1 |
| Neĭman, DIu | 1 |
| Chilikina, ON | 1 |
| Akhmetova, MG | 1 |
| Babaev, AB | 1 |
| Nyberg, GF | 1 |
| Blake, P | 2 |
| Lewis, JA | 2 |
| DiBianco, R | 2 |
| Schoomaker, FW | 1 |
| Singh, JB | 1 |
| Awan, NA | 1 |
| Bennett, T | 1 |
| Canosa, FL | 1 |
| Kawanishi, DT | 4 |
| Bamrah, VS | 1 |
| Barry, W | 1 |
| Seriakov, VV | 2 |
| Konovalova, GG | 1 |
| Lankin, VZ | 1 |
| van der Does, R | 2 |
| Eberhardt, R | 2 |
| Derr, I | 2 |
| Ehmer, B | 2 |
| Iriarte, MM | 1 |
| Fernández Vidal, P | 1 |
| el-Tamimi, H | 1 |
| Davies, GJ | 1 |
| Bortolotti, M | 1 |
| Labriola, E | 1 |
| Bacchelli, S | 1 |
| Degli Esposti, D | 1 |
| Sarti, P | 1 |
| Brunelli, F | 1 |
| Del Campo, L | 1 |
| Barbara, L | 1 |
| Revenko, VN | 1 |
| Bezu, GG | 1 |
| Grib, LF | 1 |
| Razmadze, MV | 1 |
| Rabkin, IE | 1 |
| Levina, GA | 1 |
| Shabalkin, BV | 1 |
| Dobrotvorskaia, TE | 2 |
| Rettig, GF | 2 |
| Jakob, M | 2 |
| Koch, HP | 1 |
| Shaheen, BE | 1 |
| Alaniz, C | 1 |
| Bobrov, VA | 1 |
| Simorot, VN | 1 |
| Woodcock, BG | 1 |
| Thürmann, PA | 1 |
| Pfleiderer, S | 1 |
| Reifart, N | 1 |
| Bristol, DR | 1 |
| Vandenburg, MJ | 1 |
| Lazzeroni, E | 1 |
| Morozzi, L | 1 |
| Campana, M | 1 |
| Botti, G | 1 |
| Manak, NA | 2 |
| Laziuk, DG | 1 |
| Karoza, AE | 1 |
| Karpova, IS | 1 |
| Prokopchuk, VP | 1 |
| Efuni, SN | 1 |
| Katz, J | 1 |
| Rotstein, I | 1 |
| Ben Yehuda, A | 1 |
| Barak, S | 1 |
| Glushko, LV | 1 |
| Zeĭnalov, FI | 1 |
| Malov, AG | 1 |
| Sergienko, VB | 1 |
| Rubanovich, AI | 1 |
| Guy, S | 2 |
| Akhras, F | 2 |
| Berry, SC | 1 |
| Readman, A | 1 |
| Ratcliffe, M | 1 |
| Godley, M | 1 |
| Sen, S | 2 |
| Heisel, A | 2 |
| Reid, CL | 2 |
| Morrison, EC | 1 |
| Rahimtoola, SH | 2 |
| Grum, DF | 1 |
| Azmy, SS | 1 |
| Giudici, V | 1 |
| Albertini, A | 1 |
| Mannarini, A | 1 |
| Höher, M | 1 |
| Seibold, H | 1 |
| Ueberbacher, HJ | 1 |
| Patyna, WD | 1 |
| Krepp, P | 1 |
| Puespoek, J | 1 |
| Neuhaus, R | 1 |
| Hilbich, K | 1 |
| Bulitta, M | 1 |
| Rittinghausen, R | 1 |
| Borgia, MC | 1 |
| De Paola, G | 1 |
| Di Folco, G | 1 |
| Calpicchio, A | 1 |
| Chumburidze, VB | 1 |
| Zubiashvili, TG | 1 |
| Gogicheva, MI | 1 |
| Berulava, II | 1 |
| Cacciatore, L | 1 |
| Cerio, R | 1 |
| Ciarimboli, M | 1 |
| Cocozza, M | 1 |
| Coto, V | 1 |
| D'Alessandro, A | 1 |
| D'Alessandro, L | 1 |
| Grattarola, G | 1 |
| Imparato, L | 1 |
| Lingetti, M | 1 |
| Stroganova, NP | 1 |
| Pandhi, P | 1 |
| Biswas, NR | 1 |
| Wahi, PL | 1 |
| Sharma, PL | 1 |
| Kupnovyts'ka, IH | 1 |
| Chuklin, SM | 1 |
| Hellstrom, HR | 1 |
| Alfiero, R | 1 |
| Schroeder, P | 1 |
| Thaulow, E | 1 |
| Erikssen, J | 1 |
| Lund-Johansen, P | 1 |
| Currie, P | 1 |
| Saltissi, S | 1 |
| McGibney, D | 1 |
| Navarro Estrada, J | 1 |
| Saglietti, H | 1 |
| Dimarco, M | 1 |
| Casabé, H | 1 |
| Oliveri, R | 1 |
| Caponnetto, S | 2 |
| Canale, C | 1 |
| Terrachini, V | 1 |
| Masperone, MA | 1 |
| Bruzzone, F | 1 |
| Hogg, KJ | 2 |
| Hornung, RS | 2 |
| Hillis, WS | 2 |
| Grant, P | 2 |
| Singh, SP | 2 |
| Vetrovec, GW | 7 |
| Dailey, S | 1 |
| Kay, G | 1 |
| Epstein, A | 1 |
| Plumb, V | 1 |
| Novák, M | 2 |
| Koukalová, H | 2 |
| Serizawa, T | 1 |
| Ikenouchi, H | 1 |
| Sugimoto, T | 1 |
| France, LA | 1 |
| Kay, R | 1 |
| Yoneda, S | 2 |
| Kako, T | 2 |
| Koketsu, M | 1 |
| Fujinami, T | 2 |
| Karlson, BW | 1 |
| Herlitz, J | 1 |
| Nilsson, JE | 1 |
| Olsson, G | 1 |
| Gupta, AK | 1 |
| Gupta, P | 1 |
| Duckeck, W | 1 |
| Schwarzkopf, HJ | 1 |
| Bleifeld, W | 2 |
| Kett, KG | 1 |
| McAuliffe, LS | 1 |
| Roberts, M | 1 |
| Hegarty, P | 1 |
| Deedwania, PC | 1 |
| Carbajal, EV | 1 |
| Nelson, JR | 1 |
| Hait, H | 1 |
| Gonzalez, JI | 1 |
| Kolb, R | 1 |
| Rudorf, J | 1 |
| Uberbacher, HJ | 1 |
| Slavich, G | 1 |
| Rosenfeld, M | 1 |
| Feruglio, GA | 1 |
| Roncarolo, P | 1 |
| Giordano, MP | 1 |
| Bory, M | 2 |
| Gillet, T | 1 |
| Bonnet, JL | 2 |
| Sebag, CL | 1 |
| Djiane, P | 1 |
| Habib, G | 1 |
| Furkalo, NK | 3 |
| Sokolov, NF | 1 |
| Bahls, FH | 1 |
| Ozuna, J | 1 |
| Ritchie, DE | 1 |
| Nechvátal, L | 1 |
| Groch, L | 1 |
| Spinarová, L | 1 |
| Kozyreva, MP | 1 |
| Simkhaev, LS | 2 |
| Vakulovskaia, MK | 1 |
| Burton, JR | 1 |
| Haraphongse, M | 1 |
| Hsu, L | 1 |
| Kappagoda, CT | 1 |
| Rossall, RE | 1 |
| Schlaut, B | 1 |
| Senaratne, MP | 1 |
| Challenor, VF | 3 |
| Barillà, F | 1 |
| Pelliccia, F | 1 |
| Valente, A | 1 |
| Cianfrocca, C | 1 |
| Romeo, F | 1 |
| Reale, A | 1 |
| Kukes, VG | 2 |
| Rumiantsev, AS | 2 |
| Gneushev, ET | 1 |
| Al'perovich, BR | 2 |
| Svetyĭ, LI | 1 |
| Nasyrov, MN | 1 |
| Taratuta, TV | 1 |
| Fabbiocchi, F | 15 |
| Ravagnani, P | 3 |
| Montorsi, P | 15 |
| Loaldi, A | 15 |
| De Cesare, N | 14 |
| Polese, A | 15 |
| Guazzi, MD | 14 |
| Monpère, C | 1 |
| Brochier, M | 1 |
| Demange, J | 1 |
| Ducloux, G | 1 |
| Warin, JF | 1 |
| Dalla-Volta, S | 1 |
| Maraglino, G | 1 |
| Della-Valentina, P | 1 |
| Viena, P | 1 |
| Desideri, A | 1 |
| Cozzi, S | 3 |
| Annoni, L | 1 |
| Shell, WE | 1 |
| Dobson, D | 1 |
| Timogiannakis, GB | 1 |
| Kourouklis, CB | 1 |
| Chlapoutakis, EN | 1 |
| Toutouzas, PK | 1 |
| Kreuzer, J | 1 |
| von Hodenberg, E | 1 |
| Jahn, L | 1 |
| Kübler, W | 1 |
| Gibson, RS | 1 |
| DeWood, MA | 3 |
| Crawford, MH | 1 |
| Messineo, FC | 1 |
| Raby, K | 1 |
| Brunelli, C | 1 |
| Spallarossa, P | 1 |
| Ghigliotti, G | 1 |
| Caudullo, M | 1 |
| Iannetti, M | 1 |
| Zezulka, AV | 1 |
| Sharma, S | 1 |
| Mitrovic, V | 1 |
| Rieckmann, C | 1 |
| Kornecki, P | 1 |
| Burger, KJ | 1 |
| Welzel, D | 1 |
| Schlepper, M | 1 |
| Goldhammer, E | 1 |
| Sharma, SK | 2 |
| Rice, KR | 1 |
| Gervino, E | 1 |
| Jarisch, WR | 1 |
| Guliev, AB | 2 |
| Lupanov, VP | 2 |
| Kocherga, EIu | 2 |
| Glukhovtsev, EV | 2 |
| Gratsianskiĭ, NA | 2 |
| Vlay, SC | 1 |
| Olson, LC | 1 |
| Lupínek, Z | 2 |
| Kimball, BP | 1 |
| Mildenberger, RR | 1 |
| Lefkowitz, CA | 1 |
| Ross, BL | 1 |
| Houle, S | 1 |
| McLaughlin, PR | 1 |
| Pedersen, TR | 1 |
| Kantor, M | 1 |
| Rumiantsev, DO | 4 |
| Piotrovskiĭ, VK | 6 |
| Egorov, LV | 1 |
| Vishnevskiĭ, VI | 1 |
| Gromnatskiĭ, NI | 1 |
| Wolbach, RA | 1 |
| Sorkin, EM | 2 |
| Clissold, SP | 1 |
| Brill, DM | 1 |
| Fozzard, HA | 1 |
| Berman, BA | 1 |
| Ross, RN | 1 |
| Eldridge, JE | 1 |
| Burdick, DC | 1 |
| Hossack, KF | 4 |
| Shibata, S | 1 |
| Satake, N | 1 |
| Kurahashi, K | 1 |
| Ohtsuka, M | 1 |
| Hullett, FJ | 1 |
| Potkin, SG | 1 |
| Levy, AB | 1 |
| Ciasca, R | 1 |
| Kinnard, DR | 3 |
| Harris, M | 3 |
| Thadani, U | 2 |
| Tijssen, JG | 8 |
| Choong, CY | 5 |
| Freedman, SB | 2 |
| Roubin, GS | 5 |
| Shen, WF | 5 |
| Bautovich, GJ | 1 |
| Harris, PJ | 6 |
| Kelly, DT | 7 |
| Murphy, GW | 1 |
| Berzuini, C | 1 |
| Poma, E | 2 |
| Ghio, S | 3 |
| Sciré, A | 1 |
| Cioffi, P | 1 |
| Harron, DW | 1 |
| Deering, AH | 1 |
| Scott, M | 1 |
| McMahon, M | 1 |
| Shanks, RG | 1 |
| Joly, P | 1 |
| Coutelen, N | 1 |
| Chambers, J | 1 |
| Jefferies, S | 1 |
| Satoh, Y | 1 |
| Taniguchi, K | 2 |
| Hofmann, T | 1 |
| Kasper, W | 1 |
| Geibel, A | 1 |
| Wollschläger, H | 1 |
| Meinertz, T | 1 |
| Just, H | 1 |
| Renwick, AG | 1 |
| George, CF | 3 |
| Picca, M | 1 |
| Azzollini, F | 1 |
| Cereda, A | 1 |
| Pelosi, G | 1 |
| Burger, W | 1 |
| Neidel, S | 1 |
| Brunke, W | 1 |
| Anders, G | 1 |
| Müller, JH | 1 |
| Abet, U | 1 |
| Bodammer, M | 1 |
| Abernethy, DR | 1 |
| West, TW | 2 |
| Giles, TD | 1 |
| Raizner, AE | 1 |
| Deedwania, P | 1 |
| Cheitlin, M | 1 |
| Das, S | 1 |
| Pool, P | 1 |
| Singh, J | 1 |
| Pasternak, R | 1 |
| Carabello, B | 1 |
| Lee, P | 1 |
| Jackson, N | 2 |
| Singh, S | 1 |
| Doherty, J | 1 |
| Udhoji, V | 1 |
| Smith, K | 1 |
| Gorwit, J | 1 |
| Bekheit, S | 1 |
| Mather, S | 1 |
| Stein, W | 1 |
| San Fellippo, J | 1 |
| Hearan, P | 1 |
| Nesto, R | 1 |
| Gerber, FR | 1 |
| Readman, AS | 1 |
| Vodop'ianova, RS | 2 |
| Urumbaev, RK | 2 |
| Matsevich, SIu | 1 |
| al-Khafaji, M | 1 |
| al-Salem, IH | 1 |
| Guazzi, M | 2 |
| Huang, L | 1 |
| Zhu, SJ | 1 |
| Xin, Q | 1 |
| Higginbotham, MB | 2 |
| Morris, KG | 2 |
| Coleman, RE | 2 |
| Cobb, FR | 2 |
| Douard, H | 1 |
| Mora, B | 1 |
| Karpov, RS | 1 |
| Idrisova, EM | 1 |
| Dudko, VA | 1 |
| Shapiro, W | 1 |
| Narahara, KA | 1 |
| Kostis, JB | 1 |
| Thandroyen, F | 1 |
| Zohman, LR | 1 |
| Rybanovich, AI | 1 |
| Chernousova, TV | 1 |
| Mironova, IIu | 1 |
| Bittar, N | 2 |
| Fleischer, K | 1 |
| Forster, A | 1 |
| Mohler, C | 1 |
| Schulz, PC | 1 |
| Ajisaka, R | 1 |
| Masuoka, T | 1 |
| Fujita, T | 1 |
| Matsumoto, R | 1 |
| Iida, K | 1 |
| Sugishita, Y | 1 |
| Ito, I | 1 |
| Takeda, T | 1 |
| Toyama, H | 1 |
| Ishikawa, N | 1 |
| Kamihara, S | 2 |
| Iwase, M | 1 |
| Miyahara, T | 2 |
| Saito, H | 1 |
| Sugiyama, S | 1 |
| DeCesare, N | 1 |
| Bartorelli, A | 9 |
| Folli, A | 2 |
| Kohketsu, M | 1 |
| Peart, I | 1 |
| Bullock, RE | 1 |
| Albers, C | 1 |
| Hall, RJ | 1 |
| Goldberger, J | 3 |
| Riaboko'n, OS | 1 |
| Robinson, K | 1 |
| Manfredi, M | 1 |
| Sharaeva, ML | 1 |
| Boden, WE | 2 |
| Korr, KS | 1 |
| Bough, EW | 1 |
| Epstein, SE | 1 |
| Shub, C | 1 |
| Vlietstra, RE | 1 |
| McGoon, MD | 1 |
| Hanger, KH | 1 |
| Assey, ME | 2 |
| Cheron, P | 1 |
| Frais, MA | 5 |
| Lipkin, DP | 1 |
| Massie, BM | 1 |
| Babarskene, RS | 1 |
| Bloznialene, KP | 1 |
| Bluzhaĭte, II | 1 |
| Gaulene, AP | 1 |
| Kolski, H | 1 |
| Yvenou, L | 1 |
| Hartwell, BL | 1 |
| Mark, JB | 1 |
| Parker, VE | 4 |
| Pflugfelder, P | 1 |
| O'Keefe, JC | 1 |
| Creamer, JE | 1 |
| Banim, SO | 1 |
| Sansa, M | 1 |
| Cernigliaro, C | 1 |
| Bolognese, L | 1 |
| Bongo, SA | 1 |
| Rossi, P | 1 |
| de Feijter, PJ | 2 |
| Keegan, J | 1 |
| Cunningham, D | 1 |
| Quyyumi, A | 1 |
| Crean, P | 2 |
| Park, A | 1 |
| Ware, JH | 1 |
| Gore, JM | 1 |
| Eich, RH | 1 |
| Pietro, DA | 1 |
| Sharma, SC | 1 |
| Corder, CN | 1 |
| Eich, R | 1 |
| McGrew, FA | 1 |
| Paulk, EA | 1 |
| Zellner, S | 1 |
| Casolo, GC | 1 |
| Balli, E | 1 |
| Poggesi, L | 1 |
| Gensini, GF | 1 |
| Ram, J | 1 |
| Thomson, A | 2 |
| Stecken, F | 1 |
| De Charry, E | 1 |
| Therain, F | 1 |
| Oblet, B | 1 |
| Poirot, G | 1 |
| Daumas, PL | 1 |
| Cornuau, C | 1 |
| Valois, M | 1 |
| Anderson, P | 1 |
| Bradley, AB | 1 |
| Baim, DS | 1 |
| Allen, J | 1 |
| Pool, PE | 1 |
| Leitold, M | 1 |
| Hader, S | 1 |
| Hayata, N | 1 |
| Matsuguchi, T | 1 |
| Handler, CE | 1 |
| Rosenthal, E | 1 |
| Tsagadopoulos, D | 1 |
| Najm, Y | 1 |
| Mauser, M | 2 |
| Lopez, LM | 2 |
| Morse, JR | 2 |
| Klinke, WP | 1 |
| Kvill, L | 1 |
| Dempsey, EE | 1 |
| Grace, M | 1 |
| Friedel, HA | 1 |
| Papa, M | 2 |
| Gallucci, F | 1 |
| Leosco, D | 1 |
| Covelluzzi, F | 2 |
| Borgnino, C | 1 |
| Cicatiello, M | 2 |
| Cosentino, F | 1 |
| Crake, T | 3 |
| Riabokon', OS | 3 |
| Lai, C | 1 |
| Onnis, E | 1 |
| Pirisi, R | 1 |
| Orani, E | 1 |
| Delogu, G | 1 |
| Singer, M | 1 |
| Trotman, IF | 1 |
| Román, O | 1 |
| Gac, JC | 1 |
| Ramírez, J | 1 |
| Rebolledo, H | 1 |
| Valenzuela, MA | 1 |
| Antunez, C | 1 |
| de Buitleir, M | 2 |
| MacLeod, K | 1 |
| Ford, M | 1 |
| Gillen, G | 1 |
| Elliott, AT | 1 |
| Uusitalo, A | 1 |
| Arstila, M | 1 |
| Härkönen, R | 1 |
| Keyriläinen, O | 1 |
| Rytkönen, U | 1 |
| Wendelin, H | 1 |
| Atkins, JM | 1 |
| Spacek, R | 1 |
| Kozák, P | 1 |
| Hes, I | 1 |
| Stárek, A | 1 |
| Gibelli, G | 1 |
| Negrini, M | 1 |
| Mazzocchi, F | 1 |
| Prina, L | 1 |
| Pollavini, P | 1 |
| Saito, S | 1 |
| Tamura, Y | 1 |
| Moriuchi, M | 1 |
| Honye, J | 1 |
| Kamata, T | 1 |
| Kaseda, N | 1 |
| Tsuji, M | 1 |
| Yumikura, S | 1 |
| Hibiya, K | 1 |
| Ozawa, Y | 1 |
| Simsarian, G | 1 |
| Amisola, Y | 1 |
| Gonzales, A | 1 |
| Boje, KM | 1 |
| Fung, HL | 1 |
| Yoshitomi, K | 1 |
| Parker, JO | 1 |
| Sandberg, M | 1 |
| Cole, S | 1 |
| Procacci, PM | 1 |
| Terry, R | 1 |
| Gel'fgat, EB | 3 |
| Muradova, SA | 1 |
| Iagizarova, NM | 1 |
| Abdullaeva, IA | 1 |
| Metra, M | 1 |
| Nodari, S | 1 |
| Nordio, G | 1 |
| Bonandi, L | 1 |
| Raddino, R | 1 |
| Feroldi, P | 1 |
| Reiniger, G | 2 |
| Shimizu, Y | 1 |
| Takayama, Y | 1 |
| Hayashi, T | 1 |
| Ito, Y | 1 |
| Abe, M | 1 |
| Matsuda, M | 1 |
| Ida, T | 1 |
| Sakakibara, T | 1 |
| Obunai, Y | 1 |
| Riva, S | 1 |
| van Es, GA | 1 |
| Lupínková, Z | 1 |
| Janousek, S | 1 |
| Oleksowicz, L | 1 |
| Bruckner, HW | 1 |
| Zamotaev, IP | 1 |
| Venediktova, MG | 1 |
| Zakharova, GIu | 1 |
| Romano, M | 1 |
| Di Maro, T | 1 |
| Carella, G | 1 |
| Cotecchia, MR | 1 |
| Caiazzo, MR | 1 |
| de Arcangelis, E | 1 |
| Chiariello, M | 1 |
| Karasawa, A | 1 |
| Kubo, K | 1 |
| Shuto, K | 1 |
| Oka, T | 1 |
| Nakamizo, N | 1 |
| Lage Bouzamayor, B | 1 |
| Eguileta Martínez, T | 1 |
| Zubizarreta Alberdi, R | 1 |
| Gil de la Peña, M | 1 |
| Bracchetti, D | 1 |
| Sangiorgio, P | 1 |
| Fulvi, M | 1 |
| Rubboli, A | 1 |
| Halawa, B | 1 |
| Mazurek, W | 1 |
| Umezawa, S | 1 |
| Takeuchi, J | 1 |
| Tejerina Lobo, JM | 1 |
| Mencia Fernandez, C | 1 |
| Martos Molino, F | 1 |
| Simarro Martin-Ambrosio, E | 1 |
| Weihrauch, T | 1 |
| Frishman, W | 1 |
| Charlap, S | 5 |
| Kimmel, B | 3 |
| Teicher, M | 1 |
| Cinnamon, J | 1 |
| Allen, L | 2 |
| Strom, J | 2 |
| Boström, PA | 1 |
| Toyosaki, N | 1 |
| Toyo-oka, T | 1 |
| Natsume, T | 1 |
| Katsuki, T | 1 |
| Tateishi, T | 1 |
| Yaginuma, T | 1 |
| Rettig, G | 1 |
| Vogel, W | 1 |
| Schieffer, H | 1 |
| Bette, L | 1 |
| Fazzini, PF | 1 |
| Pucci, PD | 1 |
| Santoro, GM | 1 |
| Buonamici, P | 1 |
| Buzzigoli, A | 1 |
| Sarro, F | 1 |
| Quyyumi, AA | 2 |
| Wright, CM | 1 |
| Mockus, LJ | 1 |
| Luca, C | 1 |
| Marchini, F | 1 |
| Pacei, E | 1 |
| Mockus, L | 1 |
| Katz, AM | 1 |
| Leach, NM | 1 |
| Trigulova, RKh | 2 |
| Kerkkamp, HJ | 5 |
| Viersma, JW | 1 |
| de Beijer, JM | 1 |
| Hayward, R | 1 |
| Hunter, GJ | 1 |
| Swanton, H | 1 |
| Cyran, J | 1 |
| Kuthan, P | 1 |
| Remien, P | 1 |
| Fischer, J | 1 |
| Henselmann, L | 1 |
| Leonowicz, K | 1 |
| Niemczuk-Lopaszyńska, E | 1 |
| Deptulski, T | 1 |
| Zelechowska, K | 1 |
| Asenjo, R | 1 |
| Valenzuela, P | 1 |
| Sherman, D | 1 |
| Feinfeld, DA | 1 |
| Fletcher, PJ | 2 |
| Freedman, B | 1 |
| Alpert, DA | 1 |
| Lawson, WE | 1 |
| Allely, MC | 1 |
| Alps, BJ | 1 |
| Shimizu, K | 1 |
| Ogawa, KB | 1 |
| Lee, JD | 1 |
| Hara, A | 1 |
| Nakamura, T | 1 |
| Schneeweiss, A | 2 |
| Erath, A | 1 |
| Reuschel-Janetschek, E | 2 |
| Shaw, DR | 1 |
| Misan, GM | 1 |
| Johnson, RD | 1 |
| Vuori, I | 1 |
| Hämäläinen, H | 1 |
| Pietilä, J | 1 |
| Kallio, V | 1 |
| Griffin, B | 1 |
| Timmis, AD | 1 |
| Araujo, LI | 1 |
| Camici, P | 1 |
| Spinks, TJ | 1 |
| Jones, T | 1 |
| Maseri, A | 1 |
| James, WE | 1 |
| Leman, RB | 1 |
| Burgess, CD | 1 |
| Kugiyama, K | 1 |
| Horio, Y | 1 |
| Morikami, Y | 1 |
| Fujii, H | 2 |
| Koga, Y | 1 |
| Kojima, A | 1 |
| Takahashi, M | 1 |
| Yamakado, T | 1 |
| Higashiyama, S | 1 |
| Nakano, T | 2 |
| Takezawa, H | 2 |
| McGill, D | 1 |
| McKenzie, W | 1 |
| McCredie, M | 1 |
| Shapiro, EP | 1 |
| Chandra, NC | 1 |
| O'Hara, MJ | 2 |
| Phillippides, G | 1 |
| Klein, N | 1 |
| Mangini, SG | 2 |
| Stowe, HO | 1 |
| van der Wall, EE | 3 |
| van Rijk, PP | 3 |
| Reiber, JH | 3 |
| Bom, N | 3 |
| Lubsen, JC | 2 |
| Ferlinz, J | 1 |
| Erlemeier, HH | 1 |
| Lange, S | 1 |
| Tan, WP | 1 |
| Ku, FS | 1 |
| Liu, YY | 1 |
| Crean, PA | 1 |
| Gill, JB | 1 |
| Cairns, JA | 1 |
| McEwan, MP | 1 |
| Madhu, S | 1 |
| Singh Verma, NP | 1 |
| Singh, B | 1 |
| Abasova, LI | 3 |
| Zaĭtseva, VI | 1 |
| Chhetri, MK | 2 |
| Sen, P | 1 |
| Roy, RP | 1 |
| Dutta, A | 1 |
| White, HD | 2 |
| Wynne, J | 2 |
| Joy, M | 1 |
| Cairns, AW | 1 |
| Sprigings, D | 1 |
| Artiaco, D | 1 |
| Santangelo, L | 1 |
| Koide, M | 1 |
| Tsunekawa, A | 1 |
| Noda, S | 1 |
| Piovella, C | 1 |
| Mastropasqua, F | 1 |
| Caporale, R | 1 |
| Caiati, C | 1 |
| Zanna, D | 1 |
| Chiddo, A | 1 |
| Hanet, C | 1 |
| Pardonge-Lavenne, E | 1 |
| Carboni, GP | 2 |
| D'Ermo, M | 2 |
| Tishler, M | 1 |
| Armon, S | 1 |
| Graham, DJ | 1 |
| Finlayson, JR | 1 |
| Myrhed, M | 1 |
| Wiholm, BE | 1 |
| Mattioli, G | 1 |
| Cioni, G | 1 |
| Andreoli, C | 1 |
| Bosso, JV | 1 |
| Gazzara, PC | 1 |
| Rosati, M | 1 |
| Strizhak, IG | 1 |
| Shanygina, KI | 1 |
| Novikova, NA | 1 |
| Chernysheva, IN | 1 |
| Kasymkhodzhaev, ASh | 1 |
| Nishida, S | 2 |
| Horie, M | 2 |
| Kubota, J | 2 |
| Werdan, K | 1 |
| Erdmann, E | 1 |
| Autenrieth, G | 1 |
| Russek, HI | 1 |
| Maresta, A | 1 |
| Marzocchi, A | 1 |
| Capucci, A | 1 |
| Galiè, N | 1 |
| Marrozzini, C | 1 |
| Magnani, B | 1 |
| Ostapiuk, FE | 1 |
| Al'khavazha, Kh | 1 |
| Kahn, JK | 1 |
| Anderson, SD | 1 |
| Midtbo, KA | 1 |
| Müller, P | 1 |
| Nitsch, J | 1 |
| Kuhnen, R | 1 |
| Lüderitz, B | 1 |
| Hutton, BF | 1 |
| Turitto, G | 1 |
| Pezzella, A | 1 |
| Prati, PL | 1 |
| Korabel'shchikova, NI | 2 |
| Rishko, NV | 2 |
| Bichko, MV | 2 |
| Bos, RJ | 1 |
| ten Katen, HJ | 1 |
| Vanhaleweyk, G | 1 |
| Johnston, DL | 1 |
| Lesoway, R | 1 |
| Humen, DP | 1 |
| Kendall, MJ | 1 |
| Horton, RC | 1 |
| Touloukian, JE | 1 |
| Schroeder, JS | 1 |
| Fino, E | 1 |
| Colonna, L | 1 |
| Roos, JP | 1 |
| Blum, R | 1 |
| Eisenberg, PR | 1 |
| Lee, RG | 1 |
| Biello, DR | 1 |
| Geltman, EM | 1 |
| Komar, OA | 1 |
| Batyrbekova, LM | 1 |
| Kulikova, TV | 1 |
| Ganz, P | 1 |
| Koslowski, J | 1 |
| Bekhbudova, DA | 1 |
| Ostrovskaia, TP | 1 |
| Gelman, JS | 1 |
| Scheidt, S | 1 |
| Lewinter, MM | 1 |
| Hermanovich, J | 1 |
| Venkataraman, K | 1 |
| Freedman, D | 2 |
| Gheorghiade, M | 1 |
| St Clair, C | 1 |
| St Clair, J | 1 |
| Schwemer, G | 1 |
| Kenny, J | 1 |
| Rubin, MR | 1 |
| Holland, JP | 1 |
| Mehta, JL | 1 |
| Stroh, J | 1 |
| Dorsa, F | 1 |
| Flugelman, MY | 1 |
| Shefer, A | 1 |
| Halon, DA | 1 |
| Witt, H | 1 |
| Gotsman, MS | 1 |
| Anandadas, JA | 1 |
| Narayan, TR | 1 |
| Banerjee, AK | 1 |
| Mancuso, L | 1 |
| Bondì, F | 1 |
| Marchì, S | 1 |
| Iacona, MA | 1 |
| Di Gregorio, L | 1 |
| Lambert, CR | 1 |
| Mattioli, M | 1 |
| Lioy, E | 1 |
| Biffani, G | 1 |
| Kramer, P | 1 |
| Namekawa, M | 1 |
| Fulton, KL | 1 |
| Corbett, JR | 1 |
| Croft, CH | 1 |
| Braun, S | 1 |
| Terdiman, R | 1 |
| Berenfeld, D | 1 |
| Laniado, S | 1 |
| Konishi, T | 1 |
| Tokuyasu, Y | 1 |
| Tordjman, K | 1 |
| Rosenthal, T | 2 |
| Bursztyn, M | 2 |
| Coplin, B | 1 |
| Bagger, JP | 1 |
| Nielsen, TT | 1 |
| Grossman, E | 1 |
| Sachs, R | 1 |
| Shakarova, SSh | 1 |
| Bertazzoni, G | 1 |
| Migliau, G | 1 |
| Pantani, E | 1 |
| De Castro, S | 1 |
| Rosini, A | 1 |
| Wagner, S | 1 |
| Fazekas, T | 1 |
| Cantor, A | 1 |
| Crital, N | 1 |
| Buskila, D | 1 |
| Prajgrod, G | 1 |
| Gueron, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prognostic Models for People With Stable Coronary Artery Disease[NCT01609465] | 300,000 participants (Anticipated) | Observational | 2010-01-31 | Active, not recruiting | |||
| A European Multicentre Double-blind Placebo-controlled Phase III Trial of Nilvadipine in Mild to Moderate Alzheimer's Disease[NCT02017340] | Phase 3 | 511 participants (Actual) | Interventional | 2013-04-24 | Completed | ||
| [NCT00000478] | Phase 3 | 0 participants | Interventional | 1990-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
91 reviews available for nifedipine and Angina Pectoris
| Article | Year |
|---|---|
The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Comorbidity; Cor | 2008 |
Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis.
Topics: Amlodipine; Angina Pectoris; Asian People; Calcium Channel Blockers; Coronary Vasospasm; Dihydropyri | 2010 |
New advances in the field of calcium channel antagonists: cardiovascular effects and structure-activity relationships.
Topics: Angina Pectoris; Animals; Calcium Channel Blockers; Calcium Channels; Cardiovascular System; Diltiaz | 2003 |
Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris.
Topics: Angina Pectoris; Antihypertensive Agents; Calcium Channel Blockers; Delayed-Action Preparations; Hum | 2006 |
[Indications for calcium channel antagonist therapy according to the latest large clinical trials].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Calcium Channel Blockers; Cli | 2005 |
[Clinical experience with nifedipine in the treatment of angina pectoris in Japan].
Topics: Angina Pectoris; Humans; Japan; Nifedipine; Vasodilator Agents | 2006 |
[Nifedipine: a novel vasodilator].
Topics: Angina Pectoris; Animals; Antihypertensive Agents; Coronary Vessels; Humans; Nifedipine; Vasodilator | 2006 |
Understanding the calcium channel blockers.
Topics: Action Potentials; Angina Pectoris; Animals; Arrhythmias, Cardiac; Arteriosclerosis; Calcium; Calciu | 1984 |
Calcium blocking agents. New directions in the treatment of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium; Diltiazem; Humans; Ion Channels; Myocardial C | 1980 |
Clinical pharmacology of beta-adrenoceptor antagonism in angina pectoris: an overview.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Airway Obstruction; Angina Pectoris; Anti | 1980 |
Verapamil therapy for stable and unstable angina pectoris: calcium channel antagonists in perspective.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; De | 1982 |
Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Thera | 1982 |
Clinical value of calcium antagonists in treatment of cardiovascular disorders.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calciu | 1983 |
[Use of calcium antagonists in the therapy of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium; Coronary Disease; Diltiazem; Drug Therapy, Co | 1983 |
Anti-anginal, electrophysiologic and hemodynamic effects of combined beta-blocker/calcium antagonist therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Drug T | 1983 |
Isosorbide dinitrate in clinical practice.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Clinical Tri | 1984 |
Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.
Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Arrhythmias, Cardiac; Benzazepines; Calcium; Car | 1980 |
Calcium blocking drugs for angina pectoris.
Topics: Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Coronary Circulation; Diltiazem | 1982 |
Calcium antagonists in the treatment of individuals with ischemic heart disease.
Topics: Angina Pectoris; Angina Pectoris, Variant; Calcium; Calcium Channel Blockers; Coronary Disease; Dilt | 1982 |
Mechanism of action of calcium-channel-blocking agents.
Topics: Action Potentials; Angina Pectoris; Arrhythmias, Cardiac; Blood Vessels; Calcium; Calcium Channel Bl | 1982 |
Calcium channel blocking drugs.
Topics: Anesthesia; Angina Pectoris; Animals; Calcium; Calcium Channel Blockers; Cardiomyopathy, Hypertrophi | 1983 |
Clinical pharmacology of calcium entry blockers.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; Diltiazem; Humans; Ion Cha | 1983 |
Slow channel blockers.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Chemical Phenomena; Chemistry; Cons | 1983 |
Calcium antagonists. Clinical use in the treatment of systemic hypertension.
Topics: Angina Pectoris; Calcium Channel Blockers; Diltiazem; Humans; Hypertension; Nifedipine; Verapamil | 1983 |
[The role of calcium antagonists in the treatment of classical angina pectoris].
Topics: Angina Pectoris; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Exercise Test; Humans; Ni | 1983 |
Nifedipine.
Topics: Angina Pectoris; Angina Pectoris, Variant; Humans; Nifedipine; Pyridines | 1983 |
Nifedipine for angina and acute myocardial ischaemia.
Topics: Acute Disease; Angina Pectoris; Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Di | 1983 |
Use of calcium channel blocking agents in angina pectoris.
Topics: Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Clinical Trials as Topic; Dilti | 1984 |
Nifedipine in acute myocardial infarction.
Topics: Angina Pectoris; Animals; Clinical Enzyme Tests; Clinical Trials as Topic; Creatine Kinase; Dogs; Do | 1984 |
New antiarrhythmic drugs.
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Blood Circulation; Bradycardia; Diltiazem; Half | 1983 |
The clinical uses of calcium antagonists.
Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel B | 1982 |
Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris.
Topics: Angina Pectoris; Animals; Blood Pressure; Clinical Trials as Topic; Diltiazem; Dogs; Dose-Response R | 1982 |
[Treatment of angina pectoris with calcium antagonists].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Therapy, Combination; E | 1982 |
Effects of antianginal agents on the coronary circulation.
Topics: Angina Pectoris; Animals; Arteriosclerosis; Calcium; Collateral Circulation; Coronary Circulation; C | 1981 |
Syndrome of symptomatic coronary arterial spasm with nearly normal coronary arteriograms.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Angiography; Coronary Vessels; Electrocardiog | 1980 |
Calcium antagonists.
Topics: Action Potentials; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Bronchial Spasm; | 1980 |
S-T segment elevation and coronary spasm in response to exercise.
Topics: Angina Pectoris; Angina Pectoris, Variant; Constriction, Pathologic; Coronary Angiography; Diltiazem | 1981 |
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Confidence Intervals; Coronary Dise | 1995 |
Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina.
Topics: Aging; Angina Pectoris; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cerebrovascular | 1995 |
[Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Calcium Channel Blockers; Delayed-Action Pre | 1993 |
Clinical features of an anti-anginal drug in angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Dr | 1993 |
Similarities and differences between calcium antagonists: pharmacological aspects.
Topics: Angina Pectoris; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Diltiazem; Hum | 1993 |
Nifedipine gastrointestinal therapeutic system (GITS). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Drug Delivery Systems; Humans; Hypertension; Nifedipine; Phar | 1995 |
[Silent myocardial ischemia. Arguments against treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Atenolol; Bisoprolol; Calcium Channe | 1996 |
Diversity of calcium antagonists.
Topics: Angina Pectoris; Arteriosclerosis; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Humans; Hype | 1997 |
Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature.
Topics: Adverse Drug Reaction Reporting Systems; Angina Pectoris; Calcium Channel Blockers; Female; Humans; | 1997 |
Safety of nifedipine in angina pectoris: a meta-analysis.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Delayed-Action Preparations; | 1999 |
[An anomalous origin of the left coronary artery associated with a right coronary spasm as the cause of angina and presyncope].
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Coronary Vessel Anomalies; Dru | 1999 |
[Edema and skin ulcers of the lower limbs as a collateral effect of nifedipine. A clinical case report].
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chronic Disease; | 1999 |
An evaluation of beta-blockers, calcium antagonists, nitrates, and alternative therapies for stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Complementary Therapies; Evi | 1999 |
[Calcium antagonists in cardiology].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium; Coronary Disease; Human | 1978 |
Clinical aspects of Ca-blocking agents.
Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Calcium; Coronary Disease; Cricetinae; Humans; Hyper | 1978 |
[Treatment of angina pectoris (III)].
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Artery Bypass; Humans; Nifedipine; Perhexiline; | 1979 |
[Calcium antagonists in the therapy of angina pectoris of effort].
Topics: Angina Pectoris; Calcium; Hemodynamics; Humans; Myocardium; Nifedipine; Oxygen Consumption; Piperazi | 1978 |
Calcium-channel blockers used in combination.
Topics: Angina Pectoris; Calcium Channel Blockers; Diltiazem; Drug Therapy, Combination; Electrocardiography | 1992 |
Bepridil treatment of chronic stable angina: a review of comparative studies versus placebo, nifedipine, and diltiazem.
Topics: Adult; Aged; Angina Pectoris; Bepridil; Chronic Disease; Diltiazem; Female; Humans; Male; Meta-Analy | 1992 |
Clinical pharmacokinetics of amlodipine.
Topics: Absorption; Amlodipine; Angina Pectoris; Biological Availability; Calcium Channel Blockers; Drug Int | 1992 |
[Amlodipine].
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Humans; Hypertension; Nifedipine | 1991 |
[Amlodipin (Norvasc). A new calcium antagonist with long half-life].
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Half-Life; Humans; Hypertension; Nifedipine | 1991 |
The efficacy of amlodipine in the management of ischaemic heart disease.
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Therapy, Combination; | 1991 |
A review of amlodipine in myocardial ischaemia.
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; H | 1991 |
The combination of slow-release nifedipine and atenolol for stable angina.
Topics: Angina Pectoris; Atenolol; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Nifedipin | 1990 |
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.
Topics: Absorption; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Blood Platelets; Calcium Channel | 1985 |
Treating coexisting cardiovascular and pulmonary disease with calcium antagonists.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Asthma, Exercise-Induced; Bronchial Spasm; Calcium; Ca | 1986 |
The pharmacokinetic profile of amlodipine.
Topics: Administration, Oral; Aging; Amlodipine; Angina Pectoris; Animals; Biological Availability; Calcium | 1989 |
High-dose monotherapy and combination therapy with calcium channel blockers for angina. A comprehensive review of the literature.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Diltiazem; Drug Therapy, Combination; Humans; Nifedipi | 1989 |
The efficacy of amlodipine in myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel | 1989 |
Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Chronic Disease; Dihydropyridines; Drug Therapy, Combi | 1989 |
Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Calcium Channel Blockers; Chronic Disease; Cl | 1985 |
Selection of optimal drug therapy for the patient with angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel | 1985 |
Antihypertensive therapy with calcium-channel blockers: comparison with beta blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Clinical Tri | 1985 |
Calcium antagonists.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium; Calcium Channel Blockers; Coronary Circulatio | 1985 |
Calcium antagonists for chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; H | 1987 |
Nifedipine and metoprolol in suspected unstable angina. Unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Clinical T | 1987 |
Nifedipine and metoprolol in suspected unstable angina. Review of other trials.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Humans; My | 1987 |
Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Diseases; Dil | 1988 |
Pharmacokinetics of calcium channel blocking agents.
Topics: Administration, Oral; Angina Pectoris; Atrial Fibrillation; Biological Availability; Cardiomegaly; C | 1986 |
Measurement of coronary blood flow in man: methods and implications for clinical practice.
Topics: Amrinone; Angina Pectoris; Animals; Cardiomegaly; Coronary Circulation; Coronary Disease; Coronary V | 1985 |
Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Topics: Angina Pectoris; Calcium Channel Blockers; Cardiovascular Diseases; Humans; Hypertension; Nifedipine | 1988 |
Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.
Topics: Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Thera | 1988 |
Smoking, catecholamines, and the ischemic myocardium.
Topics: Angina Pectoris; Atenolol; Catecholamines; Coronary Disease; Female; Heart; Humans; Male; Nifedipine | 1988 |
Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications.
Topics: Angina Pectoris; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Dihydropyridines; Hemod | 1987 |
Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
Topics: Administration, Cutaneous; Angina Pectoris; Clinical Trials as Topic; Clonidine; Delayed-Action Prep | 1987 |
Review of calcium-channel blockers.
Topics: Angina Pectoris; Calcium Channel Blockers; Diltiazem; Humans; Nifedipine; Verapamil | 1986 |
Nifedipine in myocardial ischemia, systemic hypertension, and other cardiovascular disorders.
Topics: Angina Pectoris; Calcium Channel Blockers; Cardiovascular Diseases; Coronary Disease; Humans; Hypert | 1986 |
Calcium antagonists in patients with cardiovascular disease. Current perspectives.
Topics: Angina Pectoris; Angina Pectoris, Variant; Atrial Fibrillation; Atrial Flutter; Benzazepines; Cardio | 1985 |
Are calcium antagonists cardioprotective?
Topics: Angina Pectoris; Animals; Blood Viscosity; Calcium Channel Blockers; Clinical Trials as Topic; Coron | 1985 |
Calcium channel blocking agents: physiologic basis of nursing intervention.
Topics: Angina Pectoris; Angina Pectoris, Variant; Atrioventricular Node; Calcium; Calcium Channel Blockers; | 1985 |
Combination therapy with isosorbide dinitrate: current status and the future.
Topics: Angina Pectoris; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Esophageal Achalasia; Exe | 1985 |
Calcium-channel blockers and systemic hypertension.
Topics: Acute Disease; Angina Pectoris; Animals; Calcium Channel Blockers; Chronic Disease; Diltiazem; Drug | 1985 |
Calcium channel blocking agents and the heart.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Vasospasm; Digoxin; Diltia | 1985 |
409 trials available for nifedipine and Angina Pectoris
| Article | Year |
|---|---|
Importance of sustained and "tight" blood pressure control in patients with high cardiovascular risk.
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Cardio | 2016 |
Prognostic importance of pretreatment and on-treatment blood pressure: Further analysis of the ACTION database and the effect of nifedipine gastrointestinal therapeutic system.
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Cardio | 2016 |
Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the 'ACTION' database in patients with angina.
Topics: Aged; Angina Pectoris; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; B | 2011 |
Effects of treatment with once-daily nifedipine CR and twice-daily benidipine on prevention of symptomatic attacks in patients with coronary spastic angina pectoris-Adalat Trial vs Coniel in Tokyo against Coronary Spastic Angina (ATTACK CSA).
Topics: Acetylcholine; Angina Pectoris; Blood Pressure; Coronary Vasospasm; Dihydropyridines; Electrocardiog | 2010 |
Comparison of the effects of long-acting nifedipine CR and diltiazem R in patients with vasospastic angina: Aomori coronary spastic angina study.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Cross-Over Studies; Delayed-Act | 2010 |
A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Calcium Channel | 1993 |
The effects of acupuncture in treatment of coronary heart diseases.
Topics: Acupuncture Therapy; Angina Pectoris; Animals; Dogs; Electroacupuncture; Electrocardiography; Female | 2004 |
[Clinical value of degree of blood pressure lowering during use of effective doses of antianginal drugs].
Topics: Adult; Angina Pectoris; Blood Pressure; Chi-Square Distribution; Data Interpretation, Statistical; E | 2004 |
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Corona | 2005 |
Effect of nifedipine on C-reactive protein levels in the coronary sinus and on coronary blood flow in response to acetylcholine in patients with stable angina pectoris having percutaneous coronary intervention.
Topics: Acetylcholine; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Blood Flow Velocity; C-Reactiv | 2005 |
Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Cohort Studies; Female; Humans; Male; Middle | 2005 |
The development of heart failure in patients with stable angina pectoris.
Topics: Aged; Angina Pectoris; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardi | 2007 |
Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study.
Topics: Angina Pectoris; Biomarkers; Calcium Channel Blockers; Chronic Disease; Coronary Artery Disease; Cor | 2007 |
Coronary and aortic calcifications inter-relationship in stable angina pectoris: A Coronary Disease Trial Investigating Outcome with Nifedipine GITS (ACTION)--Israeli spiral computed tomography substudy.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aorta, Thoracic; Aortic Diseases; Calcinosis; Coron | 2007 |
Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions.
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output, Low; Clinical Trials as T | 2007 |
Resource utilization implications of treatment were able to be assessed from appropriately reported clinical trial data.
Topics: Angina Pectoris; Calcium Channel Blockers; Cardiovascular Diseases; Double-Blind Method; Drug Therap | 2007 |
Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome.
Topics: Aged; Angina Pectoris; Creatinine; Female; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; | 2007 |
Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy).
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronary Angiograph | 2007 |
Comparison of the acute hemodynamic effects of nifedipine with nitrendipine and a study of the electrophysiological effects of nitrendipine in man.
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Electrocardiography; El | 1984 |
Calcium-blocker therapy for unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Co | 1982 |
A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Drug Therapy, Combination; Female; Humans | 1983 |
Isosorbide dinitrate in clinical practice.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Clinical Tri | 1984 |
Effects and mechanism of nifedipine after oral, sublingual, intravenous and intracoronary administration. Survey on clinical results.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Th | 1984 |
[Clinical and hemodynamic effects of inderal and korinfar in angina pectoris].
Topics: Angina Pectoris; Clinical Trials as Topic; Hemodynamics; Humans; Male; Nifedipine; Propranolol; Pyri | 1983 |
Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm.
Topics: Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Clinical Trials as Topic; Coronary Vasosp | 1983 |
Acute myocardial ischaemia: what information can be expected in the near future from ongoing clinical trials with nifedipine?
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Humans; Metoprolol | 1983 |
Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol.
Topics: Administration, Oral; Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Drug Inte | 1983 |
[Evaluation of the effects of a new calcium antagonist, diltiazem, in patients with stable effort angina and a therapeutic comparison with nifedipine].
Topics: Aged; Angina Pectoris; Benzazepines; Clinical Trials as Topic; Diltiazem; Drug Evaluation; Female; H | 1983 |
Clinical outcome after treatment of rest angina with calcium blockers: comparative experience during the initial year of therapy with diltiazem, nifedipine, and verapamil.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Female; | 1983 |
[Anti-angina effectiveness of the calcium antagonist nifedipine in relation to coronary involvement].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Drug | 1983 |
Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration.
Topics: Adult; Aged; Angina Pectoris; Benzazepines; Clinical Trials as Topic; Diltiazem; Double-Blind Method | 1984 |
Efficacy, duration and mechanism of action of nifedipine in stable exercise-induced angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Circulation; Double | 1983 |
Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison.
Topics: Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Ma | 1984 |
Cigarette smoking and the treatment of angina with propranolol, atenolol, and nifedipine.
Topics: Angina Pectoris; Atenolol; Clinical Trials as Topic; Exercise Test; Female; Humans; Male; Middle Age | 1984 |
Use of calcium channel blocking agents in angina pectoris.
Topics: Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Clinical Trials as Topic; Dilti | 1984 |
[Calcium antagonists in the treatment of ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Calcium; Clinical Trials as Topic; Coronary Disease; Female; Hemodynam | 1984 |
[Effects of the combination nifedipine-acebutolol in patients with stable angina pectoris. Comparative double-blind study with the same drugs used separately].
Topics: Acebutolol; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therap | 1983 |
Acute nifedipine withdrawal: consequences of preoperative and late cessation of therapy in patients with prior unstable angina.
Topics: Angina Pectoris; Angina, Unstable; Blood Pressure; Clinical Trials as Topic; Coronary Artery Bypass; | 1984 |
Variables predictive of successful medical therapy in patients with unstable angina: selection by multivariate analysis from clinical, electrocardiographic, and angiographic evaluations.
Topics: Angina Pectoris; Angina, Unstable; Cardiac Catheterization; Clinical Trials as Topic; Coronary Angio | 1984 |
[Comparative study of the effectiveness of korinfar, izoptin and obzidan in patients with variant stenocardia combined with effort stenocardia].
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Clinical Trials as Topic | 1984 |
[Changes in the physical load tolerance of stenocardia patients taking obzidan, korinfar and izoptin separately and together].
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Clinical Trials as Topic; Drug Th | 1984 |
Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Metho | 1984 |
[Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Bli | 1984 |
Nifedipine in acute myocardial infarction.
Topics: Angina Pectoris; Animals; Clinical Enzyme Tests; Clinical Trials as Topic; Creatine Kinase; Dogs; Do | 1984 |
[Preliminary note on the use of calcium antagonists in ischemic cardiopathy].
Topics: Adult; Angina Pectoris; Benzazepines; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; | 1984 |
Nifedipine in chronic stable angina: a double-blind placebo-controlled crossover trial.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Fe | 1983 |
[Drug therapy combinations in angina pectoris].
Topics: Administration, Oral; Angina Pectoris; Blood Pressure; Drug Therapy, Combination; Exercise Test; Hea | 1983 |
The effects of nifedipine, atenolol and that combination on left ventricular function.
Topics: Angina Pectoris; Atenolol; Drug Therapy, Combination; Heart Function Tests; Humans; Male; Middle Age | 1983 |
Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm.
Topics: Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Clinical Trials as Topic; Coronary Vasosp | 1983 |
[Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Diseas | 1984 |
[Therapeutic effectiveness of the transdermal system with nitroglycerin in comparison with nifedipine].
Topics: Administration, Topical; Adult; Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Tes | 1984 |
[Dynamics of critical stenosis in patients with unstable angina pectoris].
Topics: Angina Pectoris; Angina, Unstable; Coronary Angiography; Coronary Circulation; Coronary Disease; Hem | 1984 |
Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in effort stable angina.
Topics: Aged; Angina Pectoris; Double-Blind Method; Drug Evaluation; Exercise Test; Female; Humans; Male; Mi | 1984 |
Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in stable effort angina.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Double-Blind Method; Drug Administration Schedule; | 1984 |
Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
Topics: Adult; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Heart Rate; Hemody | 1984 |
Effect of nicardipine on myocardial contractility and on angina induced by atrial pacing in patients with coronary artery disease (abstract).
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Pacing, Artificial; | 1984 |
Evaluation of verapamil and high dose nifedipine in patients with chronic stable angina with objective methods.
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Double-Blind Method; Drug Administration Schedule; El | 1984 |
The value of amiodarone for the treatment of unstable angina.
Topics: Adult; Aged; Amiodarone; Angina Pectoris; Angina, Unstable; Benzofurans; Drug Evaluation; Drug Thera | 1983 |
"Maximal" drug therapy is not necessarily optimal in chronic angina pectoris.
Topics: Aged; Angina Pectoris; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Exercise Tes | 1984 |
[Prazosin in exercise-induced angina pectoris. An open study of work capacity after a single dose of prazosin, isosorbide dinitrate, atenolol and nifedipine].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Age | 1984 |
Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris.
Topics: Angina Pectoris; Animals; Blood Pressure; Clinical Trials as Topic; Diltiazem; Dogs; Dose-Response R | 1982 |
Verapamil therapy for unstable angina pectoris: review of double-blind placebo-controlled randomized clinical trials.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Clinical Trials as Topic; Coronary Diseas | 1982 |
Rationale for the choice of calcium antagonists in chronic stable angina. An objective double-blind placebo-controlled comparison of nifedipine and verapamil.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Metho | 1982 |
[Effects of nifedipine and acebutolol alone and combined on work capacity in patients with exertional angina].
Topics: Acebutolol; Angina Pectoris; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Nifedipine | 1981 |
Effects of oral calcium-antagonists in spontaneous angina. Verapamil and nifedipine in a double-blind cross-over trial.
Topics: Angina Pectoris; Angina Pectoris, Variant; Clinical Trials as Topic; Coronary Vasospasm; Double-Blin | 1982 |
[Nifedipine and verapamil in unstable angina. Evaluation by the Holter method].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Fe | 1982 |
[Effects of nifedipine in slow-release preparations on exercise tolerance in angina patients].
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Humans; | 1982 |
Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combinati | 1980 |
Therapy of coronary vasoconstriction in patients with coronary artery disease.
Topics: Angina Pectoris; Cold Temperature; Coronary Disease; Coronary Vessels; Exercise Test; Heart Ventricl | 1981 |
Effect of verapamil and nifedipine on left ventricular function at rest and during exercise in patients with Prinzmetal's variant angina pectoris.
Topics: Angina Pectoris; Angina Pectoris, Variant; Exercise Test; Female; Heart Ventricles; Hemodynamics; Hu | 1981 |
Comparison of verapamil and nifedipine in the treatment of variant angina pectoris: preliminary observations in 10 patients.
Topics: Angina Pectoris; Angina Pectoris, Variant; Electrocardiography; Female; Humans; Male; Middle Aged; N | 1981 |
Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina.
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Me | 1981 |
Evaluation of antianginal drug treatment by precordial exercise electrocardiography.
Topics: Angina Pectoris; Blood Pressure; Electrocardiography; Exercise Test; Heart Rate; Humans; Nifedipine; | 1981 |
Double-blind trial of nifedipine in angina patients with normal coronary arteries.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Coronary Vessels; Double-Blind Method; Electrocard | 1981 |
Randomized double-blind comparison of nifedipine and isosorbide dinitrate in patients with coronary arterial spasm.
Topics: Adult; Aged; Angina Pectoris; Angiocardiography; Clinical Trials as Topic; Coronary Vasospasm; Doubl | 1982 |
The prophylaxis of angina pectoris in general practice. A placebo-controlled comparison of nifedipine and propranolol.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; | 1982 |
[Treatment of stable exercise angina with calcium blockers-a double-blind, placebo-controlled comparison of diltiazem and nifedipine].
Topics: Angina Pectoris; Benzazepines; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Exercise Te | 1982 |
The symptomatic and objective effects of nifedipine in combination with beta-blocker therapy in severe angina pectoris.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Hu | 1982 |
[Effect of nifedipine on echocardiographic left ventricular dimensions during progressive exercise in a seated position on a bicycle ergometer in patients suffering from exertion angina. Comparison with nitroglycerine and a placebo].
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Echocardiography; Exercise Tes | 1982 |
Acute effects of chewable nifedipine on hemodynamic responses to upright exercise in patients with prior myocardial infarction and effort angina.
Topics: Administration, Oral; Adult; Angina Pectoris; Cardiac Catheterization; Cardiac Output; Exercise Test | 1983 |
Long-term responses to nifedipine in patients with coronary spasm who have an initial favorable response.
Topics: Angina Pectoris; Coronary Vasospasm; Double-Blind Method; Drug Evaluation; Female; Humans; Isosorbid | 1983 |
Comparison of the antianginal effectiveness of nifedipine, verapamil, and isosorbide dinitrate in patients receiving propranolol: a double-blind study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; | 1983 |
Factors influencing the treatment of chronic stable angina pectoris with nifedipine.
Topics: Angina Pectoris; Chronic Disease; Exercise Test; Female; Humans; Male; Nifedipine; Pyridines; Smokin | 1983 |
Nifedipine for coronary-artery spasm.
Topics: Angina Pectoris; Clinical Trials as Topic; Humans; Nifedipine; Pyridines | 1980 |
Calcium antagonists: long-awaited new therapy for heart disease.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Calcium; Cardiomyopathies; Clinical Trials as T | 1981 |
Efficacy of nifedipine in the treatment of angina pectoris and chronic airways obstruction.
Topics: Adult; Aged; Airway Obstruction; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Female; | 1980 |
Effect of a calcium inhibitor, nifedipine, on exercise tolerance in patients with angina pectoris: a double-blind study.
Topics: Adult; Aged; Angina Pectoris; Calcium; Clinical Trials as Topic; Double-Blind Method; Female; Heart | 1981 |
[Ergometric evaluation of sublingual nifedipine in angina patients. Double-blind cross-over study compared with a placebo].
Topics: Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; N | 1980 |
[Treatment of angina pectoris in general practice with nifedipine - a calcium blocker].
Topics: Aged; Angina Pectoris; Calcium; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; | 1981 |
Nifedipine and propranolol: a beneficial drug interaction.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Metho | 1981 |
Nifedipine in medically refractory angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Angiography; Clinical Trials as Topic; Diastole; Dizziness; Female; He | 1981 |
The combination of nifedipine and propranolol in the management of patients with angina pectoris.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fe | 1981 |
Considerations in evaluating new antianginal drugs.
Topics: Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Drug Evaluation; Hum | 1982 |
[Dilzem: a new alternative to the therapy of angina pectoris and hypertension].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Calcium Channel Blockers; Clinical Trials as To | 1981 |
[Combined treatment of angina pectoris with nifedipine and metoprolol].
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fem | 1981 |
Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Double-Blin | 1981 |
Effects of nifedipine, acebutolol, and their association on exercise tolerance in patients with effort angina.
Topics: Acebutolol; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combinatio | 1981 |
Nifedipine in unstable angina: a double-blind, randomized trial.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Artery By | 1982 |
[Varying response to nifedipine during treatment of stable exertional angina pectoris: results of a double-blind, randomized, cross-over, placebo-controlled study (author's transl)].
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; El | 1982 |
[Therapeutical comparison between atenolol and nifedipine in effort angina (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Metho | 1981 |
[Dilazep vs. nifedipine in patients with stable effort angina. A double blind randomized study (author's transl)].
Topics: Aged; Angina Pectoris; Azepines; Blood Pressure; Clinical Trials as Topic; Dilazep; Double-Blind Met | 1981 |
Nifedipine in unstable angina.
Topics: Angina Pectoris; Clinical Trials as Topic; Humans; Nifedipine; Pyridines | 1982 |
Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Cardiac Volume; | 1982 |
The additive antianginal action of oral nifedipine in patients receiving propranolol: magnitude and duration of effect.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Pressure; Electrocardiography; Exercise Te | 1982 |
Randomized double-blind comparison of verapamil and nifedipine in chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Double-Blind Method; Electrocardiography; Exercise Te | 1982 |
[Comparative pharmacodynamics study of korinfar and isoptin in ischemic heart disease].
Topics: Adult; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation; Exercis | 1981 |
The dose-response effects of nifedipine of ST-segment changes in exercise testing: preliminary studies.
Topics: Angina Pectoris; Dose-Response Relationship, Drug; Electrocardiography; Exercise Test; Humans; Male; | 1981 |
Effect of nifedipine on exercise tolerance in angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Female; Humans; Male; Middle Aged; Nifedipine; Physical Exertion; Pyri | 1980 |
Effect of isradipine and nifedipine on diastolic function in patients with left ventricular dysfunction due to coronary artery disease: a randomized, double-blind, nuclear, stethoscope study.
Topics: Adult; Aged; Angina Pectoris; Atrial Function, Right; Cardiac Pacing, Artificial; Diastole; Double-B | 1994 |
A cross-over study comparing the efficacy of a combination of atenolol and nifedipine at different doses in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Atenolol; Cross-Ove | 1995 |
Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzazepines; Blood Pressure; Cardiovascular Agents | 1995 |
Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study.
Topics: Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Exercise Tes | 1995 |
Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS Investigators.
Topics: Adult; Aged; Angina Pectoris; Bisoprolol; Double-Blind Method; Electrocardiography, Ambulatory; Euro | 1995 |
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Blood Glucose; Blood Pressure; Doub | 1994 |
Duration and extent of antianginal effects of a sustained-release formulation of nifedipine in angina.
Topics: Angina Pectoris; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Exercise Test | 1994 |
[Time of drug intake in hypertension and angina pectoris. A controlled monitoring study].
Topics: Aged; Amlodipine; Angina Pectoris; Confidence Intervals; Cross-Over Studies; Female; Humans; Hyperte | 1994 |
Effects of antianginal therapy with atenolol and slow-release nifedipine on respiratory gas exchange and on the ventilatory requirements for aerobic exercise.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Carbon Dioxide; Delayed-Action Preparations; Electrocardiogr | 1994 |
Effects of intracoronary felodipine versus nifedipine on left ventricular contractility and coronary sinus blood flow in stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Coronary Circulation; Coronary Vessels; Felodipine; Humans; Injections | 1994 |
[Methodologic approaches to evaluation of interaction of anti-anginal agents in their combined use in patients with exercise-induced angina].
Topics: Angina Pectoris; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Drug Therapy, | 1993 |
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial.
Topics: Aged; Angina Pectoris; Atenolol; Diltiazem; Drug Therapy, Combination; Female; Humans; Isosorbide Di | 1994 |
Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease; Delayed-Action Preparations; Double-Blin | 1993 |
Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Delayed-Action Preparations; Diltiazem; Double-B | 1993 |
Effects of felodipine versus nifedipine on exercise tolerance in stable angina pectoris.
Topics: Analysis of Variance; Angina Pectoris; Blood Pressure; Double-Blind Method; Exercise; Felodipine; Fe | 1994 |
Increased blood pressure and neural tone in the silent ischemia of hypertension: disparate effects of immediate release nifedipine.
Topics: Activities of Daily Living; Adult; Aged; Angina Pectoris; Blood Pressure; Circadian Rhythm; Echocard | 1993 |
Atenolol versus the fixed combination of atenolol and nifedipine in stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Coronary Disease; Delayed-Action Preparation | 1993 |
Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris.
Topics: Adult; Aged; Analysis of Variance; Angina Pectoris; Atenolol; Delayed-Action Preparations; Double-Bl | 1994 |
Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Betaxolol; Chronic Disease; Diltiazem; Double-Blind | 1994 |
Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine.
Topics: Adult; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Chronic Diseas | 1994 |
[Acute effects of propranolol and its association with nifedipine in aged patients with effort stable angina. Randomized double-blind crossover study, under placebo control].
Topics: Age Factors; Aged; Angina Pectoris; Coronary Disease; Double-Blind Method; Drug Therapy, Combination | 1993 |
[Comparison of the effects and safety of atenolol and nifedipine in the treatment of angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Exercise Test; Female; Humans; Male; Middle Aged; Nifedipine | 1993 |
[The prognosis of the antianginal effect of foridon compared to other antianginal preparations].
Topics: Angina Pectoris; Blood Pressure; Cardiovascular Agents; Echocardiography; Exercise Test; Heart Rate; | 1993 |
Early experience with dobutamine stress testing and cardiac cine-tomographic imaging in the elderly: antianginal effects of nifedipine-GITS.
Topics: Age Factors; Angina Pectoris; Cineradiography; Coronary Angiography; Coronary Disease; Dobutamine; D | 1993 |
Transient myocardial ischemia during nifedipine therapy in stable angina pectoris, and its relation to coronary collateral flow and comparison with metoprolol.
Topics: Angina Pectoris; Collateral Circulation; Coronary Angiography; Coronary Circulation; Double-Blind Me | 1993 |
Harmonic regression analysis of the effect of drug treatment on the diurnal rhythm of blood pressure and angina.
Topics: Amlodipine; Angina Pectoris; Blood Pressure; Circadian Rhythm; Double-Blind Method; Humans; Hyperten | 1993 |
Usefulness of exercise testing performed with vasodilators for predicting the severity of myocardial ischaemia during daily activities and treatment.
Topics: Activities of Daily Living; Adult; Angina Pectoris; Coronary Circulation; Coronary Disease; Drug The | 1993 |
Acute effects of nifedipine, diltiazem and their combination in patients with chronic stable angina: a double-blind, randomized, cross-over, placebo-controlled study.
Topics: Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Diltiazem; Double-Blind Method; Drug Therapy | 1993 |
A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Delayed-Action Preparations; Dose-Response Relationship, Dru | 1993 |
Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
Topics: Aged; Angina Pectoris; Diltiazem; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Tes | 1993 |
Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Double-Blind Method; Drug Th | 1996 |
Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study).
Topics: Angina Pectoris; Atenolol; Case-Control Studies; Delayed-Action Preparations; Diltiazem; Drug Therap | 1996 |
Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Calcium Channel Blockers; Coron | 1996 |
The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Calcium Channel Blockers; Delay | 1996 |
A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Delayed-Action Preparations; Dose-Response R | 1996 |
[Efficacy and tolerability of felodipine and nifedipine in stable angina refractory to beta-blocker therapy].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Calcium Channel Blockers; Cross-Over Studies; Do | 1996 |
[Clinical observation on treatment of 45 angina pectoris patients of coronary heart disease with taponin].
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiography, Impedance; Drugs, Chinese Herbal; Ele | 1995 |
[Calcium antagonist therapy of middle-aged and aged patients with angina pectoris during the outpatient stage of rehabilitation].
Topics: Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agen | 1995 |
Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Topics: Angina Pectoris; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blo | 1996 |
Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN).
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Double-Blind Met | 1996 |
Patient compliance and therapeutic coverage: amlodipine versus nifedipine SR in the treatment of hypertension and angina: interim results. Steering Committee and Cardiologists and General Practitioners involved in the Belgium Multicentre Study on Patient
Topics: Amlodipine; Angina Pectoris; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Patient Co | 1994 |
Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Diltiazem; Female; Humans; Male; Middle Aged; Multi | 1997 |
[A clinical study of hehuantang in treating coronary heart disease].
Topics: Aged; Aged, 80 and over; Angina Pectoris; Drugs, Chinese Herbal; Glutathione Peroxidase; Humans; Lip | 1996 |
[Efficacy of cordipin chronotherapy with reference to anginal patients' chronosensitivity].
Topics: Adult; Aged; Angina Pectoris; Chronotherapy; Echocardiography; Female; Hemodynamics; Humans; Male; M | 1997 |
Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonist.
Topics: Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Drug A | 1997 |
[Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Topics: Aged; Amlodipine; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Drug Administration Sch | 1997 |
Differential properties of mibefradil in hypertension and angina.
Topics: Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Heart Rat | 1997 |
Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Calcium Channel | 1997 |
Action: a 30,000 patient-years double-blind, placebo-controlled trial of nifedipine GITS in stable angina. ACTION Research Group.
Topics: Angina Pectoris; Calcium Channel Blockers; Double-Blind Method; Humans; Nifedipine; Osmosis | 1997 |
Nifedipine GITS versus diltiazem in chronic stable angina: a randomised multicentre study.
Topics: Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Diltiazem; Double-Blind Method; Exercise | 1997 |
Relationship between calcium channel antagonists and nocturnal hypotension and autonomic imbalance in patients with a previous myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Autonomic Nervous System; Blood Pressure; Blood Pressure Monitoring, A | 1998 |
Withdrawal effects of antianginal therapy: comparison of isosorbide dinitrate and nifedipine.
Topics: Adult; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Exercise Test; Exercise Tolerance; | 1998 |
Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System.
Topics: Angina Pectoris; Calcium Channel Blockers; Confidence Intervals; Double-Blind Method; Humans; Nifedi | 1998 |
[The calcium antagonists diltiazem and nifedipine: a comparison of their efficacy in single and long-term use in patients with stable stenocardia of effort].
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Diltiazem; Double-Blind Method; Dr | 1998 |
Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris; influence of drug therapy and prognostic value. TIBBS Investigators Group. Total Ischemic Burden Bisoprolol Study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Bisoprolol; Calcium Channel Blockers; Cir | 1999 |
Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Chronic Disease; Double-Blind Method; | 1999 |
[Treatment of chronic stable angina: follow-up study with nifedipine gastrointestinal therapeutic system. SENIOR Study Group].
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Female; Humans; Male; Middle Aged; | 2000 |
Medical therapy, symptoms, and the distress the cause: relation to quality of life in patients with angina pectoris and/or hypertension.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris | 2000 |
[Clinical aspects of trimetazidine (preductal) administration as an antianginal drug].
Topics: Administration, Oral; Aged; Aged, 80 and over; Angina Pectoris; Cross-Over Studies; Drug Therapy, Co | 2000 |
Improved efficacy and safety of controlled-release diltiazem compared to nifedipine may be related to its negative chronotropic effect.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Delayed- | 2000 |
[Amlodipine versus nifedipine retard. A randomized double-blind comparative study on long-term efficacy and safety of amlodipine and nifedipine retard in the monotherapy of chronic stable angina pectoris].
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Data Interpreta | 2001 |
[Clinical study of purified xuefu capsule in treating angina pectoris].
Topics: Aged; Angina Pectoris; Calcitonin Gene-Related Peptide; Capsules; Drug Therapy, Combination; Drugs, | 1998 |
[Clinical study on relationship among Heart-Qi Deficiency, left ventricular function and myocardial ischemia in patients with coronary heart disease].
Topics: Aged; Angina Pectoris; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Myocardial Contract | 1998 |
Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Bisoprolol; Calcium Channel Blockers; Dou | 1990 |
[Drug therapy of coronary heart disease (author's transl)].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium; Clinical Trials as Topic; Coronary Disease; D | 1977 |
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Hemodynamics; Humans; Male; Middle Aged; Nif | 1979 |
Nifedipine therapy for stable angina pectoris: preliminary results of effects on angina frequency and treadmill exercise response.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; | 1979 |
[Nifedipine effect on exercise test evaluated by computer analysis of CB5 lead (author's transl)].
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Coronary Circulation; Diagnosis, Computer-Assisted | 1977 |
[Effects of the association of Ca-antagonists with nitroderivatives or betablocking drugs in effort angina pectoris (author's transl)].
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Electr | 1978 |
[Nifedipine (adalate) in the treatment of angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship | 1978 |
[Controlled clinical trial of 5 antianginal treatments].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Combinations; Humans; Isosorbide Dinitr | 1978 |
[Nifedipine (Adalat). A clinical study of a calcium antagonist in the treatment in angina pectoris].
Topics: Aged; Angina Pectoris; Calcium; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Huma | 1978 |
[Effectiveness of two Ca-antagonistic drugs on angina pectoris: nifedipine and verapamil versus nitroderivative and beta-blocking drugs (author's transl)].
Topics: Angina Pectoris; Calcium; Clinical Trials as Topic; Drug Evaluation; Humans; Isosorbide Dinitrate; M | 1978 |
[Ergometric evaluation of the therapeutic effect on exercise tolerance of the prolonged oral administration of nifedipine in stable effort angina].
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Drug Evaluation; Exercise Test; Heart Function Tes | 1978 |
[Nifedine (Adalat): a calcium-inhibitor with effects in angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Calcium; Clinical Trials as Topic; Double-Blind Method; Drug Evaluatio | 1979 |
A double-blind controlled trial of the anti-anginal efficacy of nifedipine compared with propranolol.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combinati | 1979 |
Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study.
Topics: Aged; Alprenolol; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Dr | 1979 |
[Calcium antagonists, nitrate derivatives and their combination in the treatment of angina pectoris: an acute study with the cycloergometer].
Topics: Angina Pectoris; Calcium; Clinical Trials as Topic; Drug Therapy, Combination; Exercise Test; Hemody | 1979 |
[Results of a trial of a coronary therapeutic agent, Adalat (author's transl)].
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Drug Evaluation; Female; Humans; | 1977 |
[Effects of nifedipine in the treatment of effort stable angina: a double blind study (author's transl)].
Topics: Angina Pectoris; Blood Pressure; Cardiac Catheterization; Clinical Trials as Topic; Coronary Angiogr | 1978 |
Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Cardiac Output; Electrocardiography; Heart Rate; Humans; Isosorbide | 1979 |
[On the clinical evaluation of therapy with nifedipine in association with various anithypertensive drugs (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Drug Evaluation; Drug Synergi | 1977 |
[Effectiveness of nifedipine on exercise tolerance in patients with angina pectoris. Comparison with a nitroderivative and a beta-blocking agent].
Topics: Adolescent; Adult; Angina Pectoris; Exercise Test; Heart; Humans; Isosorbide Dinitrate; Middle Aged; | 1977 |
Effect of nifedipine on exercise tolerance in patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Exercise Test; Heart Rate; H | 1975 |
[Evaluation and comparison of five antianginal treatments by means of a bicycle ergometer exercise test (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; | 1976 |
[Results of a field trial of the coronary drug Adalat (BAY a 1040)].
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Drug Evaluation; Female; Humans; | 1975 |
Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Double-Blind Method; Electrocardiogr | 1992 |
Effects of nifedipine and diltiazem on myocardial ischemia in patients with severe stable angina pectoris treated with nitrates and beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Diltiazem; Double-Blind Method; Electroca | 1992 |
Tolerance and long-term efficacy of a fixed combination of atenolol and nifedipine in the treatment of angina pectoris. Stuart Clinical Research Group.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Drug Combinations; Female; Humans; Long-Term Care; Male; Mid | 1992 |
[Effect of various antianginal agents on the frequency and duration of myocardial ischemic episodes in patients with stable angina pectoris].
Topics: Angina Pectoris; Drug Therapy, Combination; Humans; Myocardial Ischemia; Nifedipine; Periodicity; Pr | 1992 |
[A prospective study on the effect of nifedipine of the cardiovascular complications in the elderly hypertensives].
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Cerebrovascular Disorders; Female; Humans; Hypertension | 1992 |
Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. N-CAP Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Circadian Rhythm; Delayed-Action Preparat | 1992 |
Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angina Pectoris; Calcium Channel B | 1992 |
Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Antihypertensive Agents; Carbazoles; Carv | 1992 |
Treatment of transient myocardial ischemia in patients with stable angina: a comparative study of verapamil slow-release and nifedipine plus propranolol.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Drug Therapy, Combinati | 1992 |
Optimal control of myocardial ischaemia: the benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Coronary Disease; Double-Blind Method; Drug Administration S | 1992 |
[Effect of corinfar on hemodynamic indicators and clinical manifestations in patients with ischemic heart disease and stenocardia during psycho-emotional stress].
Topics: Adult; Angina Pectoris; Blood Pressure; Coronary Disease; Electrocardiography; Exercise Test; Heart | 1992 |
[The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris].
Topics: Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Delayed-Action Preparations; Dose-Response | 1992 |
[The clinical evaluation of the efficacy of Isoket in patients with vasospastic stenocardia].
Topics: Adult; Angina Pectoris; Bupranolol; Chi-Square Distribution; Coronary Vasospasm; Delayed-Action Prep | 1992 |
24-hour anti-ischaemic action with once daily nifedipine. Experience obtained with a fatty-alcohol matrix tablet in patients with coronary artery disease.
Topics: Aged; Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Drug Admi | 1992 |
The analysis of failure time data in crossover studies.
Topics: Angina Pectoris; Atenolol; Nifedipine; Proportional Hazards Models; Research Design; Time Factors | 1992 |
The total ischemic burden European trial (TIBET): design, methodology, and management. The TIBET Study Group.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Coronary Disease; Data Interpretation, Statistical; Double-B | 1992 |
Amlodipine in post-infarction angina.
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Circadian Rhythm; Female; Humans; Male; Middl | 1992 |
Sustained-release verapamil and nifedipine in exercise-induced angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Delayed-Action Preparations; Double-Blind Method; Elec | 1992 |
Efficacy and tolerability of gallopamil in coronary heart disease: a double blind cross-over comparison with nifedipine.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Double-Blind Method; Electrocardiogr | 1992 |
[Differential selection of anti-anginal drugs in stable stenocardia in relation to the data of central and intracardiac hemodynamics].
Topics: Adult; Angina Pectoris; Coronary Circulation; Female; Hemodynamics; Humans; Male; Middle Aged; Myoca | 1992 |
Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Celiprolol; Drug Interactions; Drug Therapy, Co | 1991 |
Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.
Topics: Aged; Angina Pectoris; Atenolol; Blood Pressure; Double-Blind Method; Drug Combinations; Exercise Te | 1991 |
A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; | 1991 |
Comparison of dihydropyridine and phenylalkylamine calcium antagonists in patients with coronary heart disease.
Topics: Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Exercise Test; Female; Gall | 1991 |
Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination.
Topics: Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Ex | 1992 |
Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Carbon Dioxide; Delayed-Action Preparations; | 1991 |
[Randomized, double-blind comparison of isosorbide-5-mononitrate and delayed-action nifedipine in patients with stable exertional angina. Multicenter Study Group].
Topics: Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Drug Costs; Exercise Test; Humans | 1991 |
[A comparative evaluation of the antianginal efficacy of aldizem and korinfar in patients with stable stenocardia].
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Double-Blind Method; Electrocardiography; Exercise | 1991 |
The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: a controlled study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Carnitine; Diltiazem; Female; Humans; Male; Middle Age | 1991 |
Controlled clinical trial of nifedipine alone and in combination with dilazep in patients with angina pectoris.
Topics: Angina Pectoris; Dilazep; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Midd | 1991 |
A double-blind dose-response study of amlodipine in patients with stable angina pectoris.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers | 1991 |
Isradipine therapy in chronic stable angina pectoris--comparison with nifedipine.
Topics: Activities of Daily Living; Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Double-Blind Met | 1991 |
Anti-ischaemic properties of amlodipine, a new calcium antagonist, in patients with severe coronary artery disease: a prospective trial.
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Exercise Test; Female; Hear | 1991 |
Open comparative study to assess the efficacy and safety of two calcium antagonists, amlodipine and diltiazem, in the treatment of symptomatic myocardial ischaemia.
Topics: Amlodipine; Angina Pectoris; Coronary Disease; Diltiazem; Hemodynamics; Humans; Middle Aged; Nifedip | 1991 |
Clinical investigation of asymptomatic cardiac ischemia.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Atenolol; Coronary Artery Bypass; Coronary Disease; | 1991 |
[Comparison of the effects of nifedipine and diltiazem in patients with stable angina pectoris of various severity and pathomorphology of the coronary arteries].
Topics: Adult; Aged; Angina Pectoris; Coronary Vessels; Diltiazem; Double-Blind Method; Electrocardiography; | 1991 |
Attenuation of circadian variation by combined antianginal therapy with suppression of morning and evening increases in transient myocardial ischemia.
Topics: Angina Pectoris; Circadian Rhythm; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; | 1991 |
Evaluation of the antianginal effect of nifedipine: influence of formulation dependent pharmacokinetics.
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Exercise Test; Female; Hemodynamics; Huma | 1991 |
Effect of nifedipine on total ischemic activity and circadian distribution of myocardial ischemic episodes in angina pectoris.
Topics: Angina Pectoris; Circadian Rhythm; Coronary Disease; Double-Blind Method; Electrocardiography, Ambul | 1991 |
Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia.
Topics: Angina Pectoris; Atenolol; Circadian Rhythm; Coronary Disease; Double-Blind Method; Electrocardiogra | 1991 |
Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Coronary Disease; Double-Blind Method; Drug Therapy, Combina | 1991 |
Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r.
Topics: Adult; Aged; Angina Pectoris; Carbazoles; Carvedilol; Chronic Disease; Delayed-Action Preparations; | 1991 |
Transient myocardial ischemia during daily life in rest and exertional angina pectoris and comparison of effectiveness of metoprolol versus nifedipine.
Topics: Angina Pectoris; Circadian Rhythm; Coronary Angiography; Coronary Disease; Double-Blind Method; Elec | 1991 |
[Comparative study of effects of diltiazem, nifedipine and their combination on exercise stable angina].
Topics: Aged; Angina Pectoris; Blood Pressure; Clinical Protocols; Diltiazem; Drug Therapy, Combination; Ele | 1991 |
[Anti-anginal effect of long-term use of obsidan, corinfar and finoptin in patients with stable exercise-induced stenocardia].
Topics: Angina Pectoris; Exercise Test; Humans; Nifedipine; Placebos; Propranolol; Time Factors; Verapamil | 1991 |
[The effect of nifedipine and diltiazem on left ventricular function in patients with stable angina pectoris and severe left ventricular dysfunction].
Topics: Adult; Aged; Angina Pectoris; Diltiazem; Double-Blind Method; Echocardiography; Humans; Male; Middle | 1991 |
[Does captopril produce an antianginal effect in patients with stable exercise-induced angina pectoris?].
Topics: Adult; Angina Pectoris; Captopril; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate; | 1991 |
Acute effects of nifedipine versus isosorbide dinitrate on exercise tolerance in patients with isolated coronary artery occlusion and collaterals.
Topics: Angina Pectoris; Angiography; Arterial Occlusive Diseases; Collateral Circulation; Coronary Disease; | 1990 |
[The comparative efficacy of nicardipine and nifedipine in stenocardia patients].
Topics: Angina Pectoris; Chronic Disease; Coronary Disease; Electrocardiography; Exercise Test; Humans; Male | 1990 |
Combination of trimetazidine with nifedipine in effort angina.
Topics: Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Humans; Male; Middle | 1990 |
Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study.
Topics: Adult; Aged; Angina Pectoris; Double-Blind Method; Exercise; Humans; Male; Middle Aged; Nifedipine; | 1990 |
Dissociation of exercise tolerance and total myocardial ischemic burden in chronic stable angina pectoris.
Topics: Administration, Cutaneous; Angina Pectoris; Coronary Circulation; Electrocardiography, Ambulatory; E | 1990 |
Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
Topics: Angina Pectoris; Blood Pressure; Coronary Disease; Diltiazem; Electrocardiography, Ambulatory; Exerc | 1990 |
Intravenous nifedipine prevents ergonovine-induced myocardial ischemia in patients with stable effort angina.
Topics: Angina Pectoris; Blood Pressure; Coronary Disease; Ergonovine; Exercise Test; Female; Heart Rate; Hu | 1990 |
Effects of the calcium antagonist, isradipine, and nifedipine on resting and exercise haemodynamics and the neurohumoral system in patients with stable chronic angina.
Topics: Angina Pectoris; Calcium Channel Blockers; Double-Blind Method; Epinephrine; Exercise Test; Hemodyna | 1990 |
An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cardiac Output; Coronary Disease; Diltiazem; | 1990 |
Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method | 1990 |
[The use of metoprolol with calcium antagonists of different mechanisms of action (diltiazem and nifedipine) in patients with stenocardia of effort].
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Diltiazem; Drug Therapy, Combina | 1990 |
[The anti-anginal effect of diltiazem in patients with stable exercise-induced stenocardia and vasospastic stenocardia compared with the effect of nifedipine].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Vasospasm; Diltiaze | 1990 |
Nifedipine and isosorbide dinitrate alone and in combination for patients with chronic stable angina: a double-blind crossover study.
Topics: Angina Pectoris; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; | 1990 |
[Effectiveness of nifedipine, diltiazem and their combination in the treatment of chronic stable angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Diltiazem; Double-Blind Method; Drug Therapy, Combina | 1990 |
Effect of intracoronary nifedipine on coronary bloodflow and myocardial metabolism during pacing-induced ischemia.
Topics: Adult; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Circulation; Female; Heart; Hemodynamic | 1990 |
Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol.
Topics: Adult; Angina Pectoris; Atenolol; Blood Pressure; Capsules; Double-Blind Method; Drug Administration | 1990 |
[Comparative effectiveness and biological equivalency of new nifedipine preparations in patients with exercise-induced stenocardia].
Topics: Angina Pectoris; Biological Availability; Exercise Test; Humans; Male; Middle Aged; Nifedipine; Plac | 1990 |
Randomized double-blind comparison of side effects of nicardipine and nifedipine in angina pectoris. The Nicardipine Investigators Group.
Topics: Adult; Angina Pectoris; Dizziness; Double-Blind Method; Edema; Flushing; Foot Diseases; Headache; Hu | 1990 |
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.
Topics: Absorption; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Blood Platelets; Calcium Channel | 1985 |
Comparison of nitroglycerin patches and nifedipine.
Topics: Administration, Cutaneous; Angina Pectoris; Female; Humans; Male; Middle Aged; Nifedipine; Nitroglyc | 1987 |
Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance.
Topics: Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Exercise Test; Female; Humans; Male; Mi | 1988 |
Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Dose-Response Relationship, Drug | 1988 |
Early treatment of unstable angina with nifedipine and metoprolol--the HINT trial.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fem | 1988 |
Nifedipine and metoprolol in unstable angina: findings from the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT).
Topics: Aged; Angina Pectoris; Angina, Unstable; Double-Blind Method; Drug Therapy, Combination; Electrocard | 1987 |
Comparison of antianginal efficacies and exercise hemodynamic effects of nifedipine and diltiazem in stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Diltiazem; Double-Blind Method; Exercise Test; Female; | 1989 |
Effect of the combination of alinidine and other anti-anginal drugs on heart rate and blood pressure in healthy volunteers.
Topics: Adult; Angina Pectoris; Atenolol; Blood Pressure; Clonidine; Double-Blind Method; Drug Evaluation; D | 1989 |
A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; E | 1989 |
Slow release nifedipine plus atenolol in chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Chronic Disease; Delayed-Action Preparations; Double-Blind M | 1989 |
Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris.
Topics: Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Double-Blind Method; | 1989 |
Hemodynamic and antianginal effects during rest and exercise of intravenous isradipine, a new dihydropyridine calcium antagonist.
Topics: Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Electrocardiography; Exercise Test; | 1989 |
Pharmacodynamics of amlodipine: hemodynamic effects and antianginal efficacy after atrial pacing.
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cardiac Catheterization; Cardiac Pacing, Arti | 1989 |
Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris.
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Drug Administration Schedule | 1989 |
Efficacy and safety of amlodipine in vasospastic angina: an interim report of a multicenter, placebo-controlled trial. The Investigators of Study 160.
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Vasospasm; | 1989 |
Double-blind crossover comparison of amlodipine at three dose levels and placebo in chronic stable angina.
Topics: Aged; Amlodipine; Angina Pectoris; Chronic Disease; Double-Blind Method; Exercise Test; Female; Huma | 1989 |
A four-week double-blind, placebo-controlled, parallel dose-response study of amlodipine in patients with stable exertional angina pectoris.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Dose-R | 1989 |
Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Dose-R | 1989 |
Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance.
Topics: Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Exercise; Exercise Test; Female; Humans | 1989 |
Amlodipine versus nadolol in patients with stable angina pectoris.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Drug Administration Schedule; Ex | 1989 |
The Nifedipine-Total Ischemia Awareness Program: a national survey of painful and painless myocardial ischemia including results of antiischemic therapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Disease; Cros | 1989 |
[Ways of individualizing use of anti-anginal preparations].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Dose-Response Relationship, | 1989 |
Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzeneacetamides; Dou | 1989 |
Chronic stable angina monotherapy. Nifedipine versus propranolol.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Female; Hemodynamics; H | 1989 |
Once-daily therapy for angina pectoris with nifedipine gastrointestinal therapeutic system. Dosing and clinical efficacy.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Drug Adminis | 1989 |
Comparison of the anti-anginal efficacy of nicardipine and nifedipine in patients receiving atenolol: a randomized, double-blind, crossover study.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Syner | 1989 |
[Effect of nifedipine (corinfar) on cerebrovascular circulation in patients with exertion-induced stenocardia].
Topics: Adult; Angina Pectoris; Cerebrovascular Circulation; Clinical Trials as Topic; Dose-Response Relatio | 1989 |
Comparison of atenolol and nifedipine in chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Atenolol; Chronic Disease; Double-Blind Method; Electrocardiography; Exercise | 1989 |
[Comparative evaluation of the anti-anginal effects of dilzem and corinfar in patients with ischemic heart disease and exertion-induced stenocardia].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Diltiazem; Female; Humans; | 1989 |
Usefulness of nifedipine for myocardial ischemia and the nifedipine gastrointestinal therapeutic system.
Topics: Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Drug Administra | 1989 |
[The development of nifedipine tolerance during its regular dosage in patients with stable exertional stenocardia].
Topics: Angina Pectoris; Dose-Response Relationship, Drug; Drug Tolerance; Exercise Test; Humans; Nifedipine | 1989 |
[Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials as Top | 1989 |
Superior efficacy of propranolol versus nifedipine in double-component angina, as related to different influences on coronary vasomotility.
Topics: Aged; Angina Pectoris; Coronary Vessels; Electrocardiography; Hemodynamics; Humans; Male; Middle Age | 1989 |
Clinical utility of nifedipine and diltiazem plasma levels in patients with angina pectoris receiving monotherapy and combination treatment.
Topics: Aged; Angina Pectoris; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ma | 1989 |
Comparative study of the effect of nifedipine versus diltiazem on exercise performance, serum propranolol levels, and ST-segment abnormalities in patients with chronic stable angina taking propranolol.
Topics: Aged; Angina Pectoris; Chronic Disease; Diltiazem; Double-Blind Method; Drug Therapy, Combination; E | 1989 |
Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Calcium Channel Blockers; Chronic Disease; Cl | 1985 |
Antihypertensive therapy with calcium-channel blockers: comparison with beta blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Clinical Tri | 1985 |
[Randomized ergometric study of vasodilators combined with betablockaders].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Therapy, C | 1986 |
Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Meto
Topics: Aged; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Coronary Care Units; Double-Blind | 1986 |
Comparative effects of calcium entry-blocking drugs, beta-blocking drugs, and their combination in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Chronic Disease | 1987 |
Efficacy of nisoldipine combined with beta-adrenergic-blocking drugs in the treatment of chronic stable angina.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Chronic Disease; Coronary Angiography; Double-Bl | 1987 |
Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT).
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Coro | 1987 |
Nifedipine and metoprolol in suspected unstable angina. Unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Clinical T | 1987 |
Circadian variation of total ischaemic burden and its alteration with anti-anginal agents.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Circadian Rhythm; Clinical Trials as Topic; Coronary Disease | 1988 |
The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Electr | 1988 |
Efficacy of nifedipine gastrointestinal therapeutic system in combination with beta blockers in the management of exertional angina. A multicenter study of 54 patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind | 1987 |
Pharmacokinetics of calcium channel blocking agents.
Topics: Administration, Oral; Angina Pectoris; Atrial Fibrillation; Biological Availability; Cardiomegaly; C | 1986 |
Efficacy of a new calcium antagonist PN 200-110 (isradipine) in angina pectoris.
Topics: Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Exercise T | 1987 |
A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output; | 1986 |
Comparison of isradipine and nifedipine in chronic stable angina.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Double- | 1988 |
Endurance testing for evaluation of antianginal therapy with amlodipine, a calcium channel blocking agent.
Topics: Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Double-Blind Method; Evaluation Studies | 1988 |
Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris.
Topics: Aged; Amlodipine; Angina Pectoris; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Double | 1988 |
[Isradipine (PN 200-110), a new dihydropyridine calcium antagonist with slight negative inotropic properties in comparison with nifedipine].
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Heart Rate; Hemodynamic | 1988 |
Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high dose diltiazem monotherapy for stable angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Diltiazem; Drug Administration Schedule; Drug Therapy, Co | 1988 |
A randomized double-blind comparison of diltiazem and nifedipine in stable angina.
Topics: Angina Pectoris; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Exercise Test; Heart Rate | 1988 |
[Anti-angina effect of foridon in patients with stable exertion-induced stenocardia].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Dose-Response Relationship, Drug; Hemodynami | 1988 |
[Acute effects of nisoldipine in patients with stable effort angina].
Topics: Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Exercise T | 1988 |
Labetalol in the treatment of stable exertional angina pectoris: a comparison with nifedipine.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; | 1988 |
[Methodological approaches to the evaluation of the effectiveness of anti-anginal preparations in patients with stenocardia by 24-hour ECG monitoring].
Topics: Adult; Angina Pectoris; Circadian Rhythm; Clinical Trials as Topic; Electrocardiography; Exercise Te | 1988 |
Anti-ischaemic and anti-anginal activity of atenolol, nifedipine and their combination in stable, chronic effort angina.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind | 1988 |
Use of exercise Doppler for non-invasive haemodynamic optimization of dose and identification of poor responders to an oral anti-anginal agent. A double-blind dose-finding study of nisoldipine.
Topics: Administration, Oral; Angina Pectoris; Aorta; Blood Flow Velocity; Calcium Channel Blockers; Clinica | 1988 |
[Comparative study of the effect of 3 calcium antagonists in chronic stable angina].
Topics: Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Clinical Trials as | 1988 |
Usefulness of PY 108-068, a new calcium channel blocker, for angina pectoris.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Double- | 1986 |
Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function.
Topics: Angina Pectoris; Atenolol; Drug Therapy, Combination; Humans; Male; Middle Aged; Nifedipine; Nitrogl | 1986 |
Metoprolol, nifedipine, and the combination in stable effort angina pectoris.
Topics: Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, | 1986 |
Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Carbon Dioxide; Cardiac Output; Clinical Trials as Top | 1986 |
Some issues concerning transdermal nitroglycerin patches.
Topics: Administration, Topical; Angina Pectoris; Clinical Trials as Topic; Drug Administration Schedule; Hu | 1986 |
Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
Topics: Administration, Cutaneous; Angina Pectoris; Blood Pressure; Delayed-Action Preparations; Double-Blin | 1986 |
Effect of pharmacologic therapy on angina frequency, ST segment depression during ambulatory ECG monitoring, and treadmill performance in patients with chronic stable mild angina.
Topics: Adult; Ambulatory Care; Angina Pectoris; Chronic Disease; Electrocardiography; Exercise Test; Female | 1988 |
Haemodynamic effects of combined oral nifedipine and sublingual nitroglycerin in patients with chronic stable angina.
Topics: Administration, Oral; Administration, Sublingual; Aged; Angina Pectoris; Chronic Disease; Delayed-Ac | 1987 |
Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Thera | 1988 |
Nifedipine gastrointestinal therapeutic system in stable angina pectoris. Results of a multicenter open-label crossover comparison with standard nifedipine.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Delayed-Action P | 1987 |
[Use of a static exercise test for evaluating anti-angina effects of drugs in patients with ischemic heart disease at a polyclinic].
Topics: Adult; Aged; Ambulatory Care; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Electroca | 1988 |
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension.
Topics: Adult; Angina Pectoris; Blood Pressure; Double-Blind Method; Heart; Humans; Hypertension; Male; Midd | 1988 |
[Antihypertensive and anti-ischemic effect of nitrendipine. Double-blind, randomized, crossover and placebo controlled acute study].
Topics: Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Double-Blind | 1985 |
Randomized double-blind comparison of metoprolol, nifedipine, and their combination in chronic stable angina: effects on total ischemic activity and heart rate at onset of ischemia.
Topics: Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Heart | 1988 |
Atenolol and/or nifedipine in effort angina: which is the treatment of choice for exercise coronary protection?
Topics: Adult; Aged; Angina Pectoris; Atenolol; Coronary Disease; Double-Blind Method; Drug Therapy, Combina | 1988 |
The effects of antianginal drugs on left ventricular function in patients with effort angina pectoris. Comparison among isosorbide dinitrate, nifedipine and propranolol by PANOVA.
Topics: Aged; Analysis of Variance; Angina Pectoris; Drug Evaluation; Female; Heart Ventricles; Hemodynamics | 1988 |
Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both.
Topics: Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Comb | 1988 |
Nifedipine and angina pectoris. Short-term changes in quantitative coronary angiography with nifedipine and clinical response to treatment in effort-induced, mixed, and spontaneous angina pectoris.
Topics: Angina Pectoris; Angina Pectoris, Variant; Cineangiography; Clinical Trials as Topic; Coronary Angio | 1988 |
Smoking, catecholamines, and the ischemic myocardium.
Topics: Angina Pectoris; Atenolol; Catecholamines; Coronary Disease; Female; Heart; Humans; Male; Nifedipine | 1988 |
Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
Topics: Angina Pectoris; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Drug Therapy, Combination | 1988 |
Hemodynamic effects of metoprolol and nifedipine in angina pectoris measured by isotope technique.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hemodynam | 1988 |
Combination therapy with diltiazem and nifedipine in patients with effort angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Drug Therapy | 1988 |
Antianginal efficacy of gallopamil in comparison to nifedipine.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Circulation; Double-Blind Method; E | 1988 |
Influence of isosorbide 5-mononitrate 20 mg, sustained-release 50 mg and sustained-release nifedipine 20 mg on ischaemic ST-segment changes during Holter monitoring. A double-blind cross-over study in patients with spontaneous angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Electro | 1987 |
[Comparative evaluation of 3 calcium antagonist drugs in patients with stable angina of effort. Double-blind placebo-controlled randomized study].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Diltiazem; Exercise Test; Humans; Male; Midd | 1987 |
Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.
Topics: Aged; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; | 1987 |
Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol.
Topics: Angina Pectoris; Atenolol; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Metho | 1987 |
Nifedipine and metoprolol in suspected unstable angina. The Holland Interuniversity Nifedipine/Metoprolol Trial.
Topics: Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Comb | 1987 |
Nifedipine and metoprolol in suspected unstable angina. Principles of intervention research.
Topics: Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Ethics, Medical; Humans; Metoprolol; Ne | 1987 |
Nifedipine and metoprolol in suspected unstable angina. Formation of the HINT cohort.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Electrocardiography; Femal | 1987 |
Nifedipine and metoprolol in suspected unstable angina. Data analysis.
Topics: Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Data Interpretation, Statistical; Doubl | 1987 |
Nifedipine and metoprolol in suspected unstable angina. Planning and conduct.
Topics: Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Comb | 1987 |
Nifedipine and metoprolol in suspected unstable angina. Treatment, observations, and outcome events.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Double-Blind Method; Drug | 1987 |
[Calcium antagonists in acute myocardial infarct? Long-term nifedipine infusion in pre-infarct angina and acute myocardial infarct].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Creatine Kinase; Female; Hemodynamics; Human | 1987 |
[Evaluation of the preparation Cordafen (Polfa) in the treatment of angina pectoris in patients after myocardial infarction].
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Humans; Male; Middle Aged; Myocardial Infarction; | 1987 |
[Comparative effects of diltiazem and nifedipine combined with propranolol, in patients with chronic stable angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Diltiazem; | 1987 |
Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
Topics: Administration, Cutaneous; Angina Pectoris; Clinical Trials as Topic; Clonidine; Delayed-Action Prep | 1987 |
Isosorbide-5-mononitrate and nifedipine can reduce ischaemic ST-segment changes during Holter monitoring in patients with spontaneous angina pectoris.
Topics: Activities of Daily Living; Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; | 1988 |
Assessment of exercise tolerance of cardiac patients by bicycle, treadmill and treadmill plus isometric exercise with and without nifedipine.
Topics: Aged; Angina Pectoris; Blood Pressure; Exercise Test; Heart Rate; Humans; Isometric Contraction; Mal | 1987 |
Effects of propranolol and nifedipine on exercise-induced attack in patients variant angina: assessment by exercise thallium-201 myocardial scintigraphy with quantitative rotational tomography.
Topics: Adult; Aged; Angina Pectoris; Coronary Circulation; Female; Humans; Male; Middle Aged; Nifedipine; P | 1986 |
Comparison of nicardipine and propranolol for chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Metho | 1986 |
Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Double-Blind Method; Femal | 1986 |
Randomized double-blind placebo-controlled comparison of nicardipine and nifedipine in patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Exer | 1986 |
Calcium-channel blockers for combined angina pectoris and systemic hypertension.
Topics: Adult; Aged; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chr | 1986 |
Randomized placebo-controlled comparative study of nifedipine, verapamil and isosorbide dinitrate in the treatment of angina at rest.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Delayed-Action Preparations; Dose-Respo | 1986 |
Effects of nifedipine on left ventricular performance in unstable angina pectoris during a follow-up of 48 hours.
Topics: Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Female; Heart; Heart Ventricles; Hum | 1986 |
Influence of nifedipine on left ventricular perfusion and function in patients with unstable angina: evaluation with radionuclide techniques.
Topics: Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Coronary Circulation; Double-Blind Meth | 1986 |
[Anti-angina action and tolerance of isosorbide-5-mononitrate or nifedipine in retard form].
Topics: Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Th | 1986 |
[The effect of diltiazem and nifedipine, alone or in combination, on exercise performance, myocardial ischemia and left ventricular function in patients with chronic stable effort angina: a double-blind, randomized and placebo-controlled clinical study].
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Diltiazem; Drug Therapy, Combination; Female; Heart | 1986 |
Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Clinical Trials as Topic; Double-B | 1987 |
Improved left ventricular performance during exercise with verapamil or nifedipine in patients with chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Myocardia | 1987 |
Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
Topics: Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Clinical Trials as Topic; Coronary Disea | 1987 |
[Comparative evaluation of the results of the bicycle ergometry test in patients with stress stenocardia after treatment with propranolol and nifedipine].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Drug Therapy, Combination; Exercise Test; Follow-Up St | 1986 |
[Comparative evaluation using an ergometric test of the efficacy of the 3 major calcium antagonists on exertion stable angina].
Topics: Adult; Angina Pectoris; Blood Pressure; Diltiazem; Double-Blind Method; Female; Heart Rate; Humans; | 1987 |
PY 108-068--acute effects of a single oral dose in chronic stable angina.
Topics: Administration, Oral; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Chronic Disea | 1986 |
Time sequence of anginal pain.
Topics: Adult; Aged; Angina Pectoris; Circadian Rhythm; Female; Humans; Isosorbide Dinitrate; Male; Metoprol | 1986 |
Pathogenesis of angina pectoris in patients with one-vessel disease: possible role of dynamic coronary obstruction.
Topics: Adult; Aged; Angina Pectoris; Angiography; Coronary Angiography; Coronary Circulation; Coronary Vaso | 1986 |
Nifedipine compared with verapamil in unstable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Drug Evaluation; Female; Follow-Up Studies; Humans; | 1986 |
Effects of nifedipine on arterial oxygenation at rest and during exercise in patients with stable angina.
Topics: Adult; Aged; Angina Pectoris; Arteries; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Oxygen; | 1986 |
A haemodynamic study of the effects of combined slow-calcium channel blockade (nisoldipine) and beta-blockade (metoprolol) in coronary heart disease.
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Therapy, Combination; Hemod | 1986 |
[Diltiazem in spontaneous angina: comparison with nifedipine and verapamil].
Topics: Adult; Aged; Angina Pectoris; Benzazepines; Diltiazem; Drug Evaluation; Electrocardiography; Female; | 1985 |
Comparative haemodynamic effects of nicardipine and verapamil in coronary artery disease.
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Artery Bypass; Exercise Test; Hemodynamic | 1985 |
Safety of acute calcium antagonist withdrawal: studies in patients with unstable angina withdrawn from nifedipine.
Topics: Angina Pectoris; Angina, Unstable; Coronary Artery Bypass; Coronary Disease; Double-Blind Method; El | 1985 |
Relation of antianginal efficacy of nifedipine to degree of coronary arterial narrowing and to presence of coronary collateral vessels.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Clinical Trials as Topic; Collateral Circ | 1985 |
Effects of nifedipine on systemic and regional oxygen transport and metabolism at rest and during exercise.
Topics: Angina Pectoris; Biological Transport; Clinical Trials as Topic; Exercise Test; Hemodynamics; Humans | 1985 |
Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Double- | 1985 |
Are calcium antagonists cardioprotective?
Topics: Angina Pectoris; Animals; Blood Viscosity; Calcium Channel Blockers; Clinical Trials as Topic; Coron | 1985 |
[Rheological properties of blood in patients with stenocardia during treatment with obsidan, corvatone and corinfar].
Topics: Adult; Angina Pectoris; Blood Viscosity; Clinical Trials as Topic; Humans; Male; Middle Aged; Molsid | 1985 |
[Evaluation of the calcium antagonist fendilin in exertion angina].
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Metho | 1985 |
Left ventricular performance in unstable angina: assessment with radionuclide techniques.
Topics: Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; | 1985 |
A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Dose-Re | 1985 |
Chest pain after nontransmural infarction: the absence of remediable coronary vasospasm.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Vasospasm; Creatine Kinase; Double-Blind M | 1985 |
[Role of many hours of ECG monitoring (Holter method) in the diagnosis of ischemic heart disease and the selection and evaluation of antianginal therapy].
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Electrocardiograp | 1985 |
Effect of short and long term administration of amiodarone on ischaemia-induced left ventricular dysfunction. Implications for combined antianginal drug therapy.
Topics: Adult; Amiodarone; Angina Pectoris; Benzofurans; Coronary Disease; Female; Hemodynamics; Humans; Mal | 1985 |
[Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
Topics: Angina Pectoris; Atenolol; Biotransformation; Coronary Disease; Delayed-Action Preparations; Drug Ad | 1985 |
Nicardipine for angina pectoris at rest and coronary arterial spasm.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Vasospasm; Doubl | 1985 |
Nicardipine for stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Exercise Test; Female; Heart | 1985 |
Short- and long-term treatment of stable effort angina with nicardipine, a new calcium channel blocker: a double-blind, placebo-controlled, randomised, repeated cross-over study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Do | 1985 |
[Ergometric evaluation of corinfar, phenoptin, obsidan and 2% nitroglycerin ointment in exercise-induced stenocardia].
Topics: Adult; Angina Pectoris; Cardiovascular Agents; Clinical Trials as Topic; Exercise Test; Humans; Male | 1985 |
Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.
Topics: Adult; Aged; Angina Pectoris; Benzazepines; Blood Pressure; Clinical Trials as Topic; Diltiazem; Dou | 1985 |
Short-term effect of nifedipine on effort tolerance in patients with angina pectoris.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Double-Blind M | 1986 |
A comparison of two nifedipine dosages in the treatment of chronic angina.
Topics: Aged; Angina Pectoris; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Male; Nife | 1986 |
Myocardial catecholamine balance during angina: effects of calcium entry blockers, verapamil and nifedipine.
Topics: Aged; Angina Pectoris; Catecholamines; Epinephrine; Heart; Humans; Middle Aged; Myocardium; Nifedipi | 1985 |
Propranolol-verapamil versus propranolol-nifedipine in severe angina pectoris of effort: a randomized, double-blind, crossover study.
Topics: Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Electrocardiography | 1985 |
Comparison of antianginal efficacy of nifedipine and isosorbide dinitrate in chronic stable angina: a long-term, randomized, double-blind, crossover study.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Pressure; Double-Blind Method; Drug Evalua | 1985 |
Objective evaluation of PY-108-068, a new calcium channel inhibitor for the treatment of chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, | 1985 |
Double-blind crossover comparison of the antianginal effects of nifedipine and isosorbide dinitrate in patients with exertional angina receiving propranolol.
Topics: Adult; Aged; Angina Pectoris; Double-Blind Method; Female; Humans; Isosorbide Dinitrate; Male; Middl | 1985 |
Haemodynamic analysis of the effects of nicardipine and metoprolol alone and in combination in coronary artery disease.
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Therapy, Combination; Femal | 1985 |
442 other studies available for nifedipine and Angina Pectoris
| Article | Year |
|---|---|
Comparison of anti-anginal effect of cilnidipine with those of nicardipine and nifedipine in the vasopressin-induced angina model of rats.
Topics: Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calciu | 2016 |
Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: a population-based study.
Topics: Acute Coronary Syndrome; Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Canada; Cohort | 2008 |
Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: the ACTION experience.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Angiography; Cross-Cultural Comparis | 2010 |
Prognostic effects of calcium channel blockers on cardiac events, stroke and end-stage renal disease in patients with angina pectoris. Retrospective comparative study of benidipine, diltiazem and nifedipine.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Dihydropyridines; Diltiazem; Female; Heart Diseases | 2008 |
A case of severe coronary spasm associated with 5-fluorouracil chemotherapy.
Topics: Aged, 80 and over; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Calcium Channel | 2012 |
Calcium channel blockers revisited.
Topics: Angina Pectoris; Antihypertensive Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; China; Cli | 2002 |
Administration of nifedipine CR immediately after awakening prevents a morning surge in hypertensive patients. Case report of three cases.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Delayed-Ac | 2003 |
Metabolism of the dihydropyridine calcium channel blockers mebudipine and dibudipine by isolated rat hepatocytes.
Topics: Angina Pectoris; Animals; Cell Culture Techniques; Half-Life; Hepatocytes; Hydroxylation; Hypertensi | 2004 |
[Effect of Long-Acting Nifedipine on Mortality and Cardiovascular Morbidity in Patients With Stable Angina Requiring Treatment. Results of the ACTION Study.].
Topics: Angina Pectoris; Angina, Stable; Calcium Channel Blockers; Humans; Nifedipine; Treatment Outcome | 2004 |
Drug safety in cardiovascular disease: a call to ACTION.
Topics: Adverse Drug Reaction Reporting Systems; Angina Pectoris; Calcium Channel Blockers; Humans; Nifedipi | 2006 |
Safety of nifedipine GITS in stable angina: the ACTION trial.
Topics: Adverse Drug Reaction Reporting Systems; Angina Pectoris; Calcium Channel Blockers; Female; Follow-U | 2006 |
Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy.
Topics: Aged; Angina Pectoris; Atherosclerosis; Calcinosis; Calcium Channel Blockers; Coronary Vessels; Fema | 2007 |
Revival of nifedipine, a dihydropyridine-based calcium blocker.
Topics: Angina Pectoris; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Diabet | 2007 |
Effects of benidipine in a rat model for experimental angina.
Topics: Amlodipine; Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Di | 2006 |
Coronary and aortic calcification: is the relationship important?
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aorta, Thoracic; Aortic Diseases; Calcinosis; Coron | 2007 |
Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.
Topics: Adult; Aged; Aging; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cohort Studies; Coronary | 2007 |
Drugs and the heart. III. Calcium antagonists.
Topics: Angina Pectoris; Aniline Compounds; Arrhythmias, Cardiac; Calcium; Cardiomegaly; Diuretics; Heart Di | 1980 |
Nifedipine.
Topics: Angina Pectoris; Calcium; Hemodynamics; Humans; Hypertension; Nifedipine; Pyridines | 1980 |
Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Angina Pectoris, Variant; Anticoagulants; Coron | 1981 |
Long-term clinical effect of calcium inhibitors in hypertrophic cardiomyopathy compared to the effect of beta-blocking agents. A preliminary report with special reference to the beneficial effect of nifedipine on angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Blood Pressure; Calcium; Cardiomyopathy, Hypert | 1981 |
[Clinical, angiographic and therapeutic aspects of variant angina (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Coronary Angiog | 1981 |
Prognostic significance of electrocardiographic findings in angina at rest. Therapeutic implications.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angina Pectoris; Coronary Angiography; Electro | 1981 |
Calcium blockers for heart disease: two approved, more to come.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Diltiazem; Drug Therapy, Com | 1982 |
Beneficial effect of adding nifedipine to beta-adrenergic blocking therapy in angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Cardiac Pacing, Artificial; Drug Therapy, Combination; | 1982 |
Shared Capgras syndrome and nifedipine.
Topics: Aged; Angina Pectoris; Capgras Syndrome; Female; Humans; Nifedipine; Psychotic Disorders; Pyridines | 1982 |
[Treatment of angina pectoris with special reference to beta-blockers].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticoagulants; Calcium Channel Blockers; Diagnosis, D | 1982 |
Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Atenolol; Blood Pressure; Dru | 1982 |
Efficacy of nifedipine therapy for refractory angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; | 1982 |
Nifedipine therapy in angina pectoris: evaluation of safety and side effects.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel | 1982 |
Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atrioventricular Node; Calcium Channel Bl | 1982 |
Managing angina with calcium channel blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Dr | 1982 |
Calcium channel blocking drugs for chronic, stable angina. Nifedipine.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Angina Pectoris; Dose-Response Relationship, Drug | 1982 |
Effects of antianginal drugs on ventricular function, myocardial blood flow and peripheral circulation.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Circulation; Calcium Channel Blockers; Diltiazem | 1982 |
[Evaluation of anti-angina therapy by means of the treadmill test].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Bupranolol; Drug Therapy, Combination; Exerc | 1982 |
What is preferable in unstable angina, beta-blockade or calcium-inhibition?
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Animals; Calcium Channel Blockers; Coronary Dise | 1983 |
Effect of nifedipine alone versus in combination with beta blockers and/or nitrates on left ventricular function in angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Humans; Nifedipine; Nitrates | 1983 |
Adjunctive nifedipine therapy in high-risk, medically refractory, unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina, Unstable; Blood Pressure; Calcium | 1983 |
Cardiorespiratory effects of isosorbide dinitrate and nifedipine in combination with nadolol: a double-blind comparative study of beneficial and adverse antianginal drug interactions.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Double-Blind Method; Drug Therapy, Combin | 1984 |
[Use of nifedipine derivatives in treating ischemic heart disease patients].
Topics: Angina Pectoris; Cardiac Complexes, Premature; Chronic Disease; Coronary Disease; Dose-Response Rela | 1984 |
Concepts for the initial management of patients with unstable angina pectoris--from the viewpoint of coronary arteriography, coronary circulation and cardiac performance including various interventional studies.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon; Coronary Angiography; Coronary Artery Bypass; Co | 1983 |
Coronary artery spasm at the site of angioplasty in the first 2 months after successful percutaneous transluminal coronary angioplasty.
Topics: Adult; Angina Pectoris; Angioplasty, Balloon; Coronary Vasospasm; Humans; Male; Middle Aged; Myocard | 1983 |
Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium; Cardiovascular Diseases; Coronary Disease; Diltiazem | 1980 |
Calcium channels in the heart.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Diltiazem; Electric Conductivity; Heart; Hypertension; Ion Ch | 1981 |
Calcium channel blockers for cardiovascular disorders.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; | 1982 |
Unstable angina in a patient with mucocutaneous lymph node syndrome.
Topics: Aneurysm; Angina Pectoris; Angina, Unstable; Aspirin; Child; Coronary Angiography; Coronary Artery B | 1984 |
Nifedipine and cardiopulmonary bypass. Post-bypass management after continuation or withdrawal of therapy.
Topics: Adult; Aged; Anesthesia, General; Angina Pectoris; Cardiopulmonary Bypass; Coronary Artery Bypass; F | 1984 |
Calcium antagonists, nitrates, and new antianginal drugs.
Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Hypertension; Isosorbide Dinitrate; Lidoflazine; | 1983 |
Treatment of angina pectoris with nifedipine: importance of dose titration.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Electrocardiography; Exercise Test; Female; Heart Rate | 1983 |
Intraoperative coronary artery spasm successfully treated with nitroglycerin and nifedipine.
Topics: Angina Pectoris; Coronary Disease; Coronary Vasospasm; Electrocardiography; Humans; Intraoperative C | 1983 |
Nifedipine therapy for coronary vasospasm.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Disease; Coronary Vasospasm; Female; Humans; Mal | 1983 |
Calcium antagonist withdrawal syndrome.
Topics: Adult; Angina Pectoris; Humans; Male; Nifedipine; Pyridines; Substance Withdrawal Syndrome; Thrombos | 1983 |
Treatment of angina pectoris with nifedipine.
Topics: Angina Pectoris; Humans; Nifedipine; Pyridines | 1983 |
Transient retinal ischaemia induced by nifedipine.
Topics: Aged; Angina Pectoris; Humans; Ischemia; Male; Nifedipine; Retinal Vessels; Visual Fields | 1983 |
Lack of inhibition of anterior pituitary hormone release during chronic treatment with calcium antagonists.
Topics: Aged; Angina Pectoris; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; | 1984 |
Clinical characteristics and current management of medically refractory unstable angina.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Blood Pressure; Coronary Artery Bypass; Female; Foll | 1984 |
Treatment of unstable angina with emphasis on calcium antagonists.
Topics: Angina Pectoris; Angina, Unstable; Anticoagulants; Coronary Circulation; Coronary Disease; Electroca | 1984 |
Antianginal drug effects on normal, ischemic and scar myocardial segments in man.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Heart; Humans; Male; Metoprolol; Middle Aged | 1984 |
Alterations in angina threshold with nifedipine during pacing induced angina.
Topics: Aged; Angina Pectoris; Coronary Circulation; Coronary Disease; Heart Function Tests; Hemodynamics; H | 1984 |
Febrile reaction following nifedipine therapy.
Topics: Aged; Angina Pectoris; Female; Fever; Humans; Nifedipine | 1984 |
Safety of nifedipine in subjects with bronchial asthma and COPD.
Topics: Adult; Aged; Angina Pectoris; Asthma; Female; Forced Expiratory Flow Rates; Forced Expiratory Volume | 1984 |
[Antianginal effect of calcium antagonists, using nisoldipine as an example].
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Electrocardiography; Exercise Test; Heart | 1984 |
Sinus node dysfunction during coronary vasospastic angina.
Topics: Angina Pectoris; Coronary Vasospasm; Electrocardiography; Humans; Male; Middle Aged; Nifedipine; Sin | 1984 |
Unstable angina precipitated by nifedipine.
Topics: Angina Pectoris; Angina, Unstable; Humans; Nifedipine | 1984 |
Therapy for stable angina pectoris.
Topics: Aged; Angina Pectoris; Humans; Male; Nifedipine | 1984 |
Elimination of unstable angina by diltiazem under temporary pacing.
Topics: Aged; Angina Pectoris; Angina, Unstable; Benzazepines; Cardiac Pacing, Artificial; Combined Modality | 1984 |
[Myocardial infarction after the first dose of nifedipine].
Topics: Adult; Aged; Angina Pectoris; Humans; Male; Myocardial Infarction; Nifedipine | 1984 |
Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Coronary Circulation; Hemodynamics; Humans; Lactate | 1984 |
[Comparative effectiveness of finoptin, corinfar and their combination in patients with angina pectoris].
Topics: Adult; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1984 |
Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
Topics: Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Disease; F | 1984 |
Mechanism(s) of calcium antagonists and ischemia.
Topics: Adenosine Triphosphate; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Coronary Circul | 1984 |
Clinical efficacy of niludipine in the treatment of angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Electrocardiography; Female; | 1984 |
[Use of beta-blockers and a calcium antagonist in angina pectoris during the period of postinfarct rehabilitation].
Topics: Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Myocardial Infarction; | 1984 |
Calcium channel blockers. New treatment for cardiovascular disease.
Topics: Adult; Angina Pectoris; Calcium; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cardiovascu | 1983 |
Nifedipine.
Topics: Angina Pectoris; Female; Humans; Nifedipine; Pregnancy; Pyridines | 1983 |
Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris.
Topics: Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Circulatio | 1983 |
Effects of nifedipine on coronary hemodynamic findings during exercise in patients with stable exertional angina.
Topics: Adult; Angina Pectoris; Blood Pressure; Cardiac Catheterization; Coronary Circulation; Coronary Vess | 1983 |
Nifedipine in continuous ambulatory peritoneal dialysis.
Topics: Angina Pectoris; Humans; Nifedipine; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory | 1983 |
Clinical use of calcium channel blockers.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem; Drug Therapy, Combinatio | 1983 |
[Effect of nifedipine on the course of unstable angina: experience with 23 patients].
Topics: Aged; Angina Pectoris; Angina, Unstable; Blood Pressure; Electrocardiography; Female; Heart Rate; Hu | 1983 |
The systemic and coronary haemodynamic effects of felodipine in patients with coronary heart disease.
Topics: Adult; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Cardiac Catheterization; Coronary C | 1983 |
Salutary effect of nifedipine in pacing-induced angina: relation to afterload reduction.
Topics: Adult; Aged; Angina Pectoris; Biomechanical Phenomena; Blood Pressure; Female; Heart Rate; Hemodynam | 1983 |
Calcium channel blocking agents. Council on scientific affairs.
Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Asthma; Calcium Channel Blockers; Cardiomyopathy, Hy | 1983 |
[Molsidomine in exertion angina].
Topics: Angina Pectoris; Exercise Test; Hemodynamics; Humans; Isosorbide Dinitrate; Molsidomine; Nifedipine; | 1983 |
Paradoxical angina after nifedipine: angiographic documentation.
Topics: Angina Pectoris; Angiography; Humans; Male; Middle Aged; Nifedipine | 1984 |
Hemodynamic effects of nifedipine during upright exercise in stable angina pectoris and either normal or severely impaired left ventricular function.
Topics: Adult; Angina Pectoris; Blood Pressure; Cardiac Output; Heart Rate; Heart Ventricles; Hemodynamics; | 1984 |
Exacerbation of asthmatic symptoms after cessation of nifedipine therapy.
Topics: Aged; Angina Pectoris; Asthma; Bronchodilator Agents; Humans; Male; Middle Aged; Nifedipine | 1984 |
The acute effects of nifedipine on red cell deformability in angina pectoris.
Topics: Aged; Angina Pectoris; Blood Viscosity; Double-Blind Method; Erythrocytes; Female; Hematocrit; Human | 1984 |
The effect on left ventricular performance of nifedipine and metoprolol singly and together in exercise-induced angina pectoris.
Topics: Adult; Angina Pectoris; Cardiac Output; Drug Therapy, Combination; Heart Ventricles; Hemodynamics; H | 1984 |
Nifedipine plasma concentration in patients treated for angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; N | 1984 |
Nifedipine-induced acute psychosis.
Topics: Angina Pectoris; Humans; Male; Middle Aged; Nifedipine; Psychoses, Substance-Induced | 1984 |
Effects of felodipine on systemic and coronary haemodynamics in patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Circulation; Electrocardiography; | 1984 |
Unstable angina precipitated by nifedipine. A case report.
Topics: Aged; Angina Pectoris; Angina, Unstable; Humans; Male; Nifedipine | 1984 |
The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris.
Topics: Adult; Angina Pectoris; Blood Pressure; Cardiac Output; Heart; Humans; Male; Middle Aged; Nifedipine | 1984 |
Nifedipine therapy for coronary-artery spasm. Experience in 127 patients.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Coronary Disease; Female; Humans; Male; Midd | 1980 |
Pathophysiology and treatment of coronary arterial spasm.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Atropine; Calcium; Coronary Disease; Coronary Vess | 1980 |
Ergonovine testing to detect spontaneous remissions of variant angina during long-term treatment with calcium antagonist drugs.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Calcium; Diltiazem; Ergonovine; Female; Foll | 1981 |
Effects of adalat (nifedipine) on left ventricular hemodynamics in angina pectoris: comparative study with propranolol.
Topics: Adult; Aged; Angina Pectoris; Female; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Propranol | 1980 |
The clinical effect of 4-(2'-nitrophenyl)2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine (BAY a 1040) on angina pectoris evaluated by sequential analysis.
Topics: Adult; Aged; Angina Pectoris; Double-Blind Method; Female; Humans; Male; Middle Aged; Nifedipine; Py | 1980 |
Effect of nifedipine on exercise tolerance in patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Double-Blind Method; Exercise Test; Humans; Male; Middle Aged; Nifedip | 1980 |
A double-blind controlled trial of the anti-anginal efficacy of nifedipine compared with propranolol.
Topics: Adult; Aged; Angina Pectoris; Double-Blind Method; Humans; Middle Aged; Nifedipine; Propranolol; Pyr | 1980 |
Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris.
Topics: Angina Pectoris; Humans; Isosorbide Dinitrate; Middle Aged; Nifedipine; Physical Exertion; Propranol | 1980 |
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Humans; Male; Middle Aged; Nifedipine; Pindo | 1980 |
Prinzmetal's variant form of angina pectoris re-evaluation of mechanisms.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Electroencephalography; Female; Humans; Male; Midd | 1980 |
Suppression of repeatedly occurring ventricular fibrillation with nifedipine in variant form of angina pectoris.
Topics: Aged; Angina Pectoris; Angina Pectoris, Variant; Humans; Male; Middle Aged; Nifedipine; Pyridines; V | 1980 |
Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs.
Topics: Adult; Angina Pectoris; Coronary Disease; Diltiazem; Female; Humans; Male; Middle Aged; Nifedipine; | 1980 |
Vasodilators for angina pectoris.
Topics: Angina Pectoris; Humans; Nifedipine; Nitroglycerin; Vasodilator Agents; Verapamil | 1981 |
[Angina at rest. Clinical, electrocardiographic and angiographic observations in 107 patients].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Angiography; Coronary Artery Bypass; Co | 1980 |
Prinzmetal's variant angina.
Topics: Aged; Angina Pectoris; Angina Pectoris, Variant; Diagnosis, Differential; Electrocardiography; Femal | 1981 |
Treatment of angina pectoris patients with niludipine a new calcium antagonistic drug.
Topics: Aged; Angina Pectoris; Electrocardiography; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male | 1981 |
[Cardiac ischemia on exercise. Effect of nifedipine and acebutolol singly and in combination (author's transl)].
Topics: Acebutolol; Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Double-Blind Method; Dru | 1981 |
Clinical effectiveness of niludipine in patients with ischemic heart disease.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Electrocardiography; Female; Humans; | 1982 |
[Therapy of instable angina pectoris].
Topics: Angina Pectoris; Coronary Care Units; Diltiazem; Humans; Intra-Aortic Balloon Pumping; Isosorbide Di | 1982 |
Different effects of nitroglycerin and nifedipine on regional myocardial blood flow during pacing induced angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Cardiac Pacing, Artificial; Coronary Circulation; Humans; Male; Mid | 1980 |
Comparison of the combination of nifedipine and atenolol with the combination of nitroglycerine and atenolol in patients with angina pectoris.
Topics: Angina Pectoris; Atenolol; Drug Therapy, Combination; Exercise Test; Heart Rate; Humans; Male; Nifed | 1980 |
Calcium channel blockers.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem | 1983 |
Therapeutic uses of calcium channel blockers.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiovascular System; Diltiazem; | 1983 |
Comparison of verapamil and nifedipine in chronic stable angina pectoris.
Topics: Angina Pectoris; Humans; Nifedipine; Pyridines; Verapamil | 1983 |
Mechanisms of angina relief after nifedipine: a hemodynamic and myocardial metabolic study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Circulation; Female; Hemodynamics; Humans; Ma | 1983 |
[Calcium antagonists. Concept and therapeutic applications].
Topics: Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; C | 1982 |
Effect of the calcium antagonistic agent nifedipine on platelet aggregation response to exercise in patients with angina pectoris.
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Female; Humans; Male; Middle Aged; Nifedipine; Phy | 1982 |
[Effects of nifedipine in delayed-action preparation on the tolerance to exertion in angina patients].
Topics: Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedul | 1982 |
[Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 8. Angina pectoris agents with effect on calcium metabolism].
Topics: Angina Pectoris; Calcium; Humans; Nifedipine; Pyridines; Verapamil | 1980 |
[Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 9. Angina pectoris agents with effect on calcium metabolism].
Topics: Angina Pectoris; Calcium; Humans; Nifedipine; Pyridines; Verapamil | 1980 |
Prinzmetal's variant angina)(PVA). Circadian variation in response to hyperventilation.
Topics: Angina Pectoris; Angina Pectoris, Variant; Circadian Rhythm; Electrocardiography; Humans; Hyperventi | 1981 |
Variant form of angina pectoris: its clinical features and treatment. The 185th Luis Guerrero Memorial Lecture given at the 6th Paul Dudley White Session, University of Santo Tomas, Manila, The Philippines, January 24, 1979.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium; Coronary Artery Bypass; Di | 1980 |
Recurrence of variant angina after bypass surgery.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Artery Bypass; Humans; Nifedipine; Recurrence | 1980 |
Early coronary graft thrombosis following surgery for Prinzmetal's angina: treatment with nifedipine and thrombolysis.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Artery Bypass; Fibrinolytic Agents; Humans; Male | 1981 |
Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Cardiac Catheterization; Coronary Angiograph | 1981 |
Effect of nifedipine on glucose tolerance and insulin secretion in diabetic and non-diabetic patients.
Topics: Adult; Aged; Angina Pectoris; Blood Glucose; Diabetes Mellitus; Female; Glucose Tolerance Test; Huma | 1980 |
Beneficial effects of nifedipine on regional myocardial blood flow in patients with coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Cardiac Catheterization; Coronary Circulation; Coronary Disease; Femal | 1982 |
Symposium on Cardiovascular Disease and Calcium Antagonists. Introduction.
Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem; Humans; Myocard | 1982 |
The effects of calcium channel blocking agents on cardiovascular function.
Topics: Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Disease | 1982 |
Use of nifedipine in older patients and patients with congestive heart failure.
Topics: Age Factors; Aged; Angina Pectoris; Female; Heart Failure; Humans; Male; Middle Aged; Nifedipine; Py | 1982 |
Are propranolol and nifedipine synergistic in angina pectoris?
Topics: Angina Pectoris; Drug Synergism; Humans; Nifedipine; Propranolol; Pyridines | 1982 |
Acute hemodynamic effects of nifedipine in patients with ischemic heart disease.
Topics: Adult; Aged; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Disease; Female; Hemodynamics; Hu | 1982 |
Adverse response to nifedipine in unstable angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Electrocardiography; Humans; Male; Middle Aged; Nifedipine; P | 1982 |
New angina drugs.
Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Nifedipine; Pyridines; Verapamil | 1982 |
Nifedipine for angina pectoris.
Topics: Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Humans; Nifedipine; Pyridines | 1982 |
Nifedipine therapy for recurrent ischemic pain following myocardial infarction.
Topics: Aged; Angina Pectoris; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nifedipine; Pyridin | 1982 |
Nifedipine in cardiac operations.
Topics: Angina Pectoris; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coronary Disease; Female; Huma | 1982 |
Nifedipine therapy for small vessel disease of the heart.
Topics: Angina Pectoris; Coronary Circulation; Humans; Male; Middle Aged; Nifedipine; Pyridines | 1982 |
Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.
Topics: Angina Pectoris; Blood Pressure; Drug Therapy, Combination; Ethanolamines; Exercise Test; Hemodynami | 1982 |
Inpatient treatment of unstable angina: clinical perspective and sequential management.
Topics: Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Coronary Disease; Female; Hospi | 1982 |
[Effect of intracoronary nifedipine on coronary sinus blood flow and myocardial oxygen consumption in patients with coronary artery disease].
Topics: Angina Pectoris; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Female; Hemodyn | 1982 |
Effect of nifedipine on exercise-induced left ventricular dysfunction and myocardial hypoperfusion in stable angina.
Topics: Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Exercise Test; Heart; Heart Rate; Heart Ven | 1982 |
Hemodynamic and electrophysiologic effects of verapamil and nifedipine in patients on propranolol.
Topics: Angina Pectoris; Cardiac Output; Coronary Circulation; Drug Therapy, Combination; Electrophysiology; | 1982 |
Effects of new calcium channel blocker of niludipine on the coronary hemodynamics, diastolic properties, and metabolic responses to tachycardia stress in patients with coronary disease.
Topics: Adult; Aged; Angina Pectoris; Cardiac Catheterization; Cardiac Pacing, Artificial; Coronary Circulat | 1982 |
Calcium channel blockers in chronic stable angina. A review.
Topics: Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Diltiazem; Electrocardiography; Humans; | 1982 |
[Anti-ischemic efficacy of varying dosages of nifedipine].
Topics: Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Hemodynamics; Humans; Nifedipin | 1982 |
[Effects of therapy with a association of nifedipine and atenolol in patients with systemic arterial hypertension and angina pectoris].
Topics: Adult; Angina Pectoris; Atenolol; Drug Therapy, Combination; Humans; Hypertension; Male; Middle Aged | 1982 |
[Calcium antagonists in stress angina pectoris (pharmacodynamic study)].
Topics: Adult; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; | 1982 |
Effects of calcium antagonists, especially nifedipine, on variant angina, resting angina, and unstable angina.
Topics: Aged; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Coronary Vasospasm; Dilti | 1982 |
[New aspects of the treatment of angina pectoris and hypertension. 2d Mediterranean symposium, Madrid, 19 and 20 September 1980].
Topics: Angina Pectoris; Calcium Channel Blockers; Hypertension; Nifedipine; Pyridines | 1982 |
[Evaluation of nifedipine treatment in angina at rest].
Topics: Adult; Aged; Angina Pectoris; Coronary Vasospasm; Drug Evaluation; Female; Humans; Male; Middle Aged | 1982 |
[Treatment of spontaneous and effort angina with nifedipine].
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Coronary Vasospasm; Drug Evaluation; Exercis | 1982 |
[Hemodynamic evaluation of nifedipine by the multi-step, standing, exercise test in patients with angina pectoris].
Topics: Adult; Angina Pectoris; Exercise Test; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Posture; | 1982 |
[Effect of nifedipine on myocardial perfusion. Gammagraphic evaluation using thallium 201].
Topics: Adult; Angina Pectoris; Coronary Circulation; Exercise Test; Female; Heart; Humans; Male; Middle Age | 1982 |
Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged | 1981 |
[The treatment of angina pectoris with nifedipine in a new administrative form].
Topics: Angina Pectoris; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Nifedipine; Pyridin | 1981 |
[The ergometric test in the evaluation of the effects of nifedipine, verapamil and ethyl cinepazat maleate in angina of effort].
Topics: Adult; Angina Pectoris; Drug Evaluation; Exercise Test; Female; Hemodynamics; Humans; Male; Middle A | 1980 |
[Hemodynamic effects of nifedipine in association with nitroderivatives and betablocking drugs (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; | 1980 |
Calcium flux antagonists: a new treatment for some patients with angina pectoris?
Topics: Angina Pectoris; Humans; Nifedipine; Vasodilator Agents | 1980 |
Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Benzazepines; Coronary Angiography; Diltiaze | 1981 |
Nifedipine blockade of ergonovine-induced coronary arterial spasm: angiographic documentation.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Angiography; Electrocardiography; Ergonovine; Fe | 1981 |
[Coronary artery spasms with normal coronary arteries as the cause of recurrent ventricular fibrillations].
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Angiography; Electrocardiography; Humans; Male; | 1981 |
The use of propranolol and nifedipine in the medical management of angina pectoris.
Topics: Angina Pectoris; Drug Therapy, Combination; Electrocardiography; Female; Heart Function Tests; Human | 1981 |
Diagnosis and management of coronary vasospasm.
Topics: Angina Pectoris; Angina Pectoris, Variant; Ergonovine; Hemodynamics; Humans; Nifedipine | 1981 |
[Calcium antagonists: use with discretion].
Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Myocardial Contraction; Nifedipine; Verapamil | 1981 |
Symposium on nifedipine in angina pectoris. Foreward.
Topics: Angina Pectoris; Animals; Calcium Channel Blockers; Dogs; Humans; Nifedipine; Pyridines | 1981 |
Influence of nifedipine left ventricular systolic and diastolic function. Relationships to manifestations of ischemia and congestive failure.
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Disease; Coronar | 1981 |
Calcium antagonists.
Topics: Angina Pectoris; Calcium Channel Blockers; Cell Membrane; Diltiazem; Heart; Humans; Hypertension; Mu | 1980 |
Clinical use of calcium entry blockers.
Topics: Angina Pectoris; Calcium Channel Blockers; Cinnarizine; Coronary Circulation; Coronary Vasospasm; Di | 1981 |
[Nifedipine--a new antianginal agent].
Topics: Angina Pectoris; Humans; Nifedipine; Pyridines | 1981 |
Antianginal effect of nifedipine after intracoronary and intravenous administration judged by reduction of ischemic ST-segment depression in exercise tests.
Topics: Angina Pectoris; Blood Pressure; Electrocardiography; Exercise Test; Heart Rate; Humans; Infusions, | 1981 |
[Prinzmetal's angina induced by nifedipine].
Topics: Angina Pectoris; Female; Humans; Middle Aged; Nifedipine; Pyridines | 1980 |
[Evaluation of calcium metabolism and pituitary gonadotropin secretion during treatment with nifedipine].
Topics: Angina Pectoris; Calcium; Female; Gonadotropins, Pituitary; Humans; Male; Middle Aged; Nifedipine; P | 1981 |
[Hemodynamic effects of nifedipine in patients with obstructive coronary disease and depressed left ventricular function].
Topics: Angina Pectoris; Coronary Disease; Hemodynamics; Humans; Male; Nifedipine; Pyridines | 1981 |
[Calcium inhibitors. Current indications in cardiology].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium; Cardiovascular Diseases; Diltiazem; Humans; Nifedipi | 1980 |
Treatment of angina at rest with nifedipine: a short-term controlled study.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Female; Follow-Up Studies; Hemo | 1980 |
[Paradoxal angina pectoris following nifedipine].
Topics: Angina Pectoris; Humans; Male; Middle Aged; Nifedipine; Pyridines | 1980 |
[Nifedipine (Adalat)].
Topics: Angina Pectoris; Chemical Phenomena; Chemistry; Humans; Nifedipine; Pyridines | 1980 |
Nifedipine: offering successful treatment of refractory life-threatening coronary artery spasm.
Topics: Angina Pectoris; Angina Pectoris, Variant; Female; Humans; Middle Aged; Nifedipine; Pyridines | 1980 |
[Effects of nifedipine on lactate metabolism in ischemic cardiopathy. Evaluation by atrial pacing].
Topics: Aged; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Disease; Female; Humans; Lactates; Male; | 1980 |
Adverse interaction between nifedipine and beta-blockade.
Topics: Angina Pectoris; Atenolol; Drug Interactions; Drug Therapy, Combination; Humans; Hypertension; Hypot | 1980 |
[Action of nifedipine on effort tolerance and on the left ventricular function during exercise in patients suffering from angina pectoris (author's transl)].
Topics: Aged; Angina Pectoris; Cardiac Catheterization; Drug Evaluation; Exercise Test; Heart; Heart Ventric | 1980 |
[Angina pectoris; variations on the nifedipine theme].
Topics: Angina Pectoris; Angina Pectoris, Variant; Hemodynamics; Humans; Nifedipine; Pyridines | 1980 |
[Therapeutic aspects of a case of Prinzmetal's angina].
Topics: Aged; Amiodarone; Angina Pectoris; Angina Pectoris, Variant; Drug Therapy, Combination; Electrocardi | 1980 |
Treatment of Prinzmetal's variant angina. Role of medical treatment with nifedipine and surgical coronary revascularization combined with plexectomy.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Coronary Angiography; Coronary Vessels; Elec | 1981 |
[Effectiveness and duration of action of nifedipine in effort angina (author's transl)].
Topics: Adult; Angina Pectoris; Exercise Test; Humans; Male; Middle Aged; Nifedipine; Pyridines | 1980 |
Refractory variant angina controlled with combined drug therapy in a patient with a single coronary artery.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Angiocardiography; Arteries; Coronary Vessel Anoma | 1980 |
A comparative study of calcium-ion antagonists in patients with variant angina.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Benzazepines; Diltiazem; Electrocardiography | 1980 |
Nifedipine and mortality. Grave defects in the dossier.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Autonomic Nervous System; Calcium Channel Blockers; Coronary | 1995 |
[The nifedipine withdrawal syndrome in patients with stable stenocardia of effort].
Topics: Angina Pectoris; Electrocardiography; Exercise Test; Exercise Tolerance; Humans; Myocardial Ischemia | 1995 |
Antianginal effects of YM-16151-4 in various experimental angina models.
Topics: 4-Aminopyridine; Amifampridine; Angina Pectoris; Animals; Arginine Vasopressin; Atrioventricular Nod | 1993 |
Withdrawal phenomenon after abrupt cessation of nifedipine in stable angina pectoris.
Topics: Angina Pectoris; Exercise Test; Exercise Tolerance; Humans; Male; Middle Aged; Myocardial Ischemia; | 1993 |
[Hemodynamic basis of antianginal effect of calcium antagonists in patients with ischemic heart disease after aortocoronary shunting: myocardial reserve potentials and their mechanisms].
Topics: Adult; Angina Pectoris; Coronary Artery Bypass; Dose-Response Relationship, Drug; Exercise Test; Hem | 1993 |
Effect of KRN2391, a novel vasodilator, on various experimental anginal models in rats.
Topics: Angina Pectoris; Animals; Disease Models, Animal; Electrocardiography; Injections, Intravenous; Isop | 1993 |
[Effect of palonidipine hydrochloride (TC-81), a new dihydropyridine derivative, on various myocardial ischemic models].
Topics: Angina Pectoris; Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dihydrop | 1993 |
Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model.
Topics: Acetylcholine; Angina Pectoris; Animals; Arginine Vasopressin; Calcium Channel Blockers; Coronary Ve | 1995 |
Zatebradine and exercise tolerance.
Topics: Angina Pectoris; Benzazepines; Calcium Channel Blockers; Cardiotonic Agents; Exercise Tolerance; Hum | 1996 |
[The use of the delayed-action form of korinfar in arterial hypertension, stenocardia and hypertrophic cardiomyopathy].
Topics: Adult; Aged; Angina Pectoris; Antihypertensive Agents; Calcium Channel Blockers; Cardiomyopathy, Hyp | 1996 |
[Carcinoid syndrome with angina pectoris treated with corinfar].
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Carcinoid Heart Disease; Electrocardiography; Huma | 1995 |
Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.
Topics: Angina Pectoris; Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Diltiaze | 1996 |
Sample sizes and withdrawals in clinical trials.
Topics: Angina Pectoris; Humans; Hypertension; Nifedipine; Patient Dropouts; Patient Selection; Publishing; | 1996 |
Calcium channel blocker debate: true lies?
Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Hypertension; Myocardial Contraction; Myocardial | 1996 |
Comments on 'A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily and isosorbide dinitrate twice daily in patients with stable angina'.
Topics: Angina Pectoris; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Nifedipine; Vasodilator | 1997 |
Antianginal effects of YM430, a novel calcium entry-blocking and beta-adrenoceptor-blocking agent in several experimental angina models.
Topics: 4-Aminopyridine; Adrenergic beta-Antagonists; Amifampridine; Angina Pectoris; Animals; Calcium Chann | 1997 |
[Stable angina pectoris: what is the role of calcium antagonists?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Calcium Channel Blockers; Clinical Trials as | 1997 |
[The possibility of the development of isosorbide dinitrate and nifedipine withdrawal syndromes in patients with stable stenocardia of effort].
Topics: Adult; Aged; Angina Pectoris; Exercise Tolerance; Humans; Isosorbide Dinitrate; Male; Middle Aged; N | 1997 |
Effect of JTV-506, a novel vasodilator, on experimental angina model in rats.
Topics: Administration, Oral; Angina Pectoris; Animals; Arginine Vasopressin; Blood Pressure; Chromans; Crom | 1998 |
The clinical effects of nifedipine on periodontal status.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Angina Pectoris; Calcium Channel Blockers; Dental Pl | 1998 |
Slow coronary flow--a cause for angina with ST segment elevation and normal coronary arteries. A case report.
Topics: Angina Pectoris; Coronary Angiography; Coronary Vessels; Female; Heart Conduction System; Humans; Mi | 1998 |
[Effects of fenigidin treatment regimen on the state of peripheral hemodynamics of patients with stable effort angina pectoris and postinfarction cardiosclerosis].
Topics: Angina Pectoris; Arm; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Female; Hem | 1998 |
P&T Committee review of nifedipine GITS: new modality for angina and hypertension.
Topics: Angina Pectoris; Drug Evaluation; Formularies, Hospital as Topic; Hypertension; Nifedipine; Pharmacy | 1990 |
Sustained-release nifedipine: new indication. Angina: safer drugs are available.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Delayed-Ac | 1998 |
Oral pathology case of the quarter.
Topics: Angina Pectoris; Calcium Channel Blockers; Diagnosis, Differential; Gingival Hyperplasia; Gingivitis | 2001 |
[Correction of coronary insufficiency by dihydropiridine antagonists of calcium in patients with coronary artery bypass].
Topics: Adult; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Volume; Coronary Artery By | 2001 |
Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats.
Topics: Administration, Oral; Angina Pectoris; Animals; Azocines; Coronary Disease; Electrocardiography; Iso | 2002 |
Paralytic ileus induced by the combined use of nifedipine and diltiazem in the treatment of vasospastic angina.
Topics: Angina Pectoris; Calcium Channel Blockers; Diltiazem; Drug Interactions; Drug Therapy, Combination; | 2002 |
[Conservative therapy of coronary disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Test; | 1976 |
[Calcium blocker (calcium antagonists) and angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Vessels; Calcium; Diltiazem; Female; Humans; Mus | 1977 |
Angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Humans; Isosorbide Dinitrate; Nifedipine; Nitroglyceri | 1978 |
[Physiopathological and therapeutical considerations of Prinzmetal's angina. Apropos of 7 cases].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Coronary Vessel | 1979 |
The treatment of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Angiography; Humans; Isosorbide Dinitrate; Mi | 1979 |
[Use of nifedipine and nitroglycerin during exercise therapy in patients with myocardial infarct. Clinical and hemodynamic studies].
Topics: Angina Pectoris; Blood Pressure; Cardiac Complexes, Premature; Cardiac Output; Digoxin; Exercise The | 1978 |
Beta-blocker withdrawal syndrome?
Topics: Angina Pectoris; Humans; Metoprolol; Nifedipine; Propanolamines; Substance Withdrawal Syndrome | 1979 |
[Comparison of hemodynamic and coronary effects of 2 antianginal vasodilator drugs: nifedipine and trinitrine].
Topics: Adult; Aged; Angina Pectoris; Blood Circulation; Blood Pressure; Coronary Circulation; Coronary Dise | 1978 |
Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs.
Topics: Adult; Angina Pectoris; Constriction, Pathologic; Coronary Angiography; Coronary Vessels; Diltiazem; | 1979 |
Objective assessment of treatment in severe angina.
Topics: Adult; Angina Pectoris; Drug Therapy, Combination; Exercise Test; Humans; Male; Middle Aged; Nifedip | 1979 |
[Prinzmetal's angina initiated by interruption of exercise. 5 cases with normal coronary radiograms].
Topics: Adult; Amiodarone; Angina Pectoris; Angina Pectoris, Variant; Atropine; Coronary Angiography; Corona | 1979 |
[Long-term treatment with nifedipine in patients with angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Drug Evaluation; Female; Hemodynamics; Humans; Male; Middle Aged; Nife | 1978 |
[Clinical and electrocardiographic evaluation of the effects of nifedipine in ischemic cardiopathy with the stenocardiac syndrome].
Topics: Aged; Angina Pectoris; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Electrocardiogr | 1978 |
[Evaluation of the effectiveness of nifedipine in a group of patients with stable angina of effort].
Topics: Adult; Aged; Angina Pectoris; Drug Evaluation; Exercise Test; Female; Humans; Male; Middle Aged; Nif | 1978 |
[Preliminary clinical evaluation of the use of nifedipine].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Drug Evaluation; Female; Humans; Male; Middle Aged; | 1978 |
Nifedipine in the treatment of life threatening Prinzmetal angina.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Humans; Male; Nifedipine; Pyridines | 1979 |
"Near maximal" exercise test by treadmill for evaluation of cardiac function.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Blood Pressure; Coronary Artery Bypass; Coronary Circulat | 1979 |
[Experience with adalat, a coronary therapeutic agent in medical practice (authors transl)].
Topics: Angina Pectoris; Blood Pressure; Drug Evaluation; Female; Headache; Humans; Male; Middle Aged; Nifed | 1977 |
[Long-term clinical study of a new molecule (nifedipine) in ischemic cardiopathy].
Topics: Adult; Aged; Angina Pectoris; Drug Evaluation; Female; Humans; Long-Term Care; Male; Middle Aged; Ni | 1977 |
Nifedipine therapy for Prinzmetal's angina.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Coronary Disease; Humans; Male; Myocardial Infarct | 1978 |
[Results of long-term therapy for angina pectoris using nifedipine (Adalat)].
Topics: Adult; Aged; Angina Pectoris; Electrocardiography; Female; Humans; Long-Term Care; Male; Middle Aged | 1978 |
Nifedipine (Adalat) for angina.
Topics: Angina Pectoris; Humans; Nifedipine; Pyridines | 1979 |
[Adalat in the treatment of intractable angina].
Topics: Adult; Aged; Angina Pectoris; Drug Evaluation; Female; Humans; Male; Middle Aged; Nifedipine; Pyridi | 1979 |
Provocative testing with ergonovine to evaluate the efficacy of treatment with calcium antagonists in variant angina.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Electrocardiography; Ergonovine; Evaluation | 1979 |
Symposium on nifedipine and calcium flux inhibition in the treatment of coronary arterial spasm and myocardial ischemia. Introduction.
Topics: Adult; Angina Pectoris; Calcium; Cardiomyopathies; Coronary Disease; Electrocardiography; Humans; Ma | 1979 |
Nifedipine in the treatment of Prinzmetal's (variant) angina.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Cold Temperature; Coronary Angiography; Dose | 1979 |
Effects of nifedipine after intravenous and intracoronary administration.
Topics: Aged; Angina Pectoris; Angina Pectoris, Variant; Coronary Circulation; Coronary Vessels; Dose-Respon | 1979 |
Nifedipine in variant angina and role of spasm in ischemic heart disease.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Disease; Humans; Nifedipine; Pyridines; Spasm | 1979 |
A retrospective evaluation of nifedipine therapy in Prinzmetal's angina.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Drug Evaluation; Female; Humans; M | 1979 |
[Coronary disease and calcium antagonists].
Topics: Angina Pectoris; Calcium; Coronary Disease; Diltiazem; Humans; Nifedipine; Verapamil | 1979 |
[Ergometric evaluation of the long-term treatment with nifedipine and a nitro derivative in subjects with angina of effort].
Topics: Adult; Aged; Angina Pectoris; Exercise Test; Female; Heart; Humans; Isosorbide Dinitrate; Male; Midd | 1979 |
[Nifedipine in angina at rest].
Topics: Aged; Angina Pectoris; Drug Evaluation; Female; Humans; Male; Middle Aged; Nifedipine; Placebos; Pyr | 1979 |
[Effects of nifedipine on pacing-induced angina in subjects with ischemic cardiopathy].
Topics: Adult; Aged; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Disease; Female; Humans; Male; Mi | 1978 |
[Combination of nifedipine with isosorbitol dinitrate and with propranolol. Verification of their effectiveness in angina of effort].
Topics: Adult; Aged; Angina Pectoris; Drug Therapy, Combination; Humans; Isosorbide Dinitrate; Male; Middle | 1978 |
[Observations on angina patients undergoing ambulatory treatment with nifedipine].
Topics: Adult; Aged; Ambulatory Care; Angina Pectoris; Female; Humans; Male; Middle Aged; Nifedipine; Pyridi | 1978 |
[Successful nifedipine therapy in coronary spasm].
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Angiography; Electrocardiography; Humans; Isosor | 1979 |
[Clinical observations on patients with myocardial and coronary sclerosis, myocardial ischemia with anginal attacks and myocardial infarct treated with nifedipine].
Topics: Adult; Aged; Angina Pectoris; Cardiomyopathies; Coronary Disease; Humans; Middle Aged; Myocardial In | 1978 |
[Analogy of response to acute and chronic nifedipine therapy in hypertensive and non-hypertensive patients].
Topics: Adult; Angina Pectoris; Coronary Disease; Electrocardiography; Female; Heart; Hemodynamics; Humans; | 1979 |
Drug treatment of chronic stable angina pectoris.
Topics: Angina Pectoris; Chronic Disease; Humans; Nifedipine; Nitrites; Perhexiline; Verapamil | 1978 |
[The effect of nifedipine on the pulmonary artery pressure in patients with coronary heart disease (author's transl)].
Topics: Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Dyspnea; Female; Heart Failure; Humans; Mal | 1978 |
[Calcium antagonists in acute coronary insufficiency].
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Calcium; Coronary Disease; Female | 1978 |
Nifedipine and Prinzmetal's angina.
Topics: Angina Pectoris; Angina Pectoris, Variant; Cardiac Output; Heart Rate; Hemodynamics; Humans; Male; M | 1979 |
[Proceedings: Effect of Nifedipine on the regional cerebral and peripheral muscle circulation].
Topics: Angina Pectoris; Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Muscles; Nifedipine | 1975 |
Antianginal effect of nifedipine in patients with ischemic heart disease.
Topics: Angina Pectoris; Coronary Disease; Female; Humans; Male; Middle Aged; Nifedipine; Pyridines | 1976 |
[Conservative therapy of angina pectoris using nifedipine (Adalat)].
Topics: Adult; Aged; Angina Pectoris; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; | 1975 |
Suppression of repeatedly occurring ventricular fibrillation with nifedipine in variant form of angina pectoris.
Topics: Aged; Angina Pectoris; Angina Pectoris, Variant; Humans; Male; Middle Aged; Nifedipine; Pyridines; V | 1977 |
[The arresting of cardiac pain with nifedipine (Adalat) in acute myocardial infarct].
Topics: Aged; Angina Pectoris; Humans; Myocardial Infarction; Nifedipine; Pyridines | 1976 |
Effects of Adalat (nifedipine) on left ventricular hemodynamics in angina pectoris: comparative study with propranolol.
Topics: Adult; Aged; Angina Pectoris; Exercise Test; Female; Heart; Heart Function Tests; Heart Ventricles; | 1976 |
[Calcium antagonists in Prinzmetals angina].
Topics: Angina Pectoris; Angina Pectoris, Variant; Calcium; Humans; Male; Middle Aged; Nifedipine; Pyridines | 1976 |
Prinzmetal's variant form of angina pectoris. Re-evaluation of mechanisms.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cineangiography; Coronary Artery Bypass; Coronary Vessels; He | 1975 |
[Nifedipine, a new coronaroactive drug].
Topics: Angina Pectoris; Animals; Coronary Vessels; Dogs; Drug Evaluation; Guinea Pigs; Heart; Hemodynamics; | 1975 |
[Extended studies on the coronary drug Adalate in practice].
Topics: Ambulatory Care; Angina Pectoris; Female; Humans; Male; Nifedipine; Pyridines | 1975 |
[ Combined therapy with isosorbide dinitrate, propranolol and nifedipine in patients with chronic ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Drug Therapy, Combination; Heart Rate; Hemodynamics; | 1992 |
Duration of efficacy of anti-anginal drugs.
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Administration Schedule; Humans; Isosorbide; Nife | 1992 |
Epanolol as a model for assessing patient preference in anti-anginal drug therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Choice Behavior; Female; Humans; Ma | 1992 |
[Hyperbaric oxygenation and antianginal agents: effects on blood levels of malondialdehyde and activities of antioxidative enzymes in patients with ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Combined Modality Therapy; Female; Glutathione P | 1992 |
"Oesophageal angina" in patients with angina pectoris: a possible side effect of chronic therapy with nitroderivates and Ca-antagonists.
Topics: Aged; Angina Pectoris; Chest Pain; Diagnosis, Differential; Female; Gastroesophageal Reflux; Humans; | 1992 |
[State of coronary circulation and results of 24-hour ECG monitoring in patients with refractory angina pectoris].
Topics: Adult; Angina Pectoris; Coronary Angiography; Coronary Circulation; Electrocardiography, Ambulatory; | 1992 |
[Amlodipine: pharmacokinetic and pharmacodynamic profile of a calcium antagonist with prolonged effect].
Topics: Amlodipine; Angina Pectoris; Animals; Calcium Channel Blockers; Chemical Phenomena; Chemistry; Dihyd | 1992 |
[Interaction of hyperbaric oxygenation with nifedipine and propranolol at the level of autonomic regulation of the heart in patients with angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Combined Modality Therapy; Depression, Chemical; Drug Synergism; Heart | 1992 |
Nifedipine-induced gingival hyperplasia.
Topics: Adult; Angina Pectoris; Female; Gingival Hemorrhage; Gingival Hyperplasia; Humans; Male; Middle Aged | 1992 |
[Effects of calcium antagonists on functional properties of monocytes in patients with ischemic heart disease].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Cyclic AMP; Humans; In Vitro Techniques | 1991 |
[Anti-anginal effects of calcium antagonists and intra-cardiac hemodynamics].
Topics: Adult; Angina Pectoris; Cardiac Output; Exercise Test; Humans; Male; Middle Aged; Myocardial Contrac | 1991 |
Efficacy of nifedipine in combination treatments for angina.
Topics: Angina Pectoris; Atenolol; Drug Administration Schedule; Drug Therapy, Combination; Nifedipine | 1991 |
Effect of chronic nifedipine therapy on the haemodynamic response to phenylephrine before and during halothane anaesthesia.
Topics: Adult; Anesthesia, Inhalation; Angina Pectoris; Coronary Artery Bypass; Female; Halothane; Hemodynam | 1992 |
Paradoxical effect of long-term treatment of nifedipine on total ischemic load in patients with stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Diltiazem; Electrocardiography, Ambulatory; Exercise Test; Female; Hea | 1992 |
[Nifedipine and gingival hypertrophy].
Topics: Angina Pectoris; Drug Therapy, Combination; Gingival Hypertrophy; Humans; Male; Middle Aged; Nifedip | 1991 |
[Effects of calcium antagonists on the pattern of intracardiac hemodynamics and functional state of the myocardium in patients with angina pectoris relapsing after aortocoronary bypass operation].
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Artery Bypass; Coronary Disease; Hemodyna | 1991 |
[The efficacy of foridon in treating stenocardia patients].
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Drug Evaluation; Drug Therapy, Combination; | 1991 |
Effects of nifedipine on total ischemic activity in angina and the importance of in-hospital psychological stress in myocardial infarction.
Topics: Angina Pectoris; Coronary Vasospasm; Humans; Myocardial Infarction; Nifedipine; Risk Factors; Stress | 1991 |
Anti-anginal efficacy of intravenous amlodipine assessed by means of atrial pacing.
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cardiac Pacing, Artificial; Electrocardiograp | 1991 |
Haemodynamic and electrophysiological effects of amlodipine, a new long-acting calcium antagonist.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Electrocardiography; Hemodynamic | 1991 |
Effects of nifedipine on diastolic abnormalities in low-flow and pacing-induced ischemia in isolated rat hearts.
Topics: Angina Pectoris; Animals; Blood Pressure; Cardiac Pacing, Artificial; Coronary Circulation; Coronary | 1991 |
The analysis of failure time data in crossover studies.
Topics: Analysis of Variance; Angina Pectoris; Atenolol; Bias; Clinical Trials as Topic; Confidence Interval | 1991 |
Effect of nifedipine on oxygen delivery in patients with angina pectoris: relation between blood viscosity and hematocrit.
Topics: Aged; Angina Pectoris; Blood Viscosity; Female; Hematocrit; Humans; Male; Middle Aged; Nifedipine; O | 1991 |
Nifedipine-induced gingival hyperplasia.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Female; Gingival Hyperplasia; Humans; Hypertension; Male; | 1991 |
[Loading-induced ST-interval elevations in the case of normal coronary arteries. The angiographic demonstration of loading-induced coronary artery spasm].
Topics: Angina Pectoris; Chronic Disease; Coronary Angiography; Coronary Vasospasm; Drug Therapy, Combinatio | 1991 |
Interactions between calcium channel blockers and the anticonvulsants carbamazepine and phenytoin.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Carbamazepine; Diltiazem; Drug Interactions; Female | 1991 |
Risk stratification after percutaneous transluminal coronary angioplasty.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Discriminant Analysi | 1990 |
[The clinical pharmacology and efficacy of the new Soviet calcium antagonist foridon].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Evaluation; Drug Therapy, Combinat | 1990 |
[Coronary vasomotor equivalents in the electrocardiographic behavior in induced ischemia].
Topics: Aged; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Angiography; Coronary Vessels; Electroca | 1990 |
[Acute coronary vasomotor effects of nifedipine and its therapeutic efficacy in syndrome X].
Topics: Adult; Angina Pectoris; Coronary Circulation; Coronary Vessels; Electrocardiography; Female; Humans; | 1990 |
Silent myocardial ischemia--classification and management.
Topics: Angina Pectoris; Atenolol; Drug Therapy, Combination; Heart Function Tests; Hemodynamics; Humans; Hy | 1990 |
Antianginal drugs and relationship between epicardial ST segment depression and moderate regional myocardial blood flow reduction in experimental partial coronary artery occlusion.
Topics: Angina Pectoris; Animals; Coronary Circulation; Coronary Disease; Dogs; Electrocardiography; Male; N | 1990 |
[Recurrent ventricular fibrillation in a patient with angiographically normal coronary arteries and intermittent ST segment elevation].
Topics: Adult; Angina Pectoris; Angiocardiography; Drug Therapy, Combination; Electrocardiography; Humans; M | 1990 |
[Differentiated and individualized approaches to the treatment of patients with angina pectoris at various stages of cardiological care].
Topics: Adult; Angina Pectoris; Electrocardiography; Exercise Test; Humans; Middle Aged; Nifedipine; Nitrogl | 1990 |
Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.
Topics: Adult; Amlodipine; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Corona | 1990 |
Development of tolerance to nifedipine in patients with stable angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Delayed-Action Preparations; Drug Tolerance; Electrocardiography; E | 1990 |
Acute coronary vasomotor effects of nifedipine and therapeutic correlates in syndrome X.
Topics: Administration, Sublingual; Angina Pectoris; Coronary Circulation; Electrocardiography; Exercise Tes | 1990 |
[Evaluation of the antianginal effects of foridon by transesophageal stimulation of the left atrium].
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Cardiac Pacing, Artificial; Drug Evaluation; Femal | 1990 |
Calcium channel blocking drugs. Part II: Clinical applications.
Topics: Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Arrhythmias, Cardiac; Calcium Channel B | 1985 |
The vasoinhibitory action of FR 46171, a new pyridine alcohol antianginal agent, on isolated rabbit vascular smooth muscles.
Topics: Angina Pectoris; Animals; Aorta, Thoracic; beta-Cyclodextrins; Clonidine; Cyclodextrins; Dextrins; E | 1988 |
Depression associated with nifedipine-induced calcium channel blockade.
Topics: Aged; Angina Pectoris; Depressive Disorder; Female; Humans; Ion Channels; Male; Middle Aged; Nifedip | 1988 |
Comparison of the effects of nifedipine and nitroglycerin on hemodynamic determinants of myocardial oxygen consumption and supply during exertional angina.
Topics: Adult; Angina Pectoris; Angiography; Exercise Test; Hemodynamics; Humans; Male; Middle Aged; Myocard | 1989 |
Long-term survival and risk stratification in patients with angina at rest undergoing medical treatment.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Coronary Angiography; Electrocardiography; Female; H | 1989 |
[A combination of nifedipine and diltiazem in the treatment of refractory spastic angina].
Topics: Adult; Aged; Angina Pectoris; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Female; Foll | 1989 |
[Update in drug delivery system in the field of cardiovascular system].
Topics: Angina Pectoris; Clonidine; Delayed-Action Preparations; Dosage Forms; Humans; Nifedipine; Nitroglyc | 1989 |
[Echocardiography detection of reversible regional disorders of contraction in patients with unstable angina pectoris and Prinzmetal angina during an attack].
Topics: Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Cardiac Catheterization; Cardiac Output | 1989 |
[The significance of a staged diagnostic-therapeutic program for the disease course in patients following unstable angina pectoris during a follow-up period of 3 1/2 years].
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Combined Modality Therapy; Coronary Disease | 1989 |
[Evaluation of the efficacy of a course of verapamil and nifedipine in patients with stable stenocardia by daily monitoring of the electrocardiogram].
Topics: Adult; Angina Pectoris; Circadian Rhythm; Drug Evaluation; Drug Therapy, Combination; Electrocardiog | 1989 |
[Nifedipine and verapamil in the treatment of ischemic heart disease and hypertension].
Topics: Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Humans; Hypertension; Nifedipin | 1989 |
[Greater efficacy of propranolol versus nifedipine in angina with 2 components, that results in varying influence on coronary vasomotility].
Topics: Angina Pectoris; Coronary Vessels; Drug Evaluation; Humans; Nifedipine; Propranolol | 1989 |
Nifedipine induced bradycardia in a patient with autonomic neuropathy.
Topics: Aged; Angina Pectoris; Autonomic Nervous System Diseases; Bradycardia; Diabetic Neuropathies; Electr | 1989 |
[Angiographic course of coronary atherosclerosis in angina pectoris. Its relation to 2 years' treatment with propranolol, nifedipine and nitrates].
Topics: Adult; Angina Pectoris; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Isosorbide Dinit | 1989 |
[Clinical characteristics of silent myocardial ischemia and the effect of nifedipine treatment].
Topics: Aged; Angina Pectoris; Coronary Disease; Electrocardiography, Ambulatory; Exercise Test; Female; Hum | 1989 |
Effect of nifedipine on left ventricular function during exercise in patients with stable effort angina. Relation of its efficacy to the severity of coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Exercise; Female; Heart; Heart Ventr | 1989 |
Early detection of myocardial ischemia by myocardial free fatty acid extraction in patients with exercise-induced angina pectoris.
Topics: Angina Pectoris; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Coronary Disease; E | 1989 |
Changes in blood viscosity following nifedipine administration and its relation to the contents of adenosine triphosphate and 2,3-diphosphoglyceric acid in red blood cells in patients with angina pectoris.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Adult; Aged; Angina Pectoris; Blood Viscosity; Dipho | 1989 |
Cold intolerance in patients with angina pectoris: effect of nifedipine and propranolol.
Topics: Adult; Angina Pectoris; Chronic Disease; Cold Temperature; Exercise Test; Female; Humans; Male; Midd | 1989 |
[Nifedipine pharmacokinetics in patients with exertion-induced stenocardia after its single and long-term administration].
Topics: Administration, Oral; Angina Pectoris; Drug Administration Schedule; Humans; Male; Middle Aged; Nife | 1989 |
Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris.
Topics: Angina Pectoris; Angiography; Constriction, Pathologic; Coronary Angiography; Humans; Isosorbide Din | 1989 |
[Angina pectoris caused by dynamic coronary obstruction and beta-blockers].
Topics: Angina Pectoris; Atenolol; Humans; Nifedipine | 1989 |
[Comparison of the coronary vasomotor response to nifedipine in syndrome X and in Prinzmetal's angina].
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Calcium; Coronary Circulation; Female; Humans; Mal | 1989 |
[The efficacy of the long-term therapy of patients with stable stenocardia using korinfar and finoptin].
Topics: Adult; Angina Pectoris; Drug Evaluation; Drug Therapy, Combination; Exercise Test; Hemodynamics; Hum | 1989 |
Assessment of the mechanism of action of antianginal drugs by the continuous thermodilution method.
Topics: Angina Pectoris; Coronary Circulation; Diltiazem; Gallopamil; Humans; Nifedipine; Physical Exertion; | 1989 |
Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Drug Therapy, | 1985 |
Angina after aortocoronary bypass grafting: combined medical therapy including nifedipine.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Coronary Artery Bypass; Drug Therapy, Com | 1985 |
Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Coronary Circul | 1985 |
Effects of nicardipine on cardiac volume at rest and during exercise-induced angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiac Volume; Dose-Respons | 1985 |
Effect of nicardipine on left ventricular function and on angina induced by atrial pacing in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Cardiac Pacing, | 1985 |
[Efficacy of fenigidin, senzit and trazikor in the treatment of patients with angina pectoris].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Calcium; Cardiac Glycosides; Drug Therapy, Combi | 1985 |
Aspirin, nifedipine, and cataract.
Topics: Angina Pectoris; Aspirin; Cataract; Humans; Nifedipine | 1986 |
Combinations of beta-blockers and calcium channel blockers: a cause of malignant perioperative conduction disturbances?
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Corona | 1986 |
Clinical and research applications of ambulatory Holter ST-segment and heart rate monitoring.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Corona | 1986 |
Alternative medical treatment for patients with angina pectoris and adverse reactions to beta blockers. Usefulness of nifedipine.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Drug Therapy, Combination; Exercise Test; Female; Hear | 1986 |
Unstable angina revisited once more.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Aspirin; Combi | 1986 |
Angiographic morphology and response to therapy in unstable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Coronary Angiography; Coronary Throm | 1988 |
Different coronary vasomotor effects of nifedipine and therapeutic correlates in angina with spontaneous and effort components versus Prinzmetal angina.
Topics: Aged; Angina Pectoris; Angina Pectoris, Variant; Angiography; Coronary Angiography; Coronary Circula | 1989 |
Different vasomotor action of nifedipine on dynamic coronary obstructions and therapeutic response in effort and prinzmetal angina.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Coronary Vessels; Electrocardiography; Femal | 1989 |
Increase in number of myocardial ischemic episodes following nifedipine administration in two patients. Detection of silent episodes by Holter monitoring and role of heart rate.
Topics: Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Heart Rate; Humans; Male; Monitoring, | 1989 |
Effects of nisoldipine on systemic and leg blood flow, oxygen transport and metabolism, and hemodynamics during exercise in effort angina pectoris.
Topics: Adult; Angina Pectoris; Cardiac Output; Heart Rate; Hemodynamics; Humans; Lactates; Lactic Acid; Leg | 1989 |
[Anginal pain caused by nifedipine: scintigraphic illustration].
Topics: Angina Pectoris; Humans; Male; Middle Aged; Nifedipine; Radionuclide Imaging | 1985 |
[Influence of antianginal drugs on Lypressin induced T-wave enhancement in the electrocardiogram of the rat].
Topics: Administration, Oral; Angina Pectoris; Animals; Coronary Vasospasm; Electrocardiography; Hypoxia; Is | 1986 |
Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Diltiazem; Drug Resistance; Drug Therapy, Combination; Fem | 1987 |
Calcium-blocker withdrawal phenomenon: increase in affinity of alpha 2 adrenoceptors for agonist as a potential mechanism.
Topics: Adult; Angina Pectoris; Blood Platelets; Calcium Channel Blockers; Coronary Disease; Epinephrine; Hu | 1986 |
[Combination of nitrates and calcium antagonists in the treatment of the angina pectoris syndrome].
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Drug Therapy, Combi | 1986 |
Exact mechanisms contributing to instability and refractoriness to therapy in patients with unstable angina: coronary arteriographic evaluation.
Topics: Adult; Angina Pectoris; Angina, Unstable; Angiocardiography; Coronary Artery Bypass; Coronary Vessel | 1987 |
Clinical experience of percutaneous transluminal coronary angioplasty--technique and results.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; | 1985 |
[Relation between the therapeutic efficacy of nifedipine in exercise-induced, mixed and spontaneous angina and acute coronary vasomotor effects evaluated by quantitative angiography].
Topics: Administration, Sublingual; Angina Pectoris; Angina Pectoris, Variant; Angiography; Coronary Angiogr | 1988 |
Serum potassium values in relation to the use of diuretics in patients with unstable angina pectoris.
Topics: Angina Pectoris; Angina, Unstable; Coronary Disease; Diuretics; Female; Humans; Hypokalemia; Male; M | 1988 |
Coronary vasomotor and clinical effects of nifedipine in effort, mixed and Prinzmental angina.
Topics: Angina Pectoris; Angina Pectoris, Variant; Angiography; Coronary Angiography; Coronary Vessels; Elec | 1988 |
[Treatment of hypertension during acute myocardial infarct and unstable angina].
Topics: Aged; Angina Pectoris; Angina, Unstable; Female; Humans; Hypertension; Male; Myocardial Infarction; | 1988 |
Prophylaxis of 5-fluorouracil-induced coronary vasospasm with calcium channel blockers.
Topics: Aged; Angina Pectoris; Coronary Vasospasm; Female; Fluorouracil; Humans; Nifedipine | 1988 |
[Treatment of patients with ischemic heart diseases using senzit].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Drug Evaluation; Female; Fendiline; Hemodynamics; Hu | 1988 |
Antianginal effects of the new calcium antagonist benidipine hydrochloride in anesthetized rats and spontaneously hypertensive rats. Electrocardiographic study.
Topics: Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Electrocar | 1988 |
[Calcium antagonists in the treatment of stenocardia].
Topics: Angina Pectoris; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Drug Therapy, Co | 1988 |
[Clinical and ergometric evaluation of diltiazem in the treatment of angina pectoris].
Topics: Aged; Angina Pectoris; Diltiazem; Drug Evaluation; Heart Function Tests; Humans; Middle Aged; Nifedi | 1988 |
Coronary vasomotor and therapeutic influences of propranolol and nifedipine on the spontaneous component of mixed angina.
Topics: Administration, Sublingual; Aged; Angina Pectoris; Angiography; Coronary Disease; Electrocardiograph | 1988 |
[Calcium antagonists in angina pectoris].
Topics: Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Diltiazem; Gallopamil; Humans; | 1988 |
[Interactions of propranolol with nifedipine, verapamil and diltiazem].
Topics: Adult; Angina Pectoris; Diltiazem; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middl | 1988 |
[Ifedipine induced gingival hyperplasia. Review and clinical cases].
Topics: Angina Pectoris; Female; Gingival Hyperplasia; Gingivectomy; Humans; Male; Middle Aged; Nifedipine | 1988 |
[Anti-angina activity of nifedipine and P0285 in the anesthetized rat].
Topics: Anesthesia; Angina Pectoris; Animals; Calcium Channel Blockers; Dihydropyridines; Electrocardiograph | 1987 |
[Effect of corinfar on the course of angina pectoris and indices of carbohydrate metabolism in relation to the type of glucose tolerance].
Topics: Angina Pectoris; Blood Glucose; Glucose Tolerance Test; Hemodynamics; Humans; Insulin; Male; Middle | 1987 |
Effects of nifedipine on coronary perfusion; recent assessment by parametric digital subtraction.
Topics: Aged; Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary Vessels; Heart Rate; Hum | 1987 |
Regional distribution of cardiac output at rest and during exercise in patients with exertional angina pectoris before and after nifedipine therapy.
Topics: Adult; Aged; Angina Pectoris; Cardiac Output; Exercise Test; Hemodynamics; Humans; Male; Middle Aged | 1988 |
Comparative dosing and efficacy of continuous-release nifedipine versus standard nifedipine for angina pectoris: clinical response, exercise performance, and plasma nifedipine levels.
Topics: Angina Pectoris; Female; Humans; Male; Middle Aged; Nifedipine; Physical Exertion | 1988 |
Effect of nifedipine on out-of-hospital silent myocardial ischemia in asymptomatic men with coronary artery disease.
Topics: Adult; Aged; Ambulatory Care; Angina Pectoris; Coronary Disease; Electrocardiography; Humans; Male; | 1988 |
The effects of the novel anti-anginal compound RS 43285 on myocardial conduction in the anaesthetized dog.
Topics: Acetanilides; Anesthesia; Angina Pectoris; Animals; Atrioventricular Node; Dogs; Electrocardiography | 1988 |
Complete prevention of acetylcholine induced coronary artery spasm with nifedipine.
Topics: Acetylcholine; Angina Pectoris; Angiography; Coronary Vasospasm; Female; Humans; Infusions, Intra-Ar | 1988 |
Nifedipine versus isosorbide dinitrate for angina pectoris.
Topics: Angina Pectoris; Humans; Isosorbide Dinitrate; Nifedipine | 1988 |
[Study of anti-ischemic effects of verapamil and nifedipine after long-term treatment of patients with exertion-induced stenocardia].
Topics: Adult; Angina Pectoris; Coronary Circulation; Female; Humans; Male; Middle Aged; Nifedipine; Physica | 1988 |
Nifedipine hepatitis.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Biopsy; Chemical and Drug Induced Liver Injury; Female; Hu | 1987 |
Coronary dilator effects of intracoronary nifedipine and isosorbide dinitrate.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Blood Pressure; Coronary Vessels; Drug Th | 1987 |
Effect of nifedipine on myocardial metabolism in patients with unstable angina.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Coronary Disease; Electrocardiography; Female; Gluco | 1987 |
Use of combined calcium channel blockers for therapy of refractory angina pectoris.
Topics: Adult; Angina Pectoris; Benzazepines; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Com | 1986 |
Calcium channel antagonists--cardiovascular therapy for the eighties?
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; | 1986 |
Nifedipine: a calcium channel blocking drug.
Topics: Angina Pectoris; Humans; Hypertension; Nifedipine; Raynaud Disease | 1987 |
[Left ventricular systolic and diastolic functions in hypertrophic cardiomyopathy: with special reference to clinical symptom and the effects of calcium blocking agent (nifedipine)].
Topics: Administration, Sublingual; Angina Pectoris; Blood Pressure; Cardiomyopathy, Hypertrophic; Complianc | 1987 |
Nifedipine in angina and blood glucose levels in diabetics.
Topics: Angina Pectoris; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Nifedi | 1986 |
[Evaluation of the efficacy of verapamil and nifedipine as long-term crossover therapy with individually selected doses in ischemic heart disease. Work Group for the Cooperative Study of Antianginal Preparations (SCAP)].
Topics: Adult; Angina Pectoris; Coronary Disease; Exercise Test; Humans; Male; Middle Aged; Nifedipine; Time | 1987 |
[Relation between the antianginal efficacy of calcium antagonists in angina pectoris patients and the length of treatment].
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Humans; Male; Middle Aged; Nifedipine; Time Factor | 1987 |
Conventional and slow release formulations of nifedipine and verapamil are more effective than slow release isosorbide dinitrate (ISDN) in preventing episodes of angina at rest.
Topics: Angina Pectoris; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Nifedipine; Verapamil | 1987 |
Nifedipine in angina pectoris.
Topics: Angina Pectoris; Angina, Unstable; Female; Humans; Male; Middle Aged; Nifedipine | 1987 |
Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris.
Topics: Angina Pectoris; Drug Therapy, Combination; Exercise Test; Female; Heart; Humans; Isosorbide Dinitra | 1987 |
Observations on the warm up phenomenon in angina pectoris.
Topics: Adaptation, Physiological; Adult; Aged; Angina Pectoris; Heart Rate; Humans; Male; Middle Aged; Nife | 1987 |
Effects of a new second generation calcium channel blocker, nilvadipine (FR34235), on exercise-induced hemodynamic changes in stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Coronary Circulation; Electrocardiography; Exercise Test; Female; Hear | 1987 |
Clinical efficacy and bioavailability of a sustained release nifedipine formulation.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Biological Availability; Delayed-Action Preparation | 1987 |
[Acute effects of various doses of nisoldipine in stable exertional angina].
Topics: Adult; Aged; Angina Pectoris; Dose-Response Relationship, Drug; Exercise Test; Female; Humans; Male; | 1987 |
Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipine.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Pacing, Artificial; Chronic Disease; Exercise | 1986 |
[Atenolol-nifedipine combination in the therapy of exertion angina. An ergometric study].
Topics: Aged; Angina Pectoris; Atenolol; Drug Therapy, Combination; Exercise Test; Female; Humans; Male; Mid | 1986 |
Nifedipine-induced hypokalemia.
Topics: Angina Pectoris; Humans; Hypokalemia; Male; Middle Aged; Nifedipine | 1986 |
Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Disease; Heart Rate; Hemodyna | 1986 |
Nifedipine--a survey of adverse effects. Four years' reporting in Sweden.
Topics: Adult; Aged; Angina Pectoris; Confusion; Erythema; Female; Headache; Heart Failure; Humans; Male; Mi | 1986 |
Tetany associated with nifedipine.
Topics: Aged; Angina Pectoris; Female; Humans; Nifedipine; Tetany | 1986 |
[Effect of corinfar on the dynamic function and various indices of glycolysis and glycogenolysis in the thrombocytes of patients with unstable stenocardia].
Topics: Adult; Angina Pectoris; Angina, Unstable; Blood Platelets; Female; Glycogen; Glycolysis; Hexokinase; | 1986 |
[Correlation between the therapeutic effectiveness of corinfar and its dose in patients with exercise-induced stenocardia].
Topics: Adult; Aged; Angina Pectoris; Dose-Response Relationship, Drug; Drug Evaluation; Exercise Test; Hemo | 1986 |
[Conservative therapy of unstable angina pectoris].
Topics: Angina Pectoris; Angina, Unstable; Drug Therapy, Combination; Humans; Isosorbide Dinitrate; Nifedipi | 1986 |
Nifedipine versus isosorbide dinitrate in patients with exertional angina receiving propranolol.
Topics: Angina Pectoris; Drug Therapy, Combination; Humans; Isosorbide Dinitrate; Nifedipine; Propranolol | 1986 |
Clinical application of monitoring techniques: coronary sinus blood flow monitoring.
Topics: Angina Pectoris; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Hemodynamics; Humans; | 1986 |
[Effect of nifedipine on the clinical manifestations of ischemic heart disease occurring with stable stenocardia and the hemodynamic indices].
Topics: Adult; Angina Pectoris; Chronic Disease; Coronary Disease; Drug Evaluation; Hemodynamics; Humans; Mi | 1986 |
Nifedipine-associated acute psychosis.
Topics: Aged; Angina Pectoris; Humans; Male; Nifedipine; Psychoses, Substance-Induced | 1986 |
[Increase in liver circulation with nifedipine].
Topics: Adult; Angina Pectoris; Blood Pressure; Cardiac Catheterization; Cardiac Output; Female; Heart Failu | 1986 |
[Mechanisms of action and clinical results of calcium blocking in exertion angina, mixed or spontaneous].
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Disease; Exercise Test; Humans; Nifedipine | 1986 |
Left ventricular response to exercise in coronary artery disease: relation to myocardial ischaemia and effects of nifedipine.
Topics: Adult; Angina Pectoris; Coronary Disease; Coronary Vessels; Female; Heart Ventricles; Hemodynamics; | 1985 |
Exercise-induced coronary artery spasm. A regional coronary blood flow study.
Topics: Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary Vasospasm; Electrocardiography | 1985 |
[Effectiveness of treating stenocardia patients with obzidan, corvaton and corinfar based on the indices of spirometric bicycle ergometry and of central hemodynamics].
Topics: Adult; Angina Pectoris; Drug Evaluation; Exercise Test; Hemodynamics; Humans; Male; Middle Aged; Mol | 1985 |
Role of coronary spasm in different anginal syndromes.
Topics: Angina Pectoris; Angina Pectoris, Variant; Angiography; Circadian Rhythm; Coronary Vasospasm; Diltia | 1985 |
Effect of long-term oral nifedipine therapy on left ventricular regional wall function at rest and during supine bicycle exercise.
Topics: Administration, Oral; Adult; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Exercise Tes | 1985 |
Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Drug Evaluation; Drug Therapy, Combination; Electrocar | 1985 |
[Characteristics of patients with ischemic heart disease under dispensary observation in a regional polyclinic and the evaluation of anti-angina therapy conducted under dispensary conditions].
Topics: Adult; Ambulatory Care; Amiodarone; Angina Pectoris; Coronary Disease; Drug Therapy, Combination; Fo | 1985 |
Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, | 1985 |
[Synergism of the anti-anginal action of beta-blockers and calcium antagonists in patients with ischemic heart disease].
Topics: Adult; Angina Pectoris; Blood Pressure; Coronary Disease; Drug Therapy, Combination; Heart Rate; Hum | 1985 |
Cardiac toxicity of 5-fluorouracil. Report of a case of spontaneous angina.
Topics: Angina Pectoris; Colonic Neoplasms; Electrocardiography; Fluorouracil; Humans; Liver Neoplasms; Male | 1986 |
Effects of nicardipine on left ventricular function and energetics in man.
Topics: Angina Pectoris; Calcium Channel Blockers; Cardiac Output; Coronary Circulation; Coronary Disease; H | 1986 |
The response of the coronary collateral circulation to acute administration of nifedipine: an angiographic and ergometric study.
Topics: Adult; Angina Pectoris; Collateral Circulation; Coronary Angiography; Coronary Circulation; Exercise | 1986 |
Effect of nifedipine on coronary hemodynamics in patients with left anterior descending coronary occlusion.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Cardiac Catheterization; Cardiac Pacing, | 1985 |
Clinical and hemodynamic effects of combined propranolol and nifedipine therapy versus propranolol alone in patients with angina pectoris.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Pressure; Drug Therapy, Combination; Heart | 1985 |
Potential prevention of myocardial rupture resulting from acute myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Female; Heart Rupture; Heart Septum; Heart Ventricles; Humans; Hyperte | 1985 |
Improvement in exercise capacity and associated changes in hemodynamics and left ventricular function after the addition of metoprolol to nifedipine in patients with stable exertional angina.
Topics: Administration, Oral; Adult; Angina Pectoris; Cardiac Output; Drug Therapy, Combination; Electrocard | 1985 |
[Long-term use of anti-angina preparations and the development of drug tolerance].
Topics: Angina Pectoris; Drug Tolerance; Humans; Isosorbide Dinitrate; Nifedipine; Propranolol; Time Factors | 1985 |
Nifedipine-induced periorbital edema.
Topics: Angina Pectoris; Edema; Female; Humans; Hypertension; Middle Aged; Nifedipine; Orbital Diseases | 1985 |
Acute electrophysiologic, hemodynamic and left ventricular effects of nifedipine and beta-blocker interactions. Maintenance of global and regional left ventricular wall motion.
Topics: Administration, Oral; Angina Pectoris; Cardiac Catheterization; Cardiac Output; Drug Evaluation; Dru | 1985 |
Influence of nifedipine on coronary haemodynamics and myocardial metabolism in coronary artery disease.
Topics: Angina Pectoris; Carbohydrate Metabolism; Coronary Disease; Energy Metabolism; Fatty Acids, Nonester | 1985 |
Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases.
Topics: Adult; Aged; Angina Pectoris; Asthma; Cerebrovascular Disorders; Diabetes Complications; Edema; Fema | 1985 |
Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris.
Topics: Angina Pectoris; Humans; Hypotension; Nifedipine | 1985 |
[Methodological approaches to assessing the effectiveness of anti-angina preparations in stenocardia patients using paired bicycle ergometry loads].
Topics: Angina Pectoris; Cardiovascular Agents; Drug Evaluation; Exercise Test; Hemodynamics; Humans; Isosor | 1985 |
[Comparative study of the activity of fendiline and nifedipine in ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Female; Fendiline; Humans; Male | 1985 |
[Effect of a single dose of anaprilin and corinfar on the results of the bicycle ergometric test in patients with stenocardia].
Topics: Angina Pectoris; Drug Therapy, Combination; Exercise Test; Humans; Male; Middle Aged; Nifedipine; Pr | 1985 |
[Changes in diastolic ventricular properties by intravenous nifedipine infusion in patients with unstable angina pectoris].
Topics: Angina Pectoris; Angina, Unstable; Cardiac Output; Coronary Circulation; Diastole; Heart Ventricles; | 1985 |
[Cooperative study on the long-term use of anti-anginal preparations (methodologic questions)].
Topics: Adult; Angina Pectoris; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Exercise Test; H | 1985 |
[Nifedipine in short supply].
Topics: Angina Pectoris; Humans; Hungary; Hypertension; Nifedipine | 1985 |
[Effect of anaprilin and corinfar on tolerance to physical loading in patients with exertional angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Drug Therapy, Combination; Humans; Middle Aged; Nifedipine; Propranolo | 1985 |
[Choice of a calcium antagonist in chronic stable angina].
Topics: Angina Pectoris; Drug Evaluation; Electrocardiography; Heart Rate; Humans; Nifedipine; Physical Exer | 1985 |